
<html lang="en"     class="pb-page"  data-request-id="21f21949-c64d-449b-b110-c69de0924136"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01927;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-5;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy" /></meta><meta name="dc.Creator" content="Ravindra&#xA;R.  Cheruku" /></meta><meta name="dc.Creator" content="Joseph  Cacaccio" /></meta><meta name="dc.Creator" content="Farukh A.  Durrani" /></meta><meta name="dc.Creator" content="Walter A.  Tabaczynski" /></meta><meta name="dc.Creator" content="Ramona  Watson" /></meta><meta name="dc.Creator" content="Aimee  Marko" /></meta><meta name="dc.Creator" content="Rahul  Kumar" /></meta><meta name="dc.Creator" content="Mohamed E.  El-Khouly" /></meta><meta name="dc.Creator" content="Shunichi  Fukuzumi" /></meta><meta name="dc.Creator" content="Joseph R.  Missert" /></meta><meta name="dc.Creator" content="Rutao  Yao" /></meta><meta name="dc.Creator" content="Munawwar  Sajjad" /></meta><meta name="dc.Creator" content="Dhyan  Chandra" /></meta><meta name="dc.Creator" content="Khurshid  Guru" /></meta><meta name="dc.Creator" content="Ravindra K.  Pandey" /></meta><meta name="dc.Description" content="The in vitro and in vivo anticancer activity of iodinated photosensitizers (PSs) with and without an erlotinib moiety was investigated in UMUC3 [epidermal growth factor (EGFR)-positive] and T24 (EG..." /></meta><meta name="Description" content="The in vitro and in vivo anticancer activity of iodinated photosensitizers (PSs) with and without an erlotinib moiety was investigated in UMUC3 [epidermal growth factor (EGFR)-positive] and T24 (EG..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 18, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01927" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01927" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01927" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01927" /></link>
        
    
    

<title>Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01927" /></meta><meta property="og:title" content="Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0014.jpeg" /></meta><meta property="og:description" content="The in vitro and in vivo anticancer activity of iodinated photosensitizers (PSs) with and without an erlotinib moiety was investigated in UMUC3 [epidermal growth factor (EGFR)-positive] and T24 (EGFR-low) cell lines and tumored mice. Both the erlotinib-conjugated PSs 3 and 5 showed EGFR target specificity, but the position-3 erlotinib–PS conjugate 3 demonstrated lower photodynamic therapy efficacy than the corresponding non-erlotinib analogue 1, whereas the conjugate 5 containing an erlotinib moiety at position-17 of the PS showed higher tumor uptake and long-term tumor cure (severe combined immunodeficient mice bearing UMUC3 tumors). PS–erlotinib conjugates in the absence of light were ineffective in vitro and in vivo, but robust apoptotic and necrotic cell death was observed in bladder cancer cells after exposing them to a laser light at 665 nm. In contrast to 18F-fluorodeoxyglucose, a positron emission tomography agent, the position-17 erlotinib conjugate (124I-analogue 6) showed enhanced UMUC3 tumor contrast even at a low imaging dose of 15 μCi/mouse." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01927"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01927">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01927&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01927&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01927&amp;href=/doi/10.1021/acs.jmedchem.8b01927" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2598-2617</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01887" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01947" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ravindra R. Cheruku</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravindra R. Cheruku</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photodynamic Therapy Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravindra%0AR.++Cheruku">Ravindra R. Cheruku</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph Cacaccio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph Cacaccio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photodynamic Therapy Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Cacaccio">Joseph Cacaccio</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Farukh A. Durrani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Farukh A. Durrani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photodynamic Therapy Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div><div class="loa-info-affiliations-info">Photolitec, LLC, 73 High Street, Buffalo, New York 14226, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Farukh+A.++Durrani">Farukh A. Durrani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Walter A. Tabaczynski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Walter A. Tabaczynski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photodynamic Therapy Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Walter+A.++Tabaczynski">Walter A. Tabaczynski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ramona Watson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ramona Watson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photodynamic Therapy Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ramona++Watson">Ramona Watson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aimee Marko</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aimee Marko</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photolitec, LLC, 73 High Street, Buffalo, New York 14226, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aimee++Marko">Aimee Marko</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rahul Kumar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rahul Kumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rahul++Kumar">Rahul Kumar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mohamed E. El-Khouly</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mohamed E. El-Khouly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Basic and Applied Sciences, Egypt-Japan University of Science and Technology, Qesm Borg Al Arab 21934, Egypt</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed+E.++El-Khouly">Mohamed E. El-Khouly</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shunichi Fukuzumi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shunichi Fukuzumi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Basic and Applied Sciences, Egypt-Japan University of Science and Technology, Qesm Borg Al Arab 21934, Egypt</div><div class="loa-info-affiliations-info">Department of Chemistry and Nano Science, Ewha Womans University, Seoul 03760, Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shunichi++Fukuzumi">Shunichi Fukuzumi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph R. Missert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph R. Missert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photodynamic Therapy Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+R.++Missert">Joseph R. Missert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rutao Yao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rutao Yao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nuclear Medicine, SUNY, Buffalo, New York 14221, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rutao++Yao">Rutao Yao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Munawwar Sajjad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Munawwar Sajjad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nuclear Medicine, SUNY, Buffalo, New York 14221, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Munawwar++Sajjad">Munawwar Sajjad</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dhyan Chandra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dhyan Chandra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dhyan++Chandra">Dhyan Chandra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Khurshid Guru</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Khurshid Guru</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Khurshid++Guru">Khurshid Guru</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ravindra K. Pandey</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravindra K. Pandey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photodynamic Therapy Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#265447504f484254470856474842435f6654495551434a4a5647544d08495441"><span class="__cf_email__" data-cfemail="027063746b6c6670632c72636c66677b42706d7175676e6e726370692c6d7065">[email protected]</span></a>. Phone: 716-845-3203.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravindra+K.++Pandey">Ravindra K. Pandey</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9889-4860" title="Orcid link">http://orcid.org/0000-0002-9889-4860</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01927&amp;href=/doi/10.1021%2Facs.jmedchem.8b01927" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2598–2617</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 18, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 December 2018</li><li><span class="item_label"><b>Published</b> online</span>18 February 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 March 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01927" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01927</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2598%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRavindra%250AR.%2BCheruku%252C%2BJoseph%2BCacaccio%252C%2BFarukh%2BA.%2BDurrani%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D5%26contentID%3Dacs.jmedchem.8b01927%26title%3DEpidermal%2BGrowth%2BFactor%2BReceptor-Targeted%2BMultifunctional%2BPhotosensitizers%2Bfor%2BBladder%2BCancer%2BImaging%2Band%2BPhotodynamic%2BTherapy%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2617%26publicationDate%3DMarch%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01927"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1246</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01927" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ravindra\nR.&quot;,&quot;last_name&quot;:&quot;Cheruku&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Cacaccio&quot;},{&quot;first_name&quot;:&quot;Farukh&quot;,&quot;last_name&quot;:&quot;A. Durrani&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;A. Tabaczynski&quot;},{&quot;first_name&quot;:&quot;Ramona&quot;,&quot;last_name&quot;:&quot;Watson&quot;},{&quot;first_name&quot;:&quot;Aimee&quot;,&quot;last_name&quot;:&quot;Marko&quot;},{&quot;first_name&quot;:&quot;Rahul&quot;,&quot;last_name&quot;:&quot;Kumar&quot;},{&quot;first_name&quot;:&quot;Mohamed&quot;,&quot;last_name&quot;:&quot;E. El-Khouly&quot;},{&quot;first_name&quot;:&quot;Shunichi&quot;,&quot;last_name&quot;:&quot;Fukuzumi&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;R. Missert&quot;},{&quot;first_name&quot;:&quot;Rutao&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Munawwar&quot;,&quot;last_name&quot;:&quot;Sajjad&quot;},{&quot;first_name&quot;:&quot;Dhyan&quot;,&quot;last_name&quot;:&quot;Chandra&quot;},{&quot;first_name&quot;:&quot;Khurshid&quot;,&quot;last_name&quot;:&quot;Guru&quot;},{&quot;first_name&quot;:&quot;Ravindra&quot;,&quot;last_name&quot;:&quot;K. Pandey&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;2598-2617&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01927&quot;},&quot;abstract&quot;:&quot;The in vitro and in vivo anticancer activity of iodinated photosensitizers (PSs) with and without an erlotinib moiety was investigated in UMUC3 [epidermal growth factor (EGFR)-positive] and T24 (EGFR-low) cell lines and tumored mice. Both the erlotinib-conjugated PSs 3 and 5 showed EGFR target specificity, but the position-3 erlotinib–PS conjugate 3 demonstrated lower photodynamic therapy efficacy than the corresponding non-erlotinib analogue 1, whereas the conjugate 5 containing an erlotinib moiety at position-17 of the PS showed higher tumor uptake and long-term tumor cure (severe combined immunodeficient mice bearing UMUC3 tumors). PS–erlotinib conjugates in the absence of light were ineffective in vitro and in vivo, but robust apoptotic and necrotic cell death was observed in bladder cancer cells after exposing them to a laser light at 665 nm. In contrast to 18F-fluorodeoxyglucose, a positron emission tomography agent, the position-17 erlotinib conjugate (124I-analogue 6) showed enhanced UMUC3 tumor contr&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01927&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01927" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01927&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01927" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01927&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01927" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01927&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01927&amp;href=/doi/10.1021/acs.jmedchem.8b01927" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01927" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01927" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01927%26sid%3Dliteratum%253Aachs%26pmid%3D30776232%26genre%3Darticle%26aulast%3DCheruku%26date%3D2019%26atitle%3DEpidermal%2BGrowth%2BFactor%2BReceptor-Targeted%2BMultifunctional%2BPhotosensitizers%2Bfor%2BBladder%2BCancer%2BImaging%2Band%2BPhotodynamic%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D5%26spage%3D2598%26epage%3D2617%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=292534" title="Oxygen">Oxygen</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/jmcmar.2019.62.issue-5/20190314/jmcmar.2019.62.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The in vitro and in vivo anticancer activity of iodinated photosensitizers (PSs) with and without an erlotinib moiety was investigated in UMUC3 [epidermal growth factor (EGFR)-positive] and T24 (EGFR-low) cell lines and tumored mice. Both the erlotinib-conjugated PSs <b>3</b> and <b>5</b> showed EGFR target specificity, but the position-3 erlotinib–PS conjugate <b>3</b> demonstrated lower photodynamic therapy efficacy than the corresponding non-erlotinib analogue <b>1</b>, whereas the conjugate <b>5</b> containing an erlotinib moiety at position-17 of the PS showed higher tumor uptake and long-term tumor cure (severe combined immunodeficient mice bearing UMUC3 tumors). PS–erlotinib conjugates in the absence of light were ineffective in vitro and in vivo, but robust apoptotic and necrotic cell death was observed in bladder cancer cells after exposing them to a laser light at 665 nm. In contrast to <sup>18</sup>F-fluorodeoxyglucose, a positron emission tomography agent, the position-17 erlotinib conjugate (<sup>124</sup>I-analogue <b>6</b>) showed enhanced UMUC3 tumor contrast even at a low imaging dose of 15 μCi/mouse.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bladder cancer is the 4th most commonly diagnosed cancer in the U.S. in men and the 10th in women.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Approximately two-thirds of newly diagnosed bladder cancers have not invaded the bladder smooth muscle and are considered as non-muscle-invasive bladder cancers (NMIBCs).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Despite a 5 year survival rate of 88%, up to 70% of NMIBCs recur after initial treatment.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> For muscle-invasive bladder cancer (MIBC), the gold standard remains radical cystectomy (RC) and lymph node dissection (LND), with or without neoadjuvant chemotherapy. However, RC remains a major procedure with a high rate of complications. Minimally invasive RC has been incorporated to reduce the morbidity associated with RC.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Still, 5 year survival rates are only 50–70% and complication rates exceed 60.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6−10)</a> Recently, trimodality (bladder preservation) therapy has emerged as an alternative to RC, with comparable survival rates in select patients. However, most guidelines do not recommend it as a standard treatment.</div><div class="NLM_p">Treatment of bladder cancer is dependent on tumor grade and stage. Non-muscle-invasive tumors are treated by transurethral resection with and without subsequent intravesical chemotherapy or immunotherapy. The high recurrence rate of NMIBC may be due to poor detection at diagnosis or regrowth of residual tumor after incomplete resection. For MIBC, more interest has been recently spurred in bladder preservation strategies as a viable alternative to RC and LND in select patients. Therefore, the concept of having a dual functional agent (diagnostic and therapeutic) will have definite advantages.</div><div class="NLM_p">Recently, the epidermal growth factor receptor (EGFR) has gained much attention for the treatment of cancer.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> EGFR is a member of the tyrosine kinase receptor family, and pathological expression of EGFR leads to uncontrolled cell proliferation.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> It also results in promotion of angiogenesis and inhibition of apoptosis, leading to malignant growth and progression. Overexpression of EGFR in bladder cancer has been widely reported, and several studies have shown that EGFR is associated with high tumor stage, tumor progression, and poor clinical outcome.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Due to the central role of EGFR in several tumors, two main types of EGFR inhibitors have been reported: monoclonal antibodies<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> and small-molecule tyrosine kinase inhibitors.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Some of the small molecules (e.g., erlotinib and related analogues) are either clinically approved or at various stages of clinical trials. These compounds alone or in combination with other chemotherapy agents have shown enhanced long-term patient survival. Thus, following this approach, photodynamic therapy (PDT)-induced tumor destruction can be maintained and significantly improved by the administration of EGFR inhibitors. Bladder and prostate have a multitude of primary lymphatic landing sites, making the sentinel node sampling concept inapplicable. However, dual-imaging techniques could be helpful in guiding surgeons in the removal of suspicious nodes, avoiding excessive or suboptimal LND. Despite advances in various imaging techniques, their sensitivity and specificity are still limited and histological examination of lymph nodes remains the standard for lymph node staging. Therefore, improved target-specific imaging agents (positron emission tomography (PET)/fluorescence) with therapeutic potential (e.g., PDT or combination therapy) will have definite advantage(s) in treating these cancers.</div><div class="NLM_p">There are only limited reports to address the choices of photosensitizers (PSs) used for PDT on the basis of specificity or affinity for ABCG2.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> Indeed, many tumors do not appear to express large amounts of ABCG2, or if they do, it is not necessarily present in the cell membrane where it functions as an effluxing pump but in the cytoplasm or nucleus. However, it has become evident that a small subset of ABCG2-expressing cells known as side population (SP) is present in most types of tissues and in many tumors and possesses stem cell-like characteristics. In many tumors, the SP has been demonstrated as enriched for cells with enhanced tumorigenic potential, known as tumor initiating cells (TICs), stem cell-like cancer cells, or cancer stem cells (CSC). The TIC and CSC have been postulated as the source and driving force of tumor growth and development. If the small number of SP cells present in tumors efflux ABCG2 substrate PS and evade PDT-mediated death, they could be responsible for repopulating tumors, causing recurrences and poor clinical outcome.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Recent demonstration of SP in bladder cancer necessitates further investigation of its potential role in characterizing CSCs. A recent report by Hepburn et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> confirmed that ABCG2 SP enriches for SCCs in human bladder cancer and provides evidence for the importance of the mitogen-activated protein kinase pathway as a suitable therapeutic target for the treatment. On the basis of published reports, it could be advantageous to verify ABCG2 expression in tumors before selecting the most appropriate PS for PDT treatment, especially if the PS is a substrate and the ABCG2-positive SP cells are part of the tumor initiating population. If the non-SP or ABCG2 negative population includes TIC, then the substrate specificity and affinity of the PS may be less important because it will not be pumped out. An alternative method to ensure adequate PS levels in all tumor cells including bladder cancer would be to combine substrate PS with an ABCG2 inhibitor for enhanced PDT outcome.</div><div class="NLM_p">Physicians at West Virginia University have evaluated Photofrin-PDT in 58 patients with refractory NMIBC and patients who could not receive local treatment with chemotherapy or Bacillus Calmette–Guérin (BCG) immunotherapy. With a single PDT treatment, 84% of patients with residual refractory papillary transitional cell carcinoma and 75% of patients with refractory carcinoma in situ demonstrated complete response. Now, over 4 years of treatment, 59% of responders are alive and only 3 out of 34 patients experienced disease recurrence. PDT was a safe and effective treatment for refractory carcinoma in situ or recurrent papillary transitional cell carcinoma. Clinical trials are ongoing to determine whether this form of treatment is superior to the standard BCG immunotherapy or chemotherapy.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Unfortunately, Photofrin has several limitations, including skin phototoxicity and limited tumor specificity. Therefore, a multifunctional PS with high tumor selectivity may help to detect the tumors by PET and improve the survival of bladder cancer patients by fluorescence-guided PDT alone or in combination with erlotinib therapy.</div><div class="NLM_p last">To make PDT more successful, our proposed study was aimed to develop a near-infrared (NIR) dual-function imaging agent (e.g., <sup>124</sup>I-PET and fluorescence, which are complimentary to each other) to optimize tumor staging and treatment of bladder cancer. The use of an NIR light source for fluorescence image-guided PDT<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> will help to locate and precisely treat NMIBC, as well as MIBC as part of bladder preservation strategies. <sup>124</sup>I-PET imaging will improve lymph node and systemic staging, which will allow better control of tumor recurrence and long-term survival.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Chemistry</h3><div class="NLM_p">Our laboratory has been investigating the utility of porphyrin-based compounds in cancer imaging and therapy for quite some time.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In our hands, the structure–activity relationship (SAR) and quantitative structure–activity relationship studies were extremely fruitful in selecting the most active agents in porphyrin and reduced porphyrin (chlorin and bacteriochlorin) systems.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> We further extended this approach by preparing a series of carbohydrate (substrate for lectin) and cRGD (substrate for integrin) analogues. Some of the conjugates showed enhanced PDT efficacy, but the target specificity following the inhibition approach could not be confirmed.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We also observed that introduction of the same functionality (including small molecules, e.g., carbohydrates, to target galectins, known for their overexpression in certain tumors) at various peripheral positions of the PS makes a significant difference in tumor uptake and PDT efficacy.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> Therefore, to investigate the impact of erlotinib-conjugated PS for targeting EGFR, known for its high expression in bladder cancer, the erlotinib moiety was introduced either at position-3 or at position-17 of PS <b>1</b>, which has already been recognized for its PET and PDT potential in various tumor types.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The PS–erlotinib conjugates <b>3</b> and <b>5</b> bearing an erlotinib moiety at position-3 and -17, respectively, were synthesized from methyl-3-[1′(<i>m</i>-iodobenzyloxy)ethyl]-3-devinylpyropheophorbide-<i>a</i> following two different synthetic strategies (PS <b>1</b> was used as a diasteriomeric mixture for the preparation of desired analogues because the respective R- and S-isomers showed similar in vitro and in vivo efficacy).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In our first approach (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B), PS <b>1</b> was conjugated with erlotinib <b>7</b> under Sonogashira cross-coupling conditions,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the intermediate <b>8</b> was isolated in 72% yield. The hydrolysis of the methyl ester analogue under mild conditions gave the corresponding carboxylic acid <b>9</b> in >95% yield, which on subsequent reaction with <i>m</i>-iodobenzylamine afforded the desired nonradioactive iodinated PS–erlotinib conjugate <b>3</b> in 76% yield.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structures of Parent Compounds (Radioactive and Nonradioactive) Derived from Chlorophyll <i>a</i> and the Synthesis of the Corresponding Erlotinib Conjugates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our second approach, as illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C for the synthesis of conjugate <b>5</b>, erlotinib was first coupled with <i>m</i>-iodobenzylamine. The resulting product <b>11</b> was reacted with the carboxylic acid <b>12</b>, obtained by hydrolyzing the corresponding methyl ester analogue <b>1</b>, and the desired position-17 erlotinib analogue was obtained in 71% yield.</div><div class="NLM_p last">For the preparation of PET imaging agents with longer half-life, conjugates of the iodinated PSs <b>3</b> and <b>5</b> were first converted to the corresponding trimethyl-tin analogues <b>10</b> and <b>13</b>, respectively, which on subsequent reaction with <sup>124</sup>I-sodium iodide (Na<sup>124</sup>I) afforded the desired PET imaging agents <b>4</b> and <b>6</b>, respectively, by following the methodology reported for the preparation of <sup>124</sup>I agent <b>2</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The purity of the radioactive PS was confirmed by high-performance liquid chromatography (HPLC) analyses.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  Characterization of Conjugates <b>2</b> and <b>3</b></h3><div class="NLM_p">The structures of all of the intermediate and final products (nonradioactive) were confirmed by NMR (<sup>1</sup>H, <sup>13</sup>C, and 2D NMR) and mass spectrometry (MS) analyses. In addition to being generally consistent with the proposed structures, the NMR data also show some interesting differences between the spectra of these compounds. These spectral features suggest significant differences in molecular conformation, which are dependent on the location of the erlotinib conjugation to the PS.</div><div class="NLM_p">Three groups of photosensitizer protons, 10-H, 12-CH<sub>3</sub>, and one of the 13<sup>2</sup>-CH<sub>2</sub> group protons, exhibit substantial shielding in compound <b>5</b> relative to the chemical shifts observed in compounds <b>1</b> and <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). Each of these three groups is in close proximity to the macrocycle’s C-ring. The 10-H resonances of compounds <b>1</b> and <b>3</b> were observed at 9.54 and 9.34 ppm, respectively. In <b>5</b>, however, 10-H appears at a much lower chemical shift (8.99 ppm). The 12-CH<sub>3</sub> protons of <b>5</b> (2.33 ppm) are shielded by more than 1 ppm relative to both <b>1</b> (3.68 ppm) and <b>3</b> (3.43 ppm). In addition, one of the protons of the 13<sup>2</sup>-CH<sub>2</sub> group of <b>5</b> (4.56 ppm) exhibits a shielding of roughly 0.5 ppm relative to the 13<sup>2</sup>-CH<sub>2</sub> group protons of <b>1</b> (5.27/5.12 ppm) and <b>3</b> (5.20/5.05 ppm). These chemical shift data suggest that differences in molecular structure among these three compounds result in substantial changes in the electronic environment of specific protons and that these changes are localized about the C-ring.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) <sup>1</sup>H NMR spectral regions of <b>1</b>, <b>3</b>, and <b>5</b> show significant chemical shift differences for specific protons. In <b>5</b>, protons in the vicinity of the photosensitizer moiety’s C-ring (10-H, 13<sup>2</sup>-CH<i>H</i>, and 12-CH<sub>3</sub>) are significantly shielded with respect to the corresponding protons of <b>1</b> and <b>3</b>. Also, 5-H of the erlotinib moiety of <b>3</b> exhibits a substantial shielding compared with the 5-H chemical shift observed in <b>5</b>. These observations suggest structural differences that are dependent on the erlotinib orientation in the conjugates (see the text for details). (B) <sup>1</sup>H NMR spectra of <b>5</b> at 28 °C (bottom) and 55 °C (top). At elevated temperature, the chemical shifts of the 10-H (open triangle), 13<sup>1</sup>-CH<i>H</i> (filled triangle), and 12-CH<sub>3</sub> (arrow) proton signals exhibit a marked deshielding toward the positions observed for the corresponding protons of <b>1</b> and <b>3</b>. This behavior is consistent with the breaking of π–π stacking interactions that may be responsible for the unusual shieldings observed for these protons in <b>5</b>. (See the figure in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">Supporting Information</a> for additional spectra taken at other temperatures.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The shieldings are observed only when the erlotinib moiety is linked through the 17-position of the photosensitizer macrocycle. Linkage through the 3-position does not yield similar shieldings. The relative flexibility of the linkers may play a role here. When linked through the 17-position (as in <b>5</b>), the linker is longer and presumably more flexible than that of the 3-linked conjugate (PS <b>3</b>). The greater flexibility may allow a conformation in which one or more of the aromatic rings of the erlotinib moiety interact with the protons around the C-ring. π–π stacking may render such a conformation more stable. Alternatively, the changes in chemical shifts might be due to differences in intermolecular stacking of macrocycle and/or erlotinib aromatic ring systems. Rotating-frame Overhauser spectroscopy data, however, showed no cross-peaks, indicating close proximity of these aromatic systems. This may be due to an unfavorable orientation of the stacked rings, which could place any potentially interacting protons too far from each other to generate observable nuclear Overhauser effects.</div><div class="NLM_p">Both stacking hypotheses agree with the <sup>1</sup>H NMR spectra acquired on <b>5</b> at elevated temperature. These data (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) exhibit substantial deshielding (relative to <sup>1</sup>H deltas obtained at lower temperature) of the 10-H, 12-CH<sub>3</sub>, and 13<sup>2</sup>-CH<i>H</i> protons as the temperature increases from 28 to 55 °C. Thus, all three groups of protons exhibiting shielding in <b>5</b>, relative to the corresponding protons in <b>1</b> and <b>3</b>, behave in a manner that is consistent with stacking of aromatic systems. A breaking of the π–π stacking is expected if energy is added to the system by increasing the temperature.</div><div class="NLM_p">Chemical shift changes can arise from a variety of sources. These include differences in pH and analyte concentration, as well as temperature. In fact, <sup>1</sup>H NMR spectra collected at 28 °C using two different samples of <b>5</b> exhibit such changes (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A,B). These differences in chemical shifts, however, are relatively small compared to those obtained by changing temperature. The temperature dependence of the chemical shifts of the 10-H, 12-CH<sub>3</sub>, and 13<sup>2</sup>-CH<i>H</i> protons is not only relatively large but also regular and reversible (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">Figure S15</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">p S16</a>, Supporting Information).</div><div class="NLM_p">A further chemical shift difference was observed for the 5-H resonance of the quinazoline ring system of the erlotinib moiety (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). In <b>5</b>, 5-H resonates at 7.82 ppm, similar to the chemical shift observed in unconjugated erlotinib analogues such as <b>11</b> (5-H δ = 7.65 ppm). In <b>3</b>, however, this proton is shielded by more than 0.5 ppm, exhibiting a chemical shift of ∼7.1 ppm. This chemical shift change may be due to differences in the orientation of the phenyl ring bound to the amino nitrogen at quinazoline C4. An orientation that places this ring near 5-H of erlotinib could result in the observed deshielding (in <b>5</b>, relative to <b>3</b>) due to ring current effects. On the other hand, rotation about the exocyclic C4–N bond can give a much different conformation, where the phenyl ring is nearer the quinazoline N3. In this arrangement, the phenyl group is far from 5-H and can impart no ring-current-induced deshielding at that site. This could account for the more shielded position of the 5-H resonance observed in <b>3</b>.</div><div class="NLM_p last">Finally, these spectra differ in still another way. The frequency differences (Δν’s) between resonances of corresponding protons of the two diastereomeric forms of <b>3</b> are larger than those observed in <b>5</b> and <b>1</b>. The 5-H (meso) proton of the photosensitizer moiety of <b>3</b> exhibits the largest Δν (60 Hz). This is much larger than that observed in either <b>5</b> (13 Hz) or <b>1</b> (0 Hz). The pyrimidine hydrogen (2-H of the quinazoline ring system) of <b>3</b> also displays a large Δν (45 Hz). In contrast, <b>5</b> shows no difference between the 2-H proton frequencies of its two diastereomers. The photosensitizer ring methyl proton resonances of the two diastereomers of <b>3</b> are also more widely separated (with Δν as large as 20 Hz) than those observed in either <b>5</b> or <b>1</b>. Other protons show similar, though much smaller, differences in Δν. In every case, the separation of the resonances of the two diastereomers is largest in <b>3</b>, where erlotinib is conjugated through the 3-position of the photosensitizer. The 3-position substituent also contains the stereogenic center responsible for the existence of diastereomers of these compounds. Conjugation of erlotinib at this point on the macrocycle places a large substituent with several (potentially interacting) functional groups in a location (i.e., on the chiral center) that allows different configurations, and these may generate large differences in conformation. This may be the source of the larger Δν’s seen in the NMR spectrum of <b>3</b>. See the Supporting Information (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">Figures S1–S15</a>) for the NMR spectra of compounds <b>3</b>, <b>5</b>, <b>8</b>–<b>11</b>, and <b>13</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.3.  Photophysical Properties and Singlet Oxygen Generation Abilities of the Photosensitizers with and without Erlotinib Moieties</h3><div class="NLM_p">Photodynamic therapy is a three-component system, which includes a photosensitizer (PS), light of an appropriate wavelength, and oxygen. In general, most PSs are nontoxic, but upon light exposure, the PS present in tumors is excited and the excited state of PS on intersystem crossing releases energy, which converts the oxygen present in the tumor to singlet oxygen, which is responsible for tumor destruction, mainly by vascular shutdown. Therefore, it is of utmost importance to determine the photophysical properties of the photosensitizer, including the singlet oxygen generation ability.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">2.3.1.  Steady-State Absorption and Fluorescence Spectra in Toluene</h4><div class="NLM_p">The absorption spectra of the investigated chlorin compounds are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. As seen, the absorption spectrum of unsubstituted chlorin <b>1</b> exhibited a strong absorption for the Q-band (at 665 nm) and Soret band at 411 nm. In addition, weak absorption bands were recorded at 317, 505, 535, and 607 nm. Chlorins <b>3</b> and <b>5</b> showed spectral features similar to those of unsubstituted <b>1</b>. The difference is the small red shift of the Q- and Soret bands (∼2 nm), indicating weak ground-state interaction between the ring and the two substituent moieties. In addition, weak absorption bands of the substituted moieties were recorded at 333 and 347 nm.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Photophysical properties of photosensitizers with and without the erlotinib moiety. (A) Absorption and fluorescence spectra of <b>1</b>, <b>3</b>, and <b>5</b> in toluene. The fluorescence spectra were recorded using excitation light of 610 nm. Inset: fluorescence decay profile of <b>1</b> in toluene; λ<sub>ex</sub> = 420 nm. (B) (Left) differential absorption spectra obtained upon femtosecond flash photolysis (λ<sub>ex</sub><b>=</b> 390 nm) of <b>1</b> in deaerated toluene at the indicated time intervals. The inset shows the singlet state at 670 nm. (Right) nanosecond transient absorption spectra at the indicated time intervals of <b>3</b> in Ar-saturated toluene solution. The inset shows the decay profile of the triplet <b>3</b> in Ar-saturated and oxygen-saturated solutions. (C) Emission spectra of the singlet oxygen produced by the examined chlorin derivatives <b>1</b>, <b>3</b>, and <b>5</b> and the standard C<sub>60</sub> in toluene; λ<sub>ex</sub> = 470 nm. Inset: decay profile of the generated singlet oxygen in the microsecond time scale.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The photochemical behavior of chlorin derivatives was investigated, first, by steady-state fluorescence measurements in toluene using 610 nm excitation light. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the emission spectrum of the unsubstituted chlorin <b>1</b> exhibited a strong emission band at 669 nm and a shoulder at 713 nm. When turning to the erlotinib-substituted PSs <b>3</b> and <b>5</b>, one can see similar spectral features with ∼3 nm red shift compared to that of <b>1</b>, indicating a considerable interaction between the ring and the substituted moieties. In addition, the spectrum of <b>5</b> showed a significant increase in the fluorescence intensity of the shoulder at 717 nm compared with <b>3</b>. The fluorescence quantum yields in toluene were determined to be 0.176 (for <b>1</b>), 0.183 (for <b>3</b>), and 0.217 (for <b>5</b>). Based on the fluorescence maxima, the energies of the singlet states were determined to be 1.85 eV (for <b>1</b>) and 1.84 eV (for <b>3</b> and <b>5</b>). As shown in the inset of <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A (right), the fluorescence lifetime measurements in toluene were determined to be 6.96 ns (for <b>1</b>), 7.24 ns (for <b>3</b>), and 7.01 ns (for <b>5</b>).</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">2.3.2.  Time-Resolved Transient Absorption Studies</h4><div class="NLM_p">Femtosecond transient absorption spectroscopy was used to obtain further insight into the excited state of the examined chlorin compounds in deaerated toluene. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B (left) shows the differential absorption spectra of <b>1</b> upon excitation with 390 nm laser light. The strong bleaching of the band at ca. 670 nm revealed the instantaneous formation of the singlet-excited chlorin, in addition to weak absorption bands at 485, 526, 553, 580, and 624 nm. By monitoring the decay of the 670 nm band with first-order kinetics, the rate of singlet decay and its lifetime were determined to be 1.0 × 10<sup>9</sup> s<sup>–1</sup> and 1.0 ns, respectively. Similar spectral features were observed in the transient absorption spectra of the substituted chlorins (<b>3</b> and <b>5</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">Figures S16 and S17</a>, Supporting Information). By monitoring the decay of the 670 nm band, the rate constants and the lifetimes of the singlet-excited states were found to be 1.2 × 10<sup>10</sup> s<sup>–1</sup> and 83 ps (for <b>3</b>) and 7.5 × 10<sup>9</sup> s<sup>–1</sup> and 133 ps (for <b>5</b>).</div><div class="NLM_p">The complementary nanosecond transient measurements of chlorin derivative <b>1</b> in toluene with 420 nm laser excitation exhibited the absorption band in the visible region with a maximum at 450 nm (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, right), which is assigned to the triplet excited state of chlorin. The decay of the triplet excited state obeyed first-order kinetics, and the decay rate constant of the triplet excited state of <b>3</b> in oxygen-free toluene solution was determined to be 6.24 × 10<sup>4</sup> s<sup>–1</sup>. The finding that the decay is getting much faster in the presence of oxygen (1.96 × 10<sup>6</sup> s<sup>–1</sup>) suggests the energy transfer from the triplet state of <b>3</b> to oxygen (with a rate constant of 9.8 × 10<sup>9</sup> M<sup>–1</sup> s<sup>–1</sup>), generating the singlet oxygen. When turning to the substituted derivatives <b>3</b> and <b>5</b>, similar spectral features were observed (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">Figures S18 and S19</a>). The triplet excited state decayed in Ar-saturated toluene solutions with the rate constants of 4.27 × 10<sup>4</sup> s<sup>–1</sup> (for <b>3</b>) and 9.8 × 10<sup>4</sup> s<sup>–1</sup> (for <b>5</b>).<named-content content-type="anchor" rid="tbl1" type="simple"></named-content><named-content content-type="anchor" rid="fig3" type="simple"></named-content>u In oxygen-saturated solution, the triplet excited states decayed with the rate constants of 6.34 × 10<sup>5</sup> s<sup>–1</sup> (for <b>3</b>) and 2.07 × 10<sup>5</sup> s<sup>–1</sup> (for <b>5</b>). From these values, the rate constants of energy transfer from the triplet chlorins to oxygen were determined to be 3.17 × 10<sup>9</sup> M<sup>–1</sup> s<sup>–1</sup> (for <b>3</b>) and 1.03 × 10<sup>10</sup> M<sup>–1</sup> s<sup>–1</sup> (for <b>5</b>).</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">S19, and S20</a>, the decay of the triplet excited states of chlorin derivatives in toluene was much accelerated on addition of oxygen because of the energy-transfer process from the triplet excited chlorins to oxygen, generating the singlet oxygen. To determine the efficiency of singlet oxygen production of the examined chlorin derivatives, which is a necessary requirement to utilize PDT, two methods are generally used. The first method is to measure singlet oxygen generation such as photo-oxidation of the chemical quenchers for singlet oxygen, whereas the second method is to measure directly photoluminescence of singlet oxygen at 1274 nm.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> The ability of chlorin derivatives to generate singlet oxygen was confirmed here by directly observing the characteristic emission band of generated singlet oxygen in the NIR region. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, the photoluminescence (at 1274 nm) characteristic of singlet oxygen was observed in toluene. By comparison with that of fullerene C<sub>60</sub> (the quantum yield of singlet oxygen generation in toluene = 0.76) used as a standard,<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33−36)</a> the quantum yields of the singlet oxygen generation in toluene were determined to be 0.60 (for <b>1</b>), 0.59 (for <b>5</b>), and 0.57 (for <b>3</b>). These findings suggest relatively high efficiency of chlorin derivatives to generate singlet oxygen in less polar toluene. Slightly lower efficiency of <b>3</b> compared to that of other two derivatives coincides with the biological activities. From <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">S17–S20</a>, the decay profiles of the singlet oxygen at 1274 nm were fitted with an exponential decay at a long time scale (up to 250 μs), from which the lifetime values of the singlet oxygen were determined to be 29.06 μs (for <b>1</b>), 29.13 μs (for <b>3</b>), and 28.92 μs (for <b>5</b>). In general, these values are close to the reported lifetime values of singlet oxygen in toluene (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of the Photophysical and Photochemical Data of PSs <b>1</b>, <b>3</b>, and <b>5</b> in Toluene</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">λ<sub class="stack">max</sub><sup class="stack">abs</sup> (nm)</td><td class="colsep0 rowsep0" align="left">317, 411, 505, 535, 607, 665</td><td class="colsep0 rowsep0" align="left">301, 318, 333, 347, 413, 666</td><td class="colsep0 rowsep0" align="left">301, 333, 413, 507, 540, 609, 667</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">λ<sub class="stack">max</sub><sup class="stack">flu</sup> (nm)</td><td class="colsep0 rowsep0" align="left">669, 713</td><td class="colsep0 rowsep0" align="left">672, 717</td><td class="colsep0 rowsep0" align="left">672, 718</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">τ<sub>f</sub> (ns)</td><td class="colsep0 rowsep0" align="left">6.96</td><td class="colsep0 rowsep0" align="left">7.24</td><td class="colsep0 rowsep0" align="left">7.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Φ<sub>S</sub></td><td class="colsep0 rowsep0" align="left">0.176</td><td class="colsep0 rowsep0" align="left">0.182</td><td class="colsep0 rowsep0" align="left">0.217</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>k</i> (s<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">1.00 × 10<sup>9</sup></td><td class="colsep0 rowsep0" align="left">1.00 × 10<sup>10</sup></td><td class="colsep0 rowsep0" align="left">7.50 × 10<sup>9</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>k</i><sub>T</sub> (s<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">6.24 × 10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">4.27 × 10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">9.80 × 10<sup>4</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">τ<sub>T</sub> (μs)</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Φ</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">0.57</td><td class="colsep0 rowsep0" align="left">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">τ (<sup>1</sup>O<sub>2</sub>) (μs)</td><td class="colsep0 rowsep0" align="left">29.06</td><td class="colsep0 rowsep0" align="left">29.13</td><td class="colsep0 rowsep0" align="left">28.92</td></tr></tbody></table></div></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">2.3.3.  Impact of Solvent<span class="strike">s</span> on Absorption and Fluorescence Intensities of PS <b>1</b> and Erlotinib Conjugates <b>3</b> and <b>5</b></h4><div class="NLM_p">The PSs with and without erlotinib moieties are water-insoluble and were formulated in 1% Tween 80. The formulations of PSs <b>1</b>–<b>3</b> were diluted to a concentration of 0.75 μM in methanol and in 17% fetal bovine serum (FBS) (v/v) Dulbecco’s phosphate-buffered saline (PBS) (for mimicking physiological conditions). Before measuring the impact of solvents on fluorescence characteristics, absorption spectra at similar concentrations (0.75 μM) were obtained. The results illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> indicate that photosensitizers <b>1</b>, <b>3</b>, and <b>5</b> with and without erlotinib showed similar absorption bands (scale: 300–800 nm) but with reduced intensities in 17% FBS formulation.<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><named-content content-type="anchor" rid="fig4" type="simple"></named-content> The fluorescence characteristics of the PSs were determined using the same concentrations by exciting the absorption band at 415 nm and recording the emission intensities in the 600–750 nm range. These are summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Among the compounds investigated, PS <b>1</b> gave the highest fluorescence emission intensity in both the solvents. However, it was reduced significantly for the erlotinib analogues <b>3</b> and <b>5</b> compared with the non-erlotinib compound <b>1</b>, which could be due to differences in self-aggregation in aqueous FBS formulation.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Impact of solvents on absorption and fluorescence spectra of photosensitizers with and without the erlotinib moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.4.  Comparative Biological Activity of PSs with and without Erlotinib Moiety</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">2.4.1.  Selection of Formulation for the PS</h4><div class="NLM_p">Most of the long-wavelength-absorbing PSs investigated in this study are derived from chlorophyll <i>a</i> and are hydrophobic in nature, with limited solubility in water. Therefore, the selection of a suitable formulation(s) for in vitro/in vivo studies was extremely important. Formulation plays a critical role in the proper absorption of PS, its delivery, and release to the target. Increasing bioavailability within the system improves pharmacokinetics (PK). A proper PK profile can also reduce the side effects of the PS and can help in the reduction of overall toxicity.</div><div class="NLM_p last">Similar to most of the porphyrin-based compounds, PSs <b>1</b>–<b>3</b> were water-insoluble, were formulated in 1% Tween 80/5% dextrose solution and 2% Pluronic F-127/phosphate buffer,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and were evaluated for biological efficacy in both the formulations with the aim to select the best formulation for the pharmacokinetic (PK) and toxicity studies of the desired PS, before moving it to phase I human clinical trials. In both formulations, the PSs showed long-term stability (stored either at −4 or −20 °C for 2 months) without any precipitation or change in pH.</div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.4.2.  Comparative in Vitro PDT Efficacy of the PS <b>1</b> and the Corresponding Erlotinib Analogues <b>3</b> and <b>5</b> in Bladder Cancer Cell Lines</h4><div class="NLM_p">To compare the cytotoxic potential of each compound, an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> was conducted. To model EGFR target specificity, two cell lines were chosen: EGFR-dependent cell line (UMUC3) and EGFR-independent cell line (T24). The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. Briefly, cells were plated in 96-well plates at 1 × 10<sup>4</sup> cells per well and incubated with the photosensitizer for 24 h before being irradiated at peak absorbance (around 665 nm) for a total of 1 J. At 48 h after light exposure, the cell viability was quantified. Interestingly, PS <b>1</b> (a non-erlotinib analogue) showed similar photosensitizing activity in both the cell lines with low (T24) and high (UMUC3) EGFR expression (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). However, under similar parameters, PS <b>3</b>, in which erlotinib was introduced at the top half of the molecule, was less effective than <b>5</b>, where it is conjugated at the lower half (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). The Tween and Pluronic formulations of the PSs investigated were effective in both cell lines with slight variations. Therefore, both formulations were investigated to determine their comparative tumor uptake in vivo.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparative <i>in vitro</i> photosensitizing efficacy of the photosensitizers formulated in Tween 80 and Pluronic-127. (A) Comparative <i>in vitro</i> photosensitizing efficacy of PS <b>1</b> formulated in Tween 80 and Pluronic-127 at the same drug concentrations in UMUC3 and T24 tumor cells, light dose: 1.0 J/cm<sup>2</sup>. The plates that receive no light are used as an internal control to determine any latent toxicity of the compound from either the structure or the formulation used. (B) Comparative <i>in vitro</i> photosensitizing efficacy of (a) PS <b>3</b> in T24, (b) PS <b>3</b> in the UMUC3, (c) PS <b>5</b> in T24, and (d) PS <b>5</b> in UMUC3 cell lines, formulated in Tween 80 and Pluronic-127 at the same PS concentrations. Light dose: 1.0 J/cm<sup>2</sup>. The IC<sub>50</sub> values of the PSs in micromolar concentrations are presented in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparative in Vitro PDT Efficacy (IC<sub>50</sub> Values) of PSs <b>1</b>, <b>3</b>, and <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">photosensitizer</th><th class="colsep0 rowsep0" align="center" char=".">UMUC3</th><th class="colsep0 rowsep0" align="center" char=".">T24</th><th class="colsep0 rowsep0" align="center" char=".">UMUC3</th><th class="colsep0 rowsep0" align="center">T24</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (Tween)</td><td class="colsep0 rowsep0" align="char" char=".">0.0952</td><td class="colsep0 rowsep0" align="char" char=".">0.0737</td><td class="colsep0 rowsep0" align="char" char=".">95.2</td><td class="colsep0 rowsep0" align="left">73.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (Pluronic)</td><td class="colsep0 rowsep0" align="char" char=".">0.1996</td><td class="colsep0 rowsep0" align="char" char=".">0.1775</td><td class="colsep0 rowsep0" align="char" char=".">199.6</td><td class="colsep0 rowsep0" align="left">177.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b> (Tween)</td><td class="colsep0 rowsep0" align="char" char=".">0.6083</td><td class="colsep0 rowsep0" align="char" char=".">1.026</td><td class="colsep0 rowsep0" align="char" char=".">608.3</td><td class="colsep0 rowsep0" align="left">1026</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b> (Pluronic)</td><td class="colsep0 rowsep0" align="char" char=".">0.326</td><td class="colsep0 rowsep0" align="char" char=".">1.256</td><td class="colsep0 rowsep0" align="char" char=".">326.3</td><td class="colsep0 rowsep0" align="left">1256</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b> (Tween)</td><td class="colsep0 rowsep0" align="char" char=".">0.0364</td><td class="colsep0 rowsep0" align="char" char=".">0.1369</td><td class="colsep0 rowsep0" align="char" char=".">36.4</td><td class="colsep0 rowsep0" align="left">136.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b> (Pluronic)</td><td class="colsep0 rowsep0" align="char" char=".">0.0584</td><td class="colsep0 rowsep0" align="char" char=".">0.3149</td><td class="colsep0 rowsep0" align="char" char=".">58.4</td><td class="colsep0 rowsep0" align="left">314.9</td></tr></tbody></table></div></div></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.4.3.  Comparative Cell-Uptake and Intracellular Localization (Mitochondria vs Lysosomes) of PS <b>1</b> and the Erlotinib Conjugates <b>3</b> and <b>5</b></h4><div class="NLM_p">To investigate the impact of structural modifications on cell uptake and intracellular localization ability of PSs <b>1</b>, <b>3</b>, and <b>5</b> in UMUC3 and T24 cell lines, MitoTracker red and FluoSpheres were used to stain the mitochondria and the lysosome, respectively.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> The cell uptake of the PSs in both formulations was determined by measuring the fluorescence intensity in tumor cells. Both PS <b>1</b> and conjugate <b>3</b> showed similar uptake in UMUC3 and T24 cell lines, regardless of the delivery vehicle used. However, the PDT efficacy of <b>3</b> in UMUC3 (EGFR-positive) was significantly higher than that observed in T24 cells (EGFR-low). This may be due to EGFR target specificity of PS <b>3</b>, as shown later in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. In contrast, PS <b>5</b> (erlotinib moiety introduced at position-17 of the PS) showed significantly more fluorescence in UMUC3 cells known for higher expression of EGFR than T24, indicating some degree of target specificity. Furthermore, the nature of formulation vehicles (Tween 80 vs Pluronic) drastically produced a significant difference in the uptake of all of the compounds. Among the compounds investigated, PS <b>5</b> in Pluronic formulation showed the highest uptake in UMUC3 cells.</div><div class="NLM_p">To investigate the impact of the erlotinib moiety on intracellular localization of the PSs, two different dyes that are known to localize in the mitochondria (MitoTracker red) and the lysosome (Lysosphere green), respectively, were used to confirm the site specificity. In both cell lines (UMUC3 and T24), the photosensitizers formulated in Tween 80 and Pluronic-127 showed localization in mitochondria and in lysosomes (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C–F).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparative uptake and intracellular localization (mitochondria vs lysosomes) of PSs <b>1</b>, <b>3</b>, and <b>5</b> formulated either in Tween 80 or Pluronic F-127 in UMUC3 and T24 cells. The uptake of PSs in Tween (A) and Pluronic F-127 (B) after 24 h incubation and the fluorescence was measured using a CARY fluorimeter. The degree of fluorescence in each cell was directly compared as a measure of uptake. The fluorescence of each cell was measured using an image stream. Simultaneously, cells were stained with lysosphere green and MitoTracker red to determine the subcellular localization specificity of the PSs: (C) PSs <b>1</b>, <b>3</b>, and <b>5</b> Tween 80 formulation in UMUC3, (D) PSs <b>1</b>, <b>3</b>, and <b>5</b> Tween formulation in T24, (E) PSs <b>1</b>, <b>3</b>, and <b>5</b> Pluronic formulation in UMUC3, and (F) PSs <b>1</b>, <b>3</b>, and <b>5</b> Pluronic formulation in the T24 cell line. The higher bright detail similarity score to a particular site reflects a stronger overlap of the PS fluorescence to that site, either lysosomes or the mitochondria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">2.4.4.  Compared with PS <b>1</b>, EGFR Conjugates PSs <b>3</b> and <b>5</b> Showed EGFR Target Specificity</h4><div class="NLM_p">To demonstrate that the PS–erlotinib analogues are effective against tumor cells that express and rely upon EGFR activation, the EGFR-dependent bladder cancer cell line, UMUC3, was treated with PSs <b>1</b>, <b>3</b>, and <b>5</b> for 30 h and the levels of p-EGFR were analyzed in whole cell lysates through western blotting using phosphorylated specific antibody. Our results showed that except compound <b>1</b> (non-erlotinib conjugate) the erlotinib conjugates <b>3</b> and <b>5</b> were able to inhibit the autophosphorylation of EGFR at the Ty1068 residue and modulated cellular signaling (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparative EGFR signal inhibition efficacy of erlotinib, PS <b>1</b>, and the corresponding erlotinib conjugates <b>3</b> and <b>5</b> in bladder cancer cell lines UMUC3 and T24, known for high and low expression levels of EGFR. (A) PS–erlotinib conjugates were treated at 1 μM concentration for 24 h followed by PDT. (B) UMUC3 cells were treated with PS–erlotinib conjugates at 100 nM concentration for 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The overexpression of p-EGFR in the presence of PS and light may be in response to robust cell death induction, as shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. There are several reports available which suggest that EGFR phosphorylation in response to external stimuli can lead to cell death in several cell types.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> We also observed inhibition in EGFR phosphorylation at the Ty1068 residue following PS <b>3</b>, PS <b>5</b>, and erlotinib treatment at 100 nM dose to UMUC3 cells for 24 h, suggesting that the PS–erlotinib conjugates are showing specificity toward EGFR.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Erlotinib conjugates induce robust apoptotic and necrotic cell death upon PDT. UMUC3 and T24 cells were treated with different erlotinib conjugates (1.0 μM) with and without PDT. Cell death was quantified using the trypan blue assay (A, B). Necrotic (C, D) and apoptotic (E, F) cell death was quantified using annexin V/propidium iodide (PI) labeling. Live cells and apoptotic cell death were quantified in UMUC3 and T24 cells treated with erlotinib conjugates (100 nM) with and without PDT (G, H).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To understand the molecular insights into cell death in response to PS–erlotinib conjugate in UMUC3 and T24 cells with or without PDT exposure, we quantified cell death using annexin V/PI staining. In contrast to PS–erlotinib conjugate <b>3</b>, PS <b>1</b> and the erlotinib conjugate <b>5</b> induced significant apoptotic and necrotic cell death upon PDT in UMUC3 and T24 cells. We also analyzed apoptotic cell death in these two cells following PS <b>1</b>, PS <b>3</b>, and PS <b>5</b> treatment at a lower concentration of 100 nM with or without PDT, and we found that even at a lower dose of 100 nM, PS <b>1</b> and PS <b>5</b> produced significant induction in apoptotic cells and therefore cell death in only UMUC3 cells with no effect on T24 cells upon light exposure (PDT). However, none of the PSs induced any cell death without exposing them to light of an appropriate wavelength, further confirming the potential therapeutic benefits and safety of these compounds.</div></div><div id="sec2_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.4.5.  Mechanistic Difference between PS <b>1</b> vs PS <b>3</b> and PS <b>5</b>: Competitive Uptake and ABCG2 Efflux</h4><div class="NLM_p">One major barrier of therapeutic efficacy for PDT is the photosensitizer’s efflux from the cell. Many cancer cells overexpress ABCG2 and certain chlorophyll <i>a</i> derivatives, e.g., 2-(1-hexyloxyethyl)-2-devinylpyropheophorbide-<i>a</i> (HPPH) and PS <b>1</b> are reported as substrates for ABCG2.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> However, erlotinib has been shown to be not effluxed by ABCG2.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> To investigate the influence of erlotinib on PSs (with and without being conjugated with the erlotinib moiety) as substrates for ABCG2 transport, tumor cells were coincubated, with or without Gleevec (5 μM), with photosensitizer <b>1</b> and the erlotinib conjugates <b>3</b> and <b>5</b> (500 nM), and their relative cell-uptake was measured. Interestingly, in UMUC3 cells, the addition of Gleevec significantly increased its uptake of PS <b>1</b> but no significant difference was observed with conjugates <b>3</b> and <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). This observation is interesting as it could help in selecting an effective treatment option for cancer patients with and without expression of the ABCG2 transporter. To further confirm the EGFR target specificity of the erlotinib–PS conjugates, the tumor cells [UMUC3 (EGFR+) and T24 (EGFR−)] were first incubated with erlotinib for 24 h, before adding the PSs <b>1</b>, <b>3</b>, and <b>5</b> formulated in both Tween and Pluronic-127, and the cell uptake was measured. The data summarized in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> indicate that both PSs <b>3</b> and <b>5</b> showed lower cell uptake than <b>1</b> in UMUC3 cells incubated with erlotinib.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. ABCG2 substrate specificity of PS with and without erlotinib in UMUC3 and T24 cells. (A, B) Uptake of PSs <b>1</b> and <b>5</b> with and without the addition of Gleevec (small-molecule inhibitor known to inhibit ABCG2 function) in UMUC3 and T24 cells. Cells were incubated with 500 nm of the photosensitizers with or without the addition of Gleevec at 1 μM concentration. (C–F) Effect of Gleevec on the toxicity of PS <b>1</b> and PS <b>5</b> at 48 h post incubation (light dose: I J).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Erlotinib competition with PSs <b>1</b>, <b>3</b>, and <b>5</b> in UMUC3 and T24 cells. UMUC3 (A) or T24 (B) cells were incubated with the photosensitizer at 1 μM or erlotinib at 3 μM for 4 h. The cells were washed with warmed PBS three times and then imaged using a Zeiss fluorescence microscope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As expected, no such difference in cell uptake between the PSs with and without the erlotinib moiety was observed in T24 cells, known for negative EGFR expression.</div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">2.5.  In Vivo Tumor Uptake, PDT Efficacy, and PET Imaging of PSs with and without Erlotinib Conjugates</h3><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">2.5.1.  Whole-Body in Vivo Fluorescence Imaging and Uptake of PSs <b>1</b>, <b>3</b>, and <b>5</b> in Severe Combined Immunodeficient (SCID) Mice Bearing T24 and UMUC3 Tumors</h4><div class="NLM_p">The main objective of this particular study was to investigate the impact of Tween 80 and Pluronic formulations on tumor uptake of PSs at various time points. The SCID mice (three mice per group) bearing either UMUC3 or T24 tumors (4–5 mm size) were injected with PS <b>1</b> and the corresponding erlotinib conjugates <b>3</b> and <b>5</b> (0.47 μmol/kg) in both Tween 80 and Pluronic F-127 formulations. The tumor uptake was measured by the IVIS system, and interesting pharmacokinetic profiles of the PSs were observed (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>a). For example, all of the PSs in Pluronic formulations showed higher tumor uptake in both UMUC3 and T24 tumors at 24 h post injection, with most significant difference observed for the erlotinib conjugate <b>5</b> in which the erlotinib moiety was introduced at the lower half of the PS.</div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Comparative uptake of PSs <b>1</b>, <b>3</b>, and <b>5</b> (formulated either in Tween or Pluronic) in tumor, liver, and skin (SCID mice bearing UMUC3 and T24 tumors) at a dose of 0.47 μmol/kg)) at variable time points (λ<sub>ex</sub>: 675 nm, λ<sub>em</sub>: 720), using the IVIS optical imaging system. (b) Comparative <i>in vivo</i> PDT efficacy (long-term antitumor activity) of PSs with and without erlotinib conjugates. (A): PS <b>1</b> (non-erlotinib PS), (B): PS <b>3</b>, erlotinib moiety is attached at position-3 of the PS (C): PS <b>5</b>, erlotinib moiety is attached at position-15 of the PS. PS <b>1</b>, <b>3</b>, and <b>5</b> were individually injected (dose: 0.47 μmol/Kg) to SCID mice bearing UMUC3 tumors at the flank. Mice were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post injection (optimal uptake time), and tumor regrowth was monitored daily. These results suggest that the position of the erlotinib moiety in the PS makes a remarkable difference in long-term tumor cure. (c) Comparative tumor necrosis of mice injected with (A) PS <b>3</b> (effective PDT agent), and (B) PS <b>5</b> that showed limited efficacy at 72 h post light exposure. Mice were treated under similar drug and light doses. Dug dose: 0.47 μmol/kg, light dose: 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>, and the tumors were exposed to light (665 nm) at 24 h post injection of the PS.  CR = Complete response (tumore cure).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">2.5.2.  In Vivo PDT Efficacy of PSs <b>1</b>, <b>3</b>, and <b>5</b> in SCID Mice Bearing UMUC3 Tumors</h4><div class="NLM_p last">The focus of the study was to compare the in vivo efficacy of the PSs under similar drug/light treatment parameters. The treatment parameters were not optimized. The drug dose 0.47 μmol/kg was selected on the basis of our previous study with PS <b>1</b> in other tumor types, where it showed moderate long-term anticancer activity at this dose. For our initial study, UMUC3 cells (1 × 10<sup>9</sup>) in SCID mice (five mice per group) were implanted in the right flank of the mice, and when the tumor size was around 4–5 mm, the PSs were intravenously injected. At 24 h post injection, the tumors were exposed to light, and tumor regrowth was measured daily. As per the approved protocol, the mice with tumor >400 mm<sup>3</sup> were euthanized. The initial results indicated that among the compounds investigated, PS <b>5</b>, in which the erlotinib moiety was present at the lower half of the PS, showed the best efficacy. To confirm these results, PS <b>5</b> was again evaluated with a set of additional six tumored mice under similar treatment parameters, and the combined results from both sets of mice (6/11 mice were tumor-free on day 60) are shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>b.</div></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">2.5.3.  In Contrast to PS <b>5</b>, No Tumor Necrosis Was Observed with PS <b>3</b></h4><div class="NLM_p">It has been shown by us and others that tumors containing effective PSs on exposure with light show significant necrosis,<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> which is generally observed at 24 h post light exposure and lasts for a week or so. Interestingly, PS <b>5</b>, which showed significant long-term PDT response (tumor cure), also produced tumor necrosis, whereas no such response was observed with PS <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>c), an ineffective PDT agent.</div><div class="NLM_p">To understand the reasons for such a remarkable difference between the PDT efficacy of PSs <b>3</b> and <b>5</b>, the retention of the PS, singlet oxygen producing ability, overall hydrophobicity (HPLC retention time), intracellular localization, and cell efflux of the PS results were compared, but no significant difference was observed. The difference in antitumor activity (tumor cure) between the erlotinib conjugates <b>3</b> and <b>5</b> could not be explained only on the basis of the difference in their tumor uptake because, in spite of similar tumor uptake demonstrated by both PSs <b>1</b> and <b>5</b>, the erlotinib conjugate <b>5</b> gave improved long-term tumor cure (20% <i>vs</i>. 55% cure on day 60). Therefore, besides higher tumor uptake of PS <b>5</b> over PS <b>3</b> in UMUC3 tumors, its EGFR targeting ability could also be playing an important role in producing improved long-term tumor cure.</div><div class="NLM_p last">It is well established that in PDT treatment the singlet oxygen, a reactive oxygen species (ROS), is a key cytotoxic agent for tumor destruction. Therefore, we measured the photophysical properties of the PSs in organic solvents (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and in aqueous formulation (with and without bovine serum albumin, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), and it showed a significant difference in absorption and fluorescence characteristics. However, compared to the in vitro parameters used to study these PSs, the environment in living cells/tumors is quite different, which could have a significant impact on aggregation characteristics of the molecules, singlet oxygen production, and PDT efficacy. Several approaches to evaluate ROS production in vitro are currently being evaluated, and among these approaches, the use of carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H<sub>2</sub>DCFDA), which is a nonfluorescent compound in the absence of ROS but fluoresces in the presence of ROS, is of particular interest, and the fluorescence intensity directly correlates to the ROS production.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Therefore, we used this methodology to measure the ROS production of PSs <b>1</b>, <b>3</b>, and <b>5</b> in living cells.</div></div><div id="sec2_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">2.5.4.  Comparative Reactive Oxygen Species (ROS) of PSs <b>1</b>, <b>3</b>, and <b>5</b> in Tumor Cells</h4><div class="NLM_p">To evaluate the ROS generation potential in vitro, UMUC3 cells were incubated with carboxy-H<sub>2</sub>DCFDA, plated in a 96-well plate, and incubated with 1 μM each PS (<b>1</b>, <b>3</b>, and <b>5</b>). After 24 h, 1 μM 2′,7′-dichlorofluorescin diacetate (DCFDA) was incubated with the cells for 20 min. The fluorescence intensity of DCFDA significantly increased for both PS <b>1</b> and PS <b>5</b> and was about 2.5- and 4.5-fold higher from the background, respectively, and only 0.9-fold higher for PS <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Such a dramatic change in the DCFDA fluorescence intensity indicates that in a living system the ROS production of <b>3</b> was relatively lower compared to that of PS <b>1</b> and <b>5</b>, which directly correlates to their in vitro PDT efficacy.</div><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparative DCFDA fluorescence before and after exposure to 665 nm light. Plates were exposed to a total of 1 J of light (665 nm) at a rate of 3.2 mW/cm<sup>2.</sup>. The fluorescence value of cells with no DCFDA (background) was subtracted from that before and after PDT. 0.05% H<sub>2</sub>O<sub>2</sub> (30% stock was diluted to 0.18%, and then, 20 μL of it was added to each well) was added to four wells as a control before the plates were exposed to light. Photosensitizers were formulated in Tween 80.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">2.5.5.  Comparative Bladder Tumor Imaging Ability of Erlotinib Conjugate <sup>124</sup>I-<b>6</b> and <sup>18</sup>F-Fluorodeoxyglucose (FDG) in SCID Mice Bearing UMUC3 Tumors</h4><div class="NLM_p">Among the PET imaging agents, <sup>18</sup>F-FDG is widely used to image a variety of cancers, but it shows limitations in imaging brain, kidney, prostate, pancreas, and bladder cancers.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Due to short half-life (2 h) of the <sup>18</sup>F radionuclide, its long-distance transportation is also a major issue. Thus, it requires an expensive cyclotron facility at short distances for the production of the <sup>18</sup>F-FDG. Therefore, efforts are underway in various laboratories, including ours, to develop a PET imaging agent with high tumor avidity and longer half-life.</div><div class="NLM_p">Due to high uptake/retention (24–72 h) of PS <b>5</b> in UMUC3 tumors and excellent long-term PDT efficacy in mice bearing UMUC3 tumors, we converted it into the corresponding <sup>124</sup>I-analogue (half-life 4 days) and its PET imaging potential was investigated. In our initial approach, SCID mice bearing UMUC3 tumors (three mice per group) were injected with <sup>18</sup>F-FDG (50 μCi) and imaged at 110 min post injection. At 24 h post imaging, compound <b>6</b> (<sup>124</sup>I-analogue of <b>5</b>, 50 μCi) was injected (i.v.) and the mice were imaged at 24, 48, and 72 h post injection. The PET imaging experiments were repeated at lower doses (25 and 15 μCi) of both imaging agents. The results summarized in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a> clearly demonstrate the superiority of PET imaging agent <b>6</b> even at a dose of 15 μCi/mouse and image acquisition recorded at 24, 48, and 72 h post injection. In contrast, <sup>18</sup>F-FDG showed limited tumor imaging ability of UMUC3 tumors even at a dose of 50 μCi/mouse.</div><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A) PET images of SCID mice bearing UMUC3 tumors using <sup>124</sup>I-6 and <sup>18</sup>F-FDG. The images were analyzed using Amide Medical Imaging software. Boxes indicate the volume of interest (VOI) in the coronal plane. Separate scale bars for <sup>18</sup>F-FDG and <sup>124</sup> I-6 images are indicated on the right. The maximum threshold for color distribution was set to 10% in the <sup>18</sup>F-FDG images and 50% in the <sup>124</sup>I-6 images. In each panel, the top row of mice shows <sup>18</sup>F-FDG uptake in the bladder, brain, chest, and muscles, whereas tumor uptake is difficult to visualize. Tumors are well-visualized by <sup>124</sup>I-6 at all time points, and uptake is primarily in the tumor and liver. <sup>124</sup>I-6 is retained in the tumor longer than in other parts of the body. (B) Relative uptake values (RUVs) were calculated as maximum tumor uptake divided by average whole-body uptake. <sup>18</sup>F-FDG (left) and <sup>124</sup>I-6 (right) RUVs indicate almost twice the specific uptake of <sup>124</sup>I-6 at 24 h as compared to that of <sup>18</sup>F-FDG. For II<sup>124</sup>I-6, the RUVs continue to rise at longer time points as it is retained well in the tumor and less in the rest of the body.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The initial dose of radiation and the residual in the syringe were measured using a well γ-counter. The actual dose varied by no more than ±5% of the intended dose. Mice were placed in the microPET at the same position for each round of imaging, with the bed set to the same height. All studies were acquired using microPET Focus 120 (Concorde MicroSystems Inc.). Image analysis was performed using open source Amide Medical Imaging software (Sourceforge). The tumor was defined using an elliptical cylinder volume of interest (VOI), and the whole-body VOI was defined using a 3D isocontour, as per the standardized imaging standard operating procedure.</div><div class="NLM_p last">The relative uptake value (RUV) was calculated as the maximum tumor value divided by the average body value (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). The RUV enables a comparison of specificity at earlier time points and retention at later time points.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">3.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The results presented in this article show a remarkable difference in in vitro and in vivo PDT efficacy and photophysical properties of PSs with and without the erlotinib moiety. The PDT efficacies of PSs <b>3</b> and <b>5</b> are significantly influenced by the position of conjugation between the erlotinib and PS moieties. For example, PS <b>5</b>, in which the erlotinib moiety was conjugated at position-17 of the PS, afforded far better efficacy than PS <b>3</b>, in which the erlotinib moiety was attached at position-3 of the PS. Between the two PSs, no significant difference was observed in singlet oxygen yields (in organic solvent), EGFR targeting ability, cell uptake, intracellular localization, and mechanism of cell death (apoptosis vs necrosis), but compared with <b>5</b>, PS <b>3</b> showed significantly lower singlet oxygen production in a biological environment. A significant difference in tumor uptake, tumor necrosis after PDT, and long-term PDT efficacy between PSs <b>3</b> and <b>5</b> was observed in vivo. The lower efficacy of PS <b>3</b>, relative to that of <b>1</b> and <b>5</b>, could also be due to its lower ROS production (singlet oxygen) in tumor cells. Further mechanistic studies to determine the factors responsible for such significant differences between PSs are currently underway.</div><div class="NLM_p last">Interestingly, the radioactive compound <b>6</b> (<sup>124</sup>I-analogue of the most effective PDT agent <b>5</b>) demonstrated excellent PET imaging ability of UMUC3 tumors implanted in SCID mice. In contrast to <sup>18</sup>F-FDG (50 μCi/mouse), the <sup>124</sup>I-analogue <b>6</b>, even at a dose of 15 μCi/mouse, showed excellent tumor contrast and imaging ability of UMUC3 tumors implanted in SCID mice at 24, 48, and 72 h post injection (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). Due to a long half-life (4 days) of the <sup>124</sup>I-radionuclide, compound <b>6</b> in a single dose can also be used for monitoring the tumor response. In contrast to <sup>18</sup>F-FDG (a current clinical standard, half-life 110 min), the <sup>124</sup>I-analogue can be shipped to long distances and could eliminate the necessity of having expensive cyclotrons at close distances of the imaging facilities. Besides, the requirements of 4- to 5-fold lower doses of <sup>124</sup>I-analogues than those of the <sup>18</sup>F-FDG in tumor imaging, the PET imaging with <sup>124</sup>I-analogue <b>6</b> should be more economical and widely acceptable. Due to the PS’s inherent fluorescence ability in the NIR region (abs: 665 nm, em: 715 nm), PS <b>5</b> (the nonradioactive analogue of <b>6</b>) showed excellent long-term tumor cure in SCID mice bearing UMUC3 tumors. Therefore, PS <b>5</b> in combination with corresponding <sup>124</sup>I-analogue <b>6</b> provides an opportunity to image the bladder tumors by PET and then treat them by fluorescence-guided PDT.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">4.1.  Chemistry Methods</h3><div class="NLM_p">All reactions were carried out in heat-gun-dried glassware under an atmosphere of nitrogen and magnetic stirring. Thin-layer chromatography (TLC) was performed on precoated silica gel sheets (layer thickness, 0.2 mm). Column chromatography was performed using either silica gel 60 (70–230 mesh) or neutral alumina grade III. In some cases, preparative TLC was used for the purification of compounds. Purity of the compounds was ascertained by TLC and HPLC analyses. All compounds including the intermediates were >95% pure. UV–visible spectra were recorded on an Fourier transform UV–visible spectrophotometer using methanol as a solvent. Mass spectrometry analyses were performed at the Mass Spectrometry Facility, University of Buffalo, NY.</div><div class="NLM_p">NMR data were acquired at 28 °C (unless otherwise noted) on a Bruker Avance III HD NMR spectrometer equipped with a 9.4 T narrow-bore magnet, a 5 mm broadband observe <i>Z</i>-gradient probe, and Topspin 3.2 software. Observed frequencies for <sup>1</sup>H and <sup>13</sup>C observations were 400 and 100 MHz, respectively. Chemical shifts were calibrated to the residual solvent resonance and are reported relative to tetramethylsilane at 0.00 ppm.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">4.1.1.  3-{1′-(3-[<i>N</i>-(3-Ethynylphenyl)-6,7-bis(2-methoxy-ethoxy)-4-quinazolinamine]benzyloxy)ethyl}-17-(3-iodobenzyamine)-pyropheophorbide-<i>a</i> (<b>3</b>)</h4><div class="NLM_p last">To a solution of compound <b>9</b> (50 mg, 0.0484 mmol) and 3-iodobenzylamine (16.90 mg, 0.0725 mmol) in 12 mL of dry dichloromethane (DCM), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDCI, 18.53 mg, 0.0967 mmol) and 4-(dimethylamino)pyridine (DMAP, 11.81 mg, 0.0967 mmol) were added. The reaction mixture was stirred overnight at room temperature under a N<sub>2</sub> atmosphere. It was then diluted with dichloromethane (40 mL), washed with water (3 × 50 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by a silica column using 6% methanol in dichloromethane to obtain pure product <b>3</b> with 76% (45.90 mg) yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.79/9.64 (1H, s, 5-H), 9.34 (1H, s, 10-H), 8.55/8.53 (1H, s, 20-H), 8.46/8.34 (1H, s, pyrimidine H), 7.71/7.67 (1H, m, phenyl H), 7.57/7.51 (1H, m, phenyl H), 7.45 (1H, m, phenyl H), 7.37–7.42 (2H, m, 2× phenyl H), 7.34–7.37 (1H, m, phenyl H), 7.28–7.34 (3H, m, 3× phenyl H), 7.21/7.18 (1H, s, erlotinib 8-H), 7.14/7.13 (1H, m, phenyl H), ∼7.1–7.2 (1H, br s, amine H), 7.08/7.06 (1H, s, erlotinib 5-H), 6.85 (1H, m, phenyl H), 6.79/6.77 (1H, dd, <i>J</i> = 7.8, 7.8 Hz, phenyl H), 6.00/5.97 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.72/5.66 (1H, t, <i>J</i> = 5.6 Hz, amide H), 5.20/5.19 (1H, d, <i>J</i> = 19.7 Hz, 13<sup>2</sup>-C<i>H</i>H), 5.05 (1H, d, <i>J</i> = 19.7 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.76/4.75 (1H, d, <i>J</i> = 11.9 Hz, −OC<i>H</i>H-phenyl−), 4.63/4.61 (1H, d, <i>J</i> = 11.9 Hz, −OCH<i>H</i>-phenyl−), 4.49/4.47 (1H, dq, <i>J</i> ∼ 7.2, 1.8 Hz, 18-H), 4.34 (1H, m, 17-H), 4.22–4.32 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.14 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.07–4.13 (1H, m, −NHC<i>H</i>H-phenyl−), 3.950/3.946 (1H, dd, <i>J</i> = 5.6, 15.0 Hz, −NHCH<i>H-</i>phenyl−), 3.87 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.69–3.76 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.55/3.54 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.49 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.44/3.43 (3H, s, 12-CH<sub>3</sub>), 3.41/3.39 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.40/3.35 (3H, s, 2-CH<sub>3</sub>), 3.18/3.17 (3H, s, 7-CH<sub>3</sub>), 2.68 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.50 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.24 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.15/2.13 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.88 (1H, ddd, <i>J</i> = 5.1, 10.0, 14.6 Hz, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.79/1.77 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), 1.59/1.58 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.43 (1H, br s, core NH), −1.70/–1.72 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.0, 172.23/172.21, 171.70/171.69, 160.2/160.1, 156.0/155.9, 155.3/155.2, 154.81/154.78, 153.4/153.3, 151.0, 148.97/148.95, 148.9, 145.04/145.00, 141.3/141.2, 140.41/140.35, 138.8, 138.74/138.72, 138.48/138.44, 138.39, 137.7, 136.54/136.53, 136.4, 136.3, 135.5/135.3, 132.9/132.7, 131.91/131.86, 130.9/130.8, 130.4, 130.2, 128.93/128.89, 128.6/128.5, 128.27/128.17, 128.19, 127.03/127.02, 126.78/126.76, 124.14/124.06, 123.9, 123.3/123.2, 121.21/121.15, 109.1/109.0, 108.9, 106.13/106.11, 104.01/103.96, 102.7/102.6, 98.3/97.7, 94.3, 92.6, 89.37/89.35, 89.36, 71.7/71.3, 71.0/70.9, 70.74/70.60, 70.56, 69.5/69.4, 68.4, 59.31, 59.31/59.28, 51.64/51.62, 50.01/49.97, 48.06/48.05, 42.60/42.59, 32.60/32.56, 30.3, 24.6/24.3, 23.12/23.07, 19.4, 17.31/17.29, 11.89/11.87, 11.3, 11.2/11.1. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (ε)): 663 (4.62 × 10<sup>4</sup>), 606 (8.25 × 10<sup>3</sup>), 537 (9.39 × 10<sup>3</sup>), 506 (9.08 × 10<sup>3</sup>), 409 (9.15 × 10<sup>4</sup>), 349 (4.99 × 10<sup>4</sup>). MS (electrospray ionization (ESI)) <i>m</i>/<i>z</i>: 1249.43 (M + H<sup>+</sup>). High-resolution mass spectrometry (HRMS) (ESI): calcd for C<sub>69</sub>H<sub>70</sub>O<sub>7</sub>N<sub>8</sub>I (M + H<sup>+</sup>) 1249.4383; found, 1249.4371. Note: small <sup>1</sup>H impurity peaks were observed at 3.80 and 3.65 ppm. <sup>1</sup>H impurity peaks at 1.60, 1.27, and 0.87 ppm (probably H<sub>2</sub>O, grease CH<sub>2</sub>, and CH<sub>3</sub>, respectively) are larger. <sup>13</sup>C impurity peaks at 29.7 and 14.1 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">4.1.2.  3-{1′-(3-Iodobenzyloxy)ethyl}17-[<i>N</i>-(3-benzylamineethynylphenyl)-6,7-bis(2-methoxy-ethoxy)-4-quinazolinamine]pyropheophorbide-<i>a</i> (<b>5</b>)</h4><div class="NLM_p last">To a solution of compound <b>12</b> (50 mg, 0.0661 mmol) and compound <b>11</b> (48.64 mg, 0.0976 mmol) in 12 mL of dry dichloromethane, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDCI, 25.30 mg, 0.132 mmol) and 4-(dimethylamino)pyridine (DMAP, 16.13 mg, 0.132 mmol) were added. The reaction mixture was stirred overnight at room temperature under a N<sub>2</sub> atmosphere. It was then diluted with dichloromethane (40 mL), washed with water (3 × 50 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by a silica column using 6% methanol in dichloromethane to obtain pure product <b>5</b> with 71% (57.68 mg) yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.76/9.73 (1H, s, 5-H), 9.00/8.98 (1H s, 10-H), 8.87/8.86 (1H, s, amine H), 8.68 (1H, s, pyrimidine H), 8.53 (1H, s, 20-H), 8.20 (1H, d, <i>J</i> = 8.2 Hz, phenyl H), 7.823/7.818 (1H, s, erlotinib 5-H), 7.79/7.76 (1H, m, phenyl H), 7.61–7.66 (2H, m, 2× phenyl H), 7.41 (1H, s, phenyl H), 7.27–7.34 (3H, m, 3× phenyl H), 7.22 (1H, s, erlotinib 8-H), ∼7.21 (1H, d, <i>J</i> ∼ 8 Hz, phenyl H), ∼7.10 (1H, br s, amide H), 7.07/7.05 (1H, t, <i>J</i> = 7.7 Hz, phenyl H), 7.01 (1H, t, <i>J</i> = 7.6 Hz, phenyl H), 6.91 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 5.98/5.97 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.08 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-C<i>H</i>H), 4.72/4.69 (1H, d, <i>J</i> ∼ 12 Hz, −OC<i>H</i>H-phenyl−), 4.57/4.56 (1H, d, <i>J</i> ∼ 12 Hz, −OCH<i>H</i>-phenyl−), 4.56 (1H, d, <i>J</i> = 19.9 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.51 (1H, dq, <i>J</i> = 7.3, 1.4 Hz, 18-H), 4.38 (1H, dd, <i>J</i> = 6.6, 14.9 Hz, −NHC<i>H</i>H-phenyl−), 4.28 (1H, m, 17-H), 4.15–4.27 (4H, m, 2× −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.00 (1H, dd, <i>J</i> = 4.5, 14.7 Hz, −NHCH<i>H</i>-phenyl−), 3.81 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.63 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.59 (2H, m, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.44 (3H, s, −OCH<sub>3</sub>), 3.37/3.35 (3H, s, 2-CH<sub>3</sub>), 3.239/3.238 (3H, s, −OCH<sub>3</sub>), 3.23/3.22 (3H, s, 7-CH<sub>3</sub>), 2.81 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.65 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.34/2.32 (3H, s, 12-CH<sub>3</sub>), ∼2.31 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.19/2.18 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 2.03 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.75 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.63/1.62 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.56 (1H, br s, core NH), −1.52 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.7, 173.15/173.14, 172.2, 160.20/160.19, 156.7, 155.55/155.53, 154.3, 153.6, 151.0, 149.0, 148.9, 147.4, 145.1, 141.5/141.4, 140.74/140.69, 139.5, 138.6, 138.5, 137.5, 136.89/136.86, 136.7, 136.40/136.39, 135.64/135.61, 133.1, 133.0, 130.77/130.75, 130.6, 130.14/130.12, 129.43/129.42, 128.9, 128.4, 127.82/127.81, 127.12/127.08, 126.7, 124.3, 123.7, 123.5, 122.1, 109.8, 108.6, 105.9, 103.9, 103.0, 97.9/97.8, 94.45/94.42, 92.8, 89.6, 88.9, 72.09/72.06, 70.7, 70.5, 70.28/70.25, 68.9, 68.3, 59.2, 59.1, 51.5, 49.8, 47.7, 43.2, 32.71/32.69, 31.0, 24.6/24.5, 22.89/22.88, 19.4, 17.4, 11.37/11.36, 11.09/11.07, 10.92/10.90. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (ε)): 664 (4.76 × 10<sup>4</sup>), 607 (8.76 × 10<sup>3</sup>), 539 (8.96 × 10<sup>3</sup>), 507 (9.06 × 10<sup>3</sup>), 410 (8.74 × 10<sup>4</sup>), 347 (5.17 × 10<sup>4</sup>). MS (ESI) <i>m</i>/<i>z</i>: 1249.43 (M + H<sup>+</sup>). HRMS (ESI): calcd for C<sub>69</sub>H<sub>70</sub>O<sub>7</sub>N<sub>8</sub>I (M + H<sup>+</sup>) 1249.4376; found, 1249.4383. Note: <sup>1</sup>H impurity peaks observed at 1.28 and 0.88 ppm are likely grease CH<sub>2</sub> and CH<sub>3</sub>, respectively. <sup>13</sup>C impurity peaks at 29.7 and 14.1 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">4.1.3.  Synthesis of Radioactive Compound <b>6</b> (<sup>124</sup>I-Labeled Analogue of PS <b>5</b>)</h4><div class="NLM_p last">Iodine-124 was purchased through Sofie (Richmond, VA). The radioactive solution was dried under a flow of nitrogen gas at 110 °C. After cooling the tube, the dried radioactive solution was dissolved in 100 μL of 5% acetic acid in methanol. Compound <b>13</b> (40 μg) was dissolved in 50 μL of 5% acetic acid in ethanol solutions and was transferred to the I-124 tube and mixed. <i>N</i>-chlorosuccinimide (10 μL) in methanol (1 mg/mL) was added. The reaction mixture was incubated at room temperature for 15 min, and the product was purified on a HPLC column (Waters Symmetry C18 5 μm, 4.6 × 250 mm<sup>2</sup>) and was eluted with a 97:3 mixture of methanol and water at a flow rate of 1 mL/min. The output was monitored by UV (254 nm) and radioactivity detectors. The labeled product <b>6</b> was collected and dried under a nitrogen gas flow at 90 °C. To the dried product tube, 1 mL of 2 mg/mL solution of Pluronic-127 in ethanol was added and the radioactive solution was dissolved by vortexing the solution. Then, ethanol was evaporated under a nitrogen flow at 90 °C. The labeled material was dissolved in 1 mL of 0.01 M PBS with vortexing. This final product solution was filtered through a 0.2 μm syringe filter with a Tuffryn membrane (Pall, #28142-340). The labeled product was eluted at 13.5 min. The specific activity was found to be >1 Ci/μmol.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">4.1.4.  3-{1′-(3-[<i>N</i>-(3-Ethynylphenyl)-6,7-bis(2-methoxy-ethoxy)-4-quinazolinamine]benzyloxy)ethyl}pyropheophorbide-<i>a</i> Methyl Ester (<b>8</b>)</h4><div class="NLM_p last">Triphenylarsine (18.76 mg, 0.06132 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (28.06 mg, 0.0306 mmol) were added to a stirred solution of compound <b>1</b> (60 mg, 0.0766) and erlotinib <b>7</b> (45.22 mg, 0.1144) in dry tetrahydrofuran (THF) (30 mL) and Et<sub>3</sub>N (6 mL). The reaction mixture was stirred overnight at room temperature under an argon atmosphere. As per TLC, only 3/4 amount of the starting material reacted to produce the desired product. The remaining 1/4 did not react even by increasing the catalyst quantity, temperature, and duration of the reaction. The product <b>8</b> and the remaining starting material <b>1</b> were purified by preparative TLC plates with 72% yield (57.85 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.76/9.73 (1H, s, 5-H), 9.48/9.47 (1H, s, 10-H), 8.64 (1H, s, pyrimidine H), 8.56 (1H, s, 20-H), 7.70–7.78 (2H, m, 2× phenyl H), 7.54/7.52 (1H, br s, phenyl H), 7.46 (1H, m, phenyl H), 7.27–7.38 (4H, m, 3× phenyl H and 1× erlotinib NH), 7.26 (1H, s, aromatic H), 7.16 (1H, m, phenyl H), 7.14/7.11 (1H, br s, aromatic H), 6.01 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.26/5.25 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-C<i>H</i>H), 5.112/5.109 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.77 (1H, d, <i>J</i> = 11.8 Hz, −OC<i>H</i>H-phenyl−), 4.62/4.61 (1H, d, <i>J</i> = 11.9 Hz, −OCH<i>H</i>-phenyl−), 4.49 (1H, dq, <i>J</i> = 7.3, 1.8 Hz, 18-H), 4.26–4.33 (3H, m, 17-H and −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.18 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.86 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.77 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.55–3.67 (8H, m, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub> and ring CH<sub>3</sub> and −COOCH<sub>3</sub>), 3.482/3.481 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.432/3.431 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.39 (3H, s, ring CH<sub>3</sub>), 3.20/3.19 (3H, s, ring CH<sub>3</sub>), 2.69 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.56 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.21–2.36 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.16 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.82 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.642/1.639 (3H, t, <i>J</i> = 7.7 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.42 (1H, br s, core NH), −1.71 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.19/196.18, 173.5, 171.4, 160.32/160.31, 156.17/156.15, 155.2, 154.8, 153.3, 151.0, 149.1, 149.01/149.00, 145.0, 141.3/141.2, 138.7, 138.62, 138.58, 137.8, 136.5, 135.5/135.4, 132.8/132.7, 131.5/131.4, 130.9, 130.5, 129.0, 128.51/128.49, 128.4, 128.12/128.10, 127.27/127.25, 124.30/124.26, 123.93/123.92, 123.3, 121.50/121.48, 109.0, 108.6, 106.1, 104.1, 102.55/102.50, 97.94/97.87, 92.7, 89.52/89.51, 89.3/89.2, 71.8/71.7, 71.0, 70.71/70.66, 70.5, 69.4, 68.4, 59.32, 59.30, 51.68, 51.67, 50.0, 48.0, 30.9, 29.9, 24.52/24.50, 23.17/23.15, 19.4, 17.4, 12.0, 11.25/11.24, 11.2. MS (ESI) <i>m</i>/<i>z</i>: 1048.49 (M + H<sup>+</sup>). HRMS (ESI): calcd for C<sub>63</sub>H<sub>66</sub>N<sub>7</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1048.4928; found, 1048.4957. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (ε)): 663 (4.58 × 10<sup>4</sup>), 608 (8.19 × 10<sup>3</sup>), 537 (9.1 × 10<sup>3</sup>), 507 (8.99 × 10<sup>3</sup>), 409 (8.8 × 10<sup>4</sup>), 349 (4.93 × 10<sup>4</sup>). Note: <sup>1</sup>H impurity peaks at 1.27 and 0.87 ppm are likely due to grease. One carbon peak is missing from this spectrum, presumably due to aggregation-induced line broadening. The <sup>13</sup>C peak at 29.7 ppm is likely due to grease impurity.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">4.1.5.  3-{1′-(3-[<i>N</i>-(3-Ethynylphenyl)-6,7-bis(2-methoxy-ethoxy)-4-quinazolinamine]benzyloxy)ethyl}pyropheophorbide-<i>a</i> Carboxylic Acid (<b>9</b>)</h4><div class="NLM_p last">Aqueous LiOH (36.02 mg in 3 mL of H<sub>2</sub>O) was added to a solution of compound <b>8</b> (30 mg) in dry THF/MeOH (4.5:3 mL), and the reaction mixture was stirred under argon at room temperature for 3 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and washed with 2% AcOH in H<sub>2</sub>O (18 mL) and with H<sub>2</sub>O (3 × 50 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified over a preparative TLC plate using 8% MeOH in CH<sub>2</sub>Cl<sub>2</sub> as eluent to yield 28.11 mg (95%) of product <b>9</b>. <sup>1</sup>H NMR (400 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 9.63 (1H, s, meso H), 9.30 (1H, br s, meso H), 8.49 (1H, s, meso H), 8.40 (1H, s, pyrimidine H), 7.68 (1H, d, <i>J</i> = 7.9 Hz, phenyl H), 7.64/7.60 (1H, s, phenyl H), 7.34–7.46 (3H, m, 3× aromatic H), 7.23–7.32 (3H, m, 3× aromatic H), 7.13 (1H, s, aromatic H), 7.10 (1H, d, <i>J</i> = 7.5 Hz, phenyl H), 5.95 (1H, q, <i>J</i> = 6.4 Hz, 3<sup>1</sup>-H), 5.21 (1H, d, <i>J</i> = 19.9 Hz, 13<sup>2</sup>-C<i>H</i>H), 5.01 (1H, d, <i>J</i> = 19.9 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.70 (1H, d, <i>J</i> = 11.8 Hz, −OC<i>H</i>H-phenyl−), 4.57 (1H, d, <i>J</i> = 11.7 Hz, −OCH<i>H</i>-phenyl−), 4.43 (1H, q, <i>J</i> ∼ 6.5 Hz, 18-H), 4.28 (2H, br s, −OC<i>H</i><sub><i>2</i></sub>CH<sub>2</sub>OCH<sub>3</sub>), ∼4.19 (1H, m, 17-H), ∼4.07 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.85 (2H, br s, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.73 (2H, br s, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.50 (2H, q, <i>J</i> = 7.5 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.45 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), ∼3.44 (3H, br s, ring CH<sub>3</sub>), 3.41 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), ∼3.31 (3H, s, ring CH<sub>3</sub>), 3.11 (3H, s, ring CH<sub>3</sub>), 2.62 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.50 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.13–2.32 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.09 (3H, d, <i>J</i> = 6.3 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.73 (3H, d, <i>J</i> ∼ 6.4 Hz, 18-CH<sub>3</sub>), 1.54 (3H, t, <i>J</i> = 7.3 Hz, 8-CH<sub>2</sub>C<i>H<sub>3</sub></i>); <sup>13</sup>C NMR (100 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 197.9, 178.7, 172.8, 161.7, 157.44/157.42, 156.08/156.06, 155.0, 153.4, 151.4, 149.4, 149.2, 146.9, 145.6, 141.8, 139.4, 138.9, 138.8, 137.8, 136.9, 136.0/135.9, 133.61/133.56, 132.0/131.9, 131.2, 130.0, 129.1, 128.9, 128.6, 128.5, 127.6/127.5, 125.7/125.6, 124.0, 123.7, 122.8/122.7, 109.9, 107.9, 106.1, 104.4, 103.7/103.6, 98.1/98.0, 93.4, 89.8, 89.5, 72.1/72.0, 71.13, 71.05/71.02, 70.9, 69.0, 68.7, 59.43, 59.40, 52.3, 50.5, 48.3, 33.0, 31.0, 24.5, 23.2, 19.6, 17.4, 11.9, 11.3, 11.2. MS (ESI) <i>m</i>/<i>z</i>: 1034.48 (M + H<sup>+</sup>). HRMS (ESI): calcd for C<sub>62</sub>H<sub>64</sub>N<sub>7</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1034.4814; found, 1034.4821. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (ε)): 663 (4.58 × 10<sup>4</sup>), 608 (8.19 × 10<sup>3</sup>), 537 (9.1 × 10<sup>3</sup>), 507 (8.99 × 10<sup>3</sup>), 409 (8.8 × 10<sup>4</sup>), 349 (4.93 × 10<sup>4</sup>). Note: one carboxylic acid and three NH protons were not observed, presumably due to chemical exchange. Small <sup>13</sup>C impurity peaks were observed at 180.2, 173.4, 29.6, and 14.2 (probably CH<sub>3</sub> of grease) ppm. A somewhat larger impurity peak, likely CH<sub>2</sub> of grease, was observed at 30.0 ppm.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">4.1.6.  3-{1′-(3-[<i>N</i>-(3-Ethynylphenyl)-6,7-bis(2-methoxy-ethoxy)-4-quinazolinamine]benzyloxy)ethyl}-17-(3-trimethyltin-benzyamine)-pyropheophorbide-<i>a</i> (<b>10</b>)</h4><div class="NLM_p last">To a solution of compound <b>3</b> (30 mg, 0.025 mmol) were added hexamethylditin (295.09 mg, 1.88 mmol) and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (8.43 mg, 0.0120 mmol) in 12 mL of dry THF. The reaction mixture was stirred overnight at room temperature under a N<sub>2</sub> atmosphere. It was then diluted with dichloromethane (40 mL), washed with water (3 × 50 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by a silica column using 4% methanol in dichloromethane to obtain pure product <b>10</b> with 92% (28.42 mg) yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.77/9.68 (1H, s, 5-H), 9.37/9.36 (1H, s, 10-H), 8.55/8.53 (1H, s, 20-H), 8.55/8.48 (1H, s, pyrimidine H), 7.72 (1H, m, phenyl H), 7.65/7.61 (1H, m, phenyl H), 7.42–7.46 (2H, m, 2× phenyl H), 7.27–7.36 (4H, m, amine H and 3× phenyl H), 7.20–7.25 (2H, m, phenyl H and aromatic H), 7.12–7.17 (3H, m, aromatic H and 2× phenyl H), 7.08/7.05 (1H, t, <i>J</i> = 7.4 Hz, phenyl H), 6.89/6.85 (1H, dt, <i>J</i> = 7.7, ∼1.4 Hz, phenyl H), 6.00/5.97 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.62/5.58 (1H, t, <i>J</i> = 5.6 Hz, amide H), 5.214/5.205 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-C<i>H</i>H), 5.06 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.75 (1H, d, <i>J</i> = 11.8 Hz, −OC<i>H</i>H-phenyl−), 4.611/4.605 (1H, d, <i>J</i> = 11.8 Hz, −OCH<i>H</i>-phenyl−), 4.50/4.48 (1H, dq, <i>J</i> ∼ 7.0, 1.8 Hz, 18-H), 4.34 (1H, m, 17-H), 4.28 (2H, m, −OC<i>H</i><sub><i>2</i></sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.23/4.22 (1H, dd, <i>J</i> = 5.6, 14.5 Hz, −NHC<i>H</i>H-phenyl−), 4.15 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.11 (1H, m, −NHCH<i>H</i>-phenyl), 3.86 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.73 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.57 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.48 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.47/3.46 (3H, s, ring CH<sub>3</sub>), 3.41/3.40 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.39/3.35 (3H, s, ring CH<sub>3</sub>), 3.19/3.18 (3H, s, ring CH<sub>3</sub>), 2.70 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.48 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.27 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.15/2.13 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.92 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.79/1.77 (3H, d, <i>J</i> = 7.0 Hz, 18-CH<sub>3</sub>), 1.61/1.60 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.40 (1H, br s, core NH), 0.144/0.137 (9H, s, Sn(CH<sub>3</sub>)<sub>3</sub>), −1.70/–1.72 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.06, 172.04/172.01, 171.71/171.69, 160.32/160.26, 156.1/156.0, 155.23/155.21, 154.72/154.69, 153.6/153.5, 151.0, 148.93/148.91, 148.89, 147.64/147.61, 145.01/144.98, 142.8, 141.2, 138.9/138.8, 138.6/138.5, 138.4, 137.8, 137.4/137.3, 136.5, 135.4/135.3, 135.2, 134.9, 132.8/132.7, 131.73/131.71, 130.84/130.79, 130.4, 128.9, 128.50/128.48, 128.22/128.15, 128.15, 127.62/127.60, 127.0, 124.2/124.1, 123.8, 123.29/123.26, 121.34/121.30, 109.2/109.1, 108.9, 106.09/106.08, 104.00/103.97, 102.62/102.60, 98.1/97.8, 92.7, 89.4, 89.4/89.3, 71.7/71.5, 71.0/70.9, 70.7/70.6, 70.5, 69.4/69.3, 68.3, 59.29, 59.29/59.27, 51.7, 50.02/50.00, 48.0, 43.68/43.66, 32.8/32.7, 30.4, 24.5/24.4, 23.12/23.07, 19.4, 17.3, 11.90/11.88, 11.23, 11.20/11.10, −9.7. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 664 (0.663), 609 (0.120), 538 (0.136), 506 (0.131), 409 (1.315), 349 (0.719). MS (ESI) <i>m</i>/<i>z</i>: 1287.50 (M + H<sup>+</sup>). HRMS (ESI): calcd for C<sub>72</sub>H<sub>78</sub>O<sub>7</sub>N<sub>8</sub>Sn (M + H<sup>+</sup>) 1287.5000; found, 1287.5010. Note: <sup>1</sup>H impurity peaks at 1.27 and 0.88 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively. One carbon peak is missing, presumably due to line broadening caused by aggregation. The <sup>13</sup>C peak at 29.7 ppm is likely due to grease (CH<sub>2</sub>) impurity.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.1.7.  [<i>N</i>-(3-(3′-Benzylamine)ethynylphenyl)-6,7-bis(2-methoxy-ethoxy)-4-quinazolinamine] (<b>11</b>)</h4><div class="NLM_p last">Triphenylarsine (104.67 mg, 0.342 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (156.50 mg, 0.1709 mmol) were added to a stirred solution of compound 3-iodobenzylamine (100 mg, 0.427) and erlotinib <b>7</b> (252.13 mg, 0.641) in dry THF (25 mL) and Et<sub>3</sub>N (5 mL). The reaction mixture was stirred overnight at room temperature under an argon atmosphere. As per TLC, only 3/4 amount of the starting material reacted to produce the desired product. The remaining 1/4 did not react even by increasing the catalyst quantity, temperature, and duration of the reaction. The product <b>11</b> was purified by column chromatography using MeOH/DCM (2/8) with 69% yield (344 mg). <sup>1</sup>H NMR (400 MHz, 80:20 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 8.46 (1H, s, pyrimidine H), 7.88 (1H, br t, <i>J</i> ∼ 1.7 Hz, phenyl H), 7.67 (1H, ddd, <i>J</i> ∼ 8.0, 2.1, 1.1 Hz, phenyl H), 7.65 (1H, s, erlotinib 5-H), 7.46 (1H, br s, phenyl H), 7.40 (1H, dt, <i>J</i> ∼ 7.3, 1.5 Hz, phenyl H), 7.34 (1H, t, <i>J</i> = 7.9 Hz, phenyl H), 7.31 (1H, t, <i>J</i> = 7.6 Hz, phenyl H), 7.24–7.29 (2H, m, 2× phenyl H), 7.13 (1H, s, erlotinib 8-H), 4.30 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.27 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.84 (6H, m, 2× −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub> and −phenyl-C<i>H</i><sub>2</sub>NH<sub>2</sub>), 3.47 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.45 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, 80:20 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 157.5, 154.9, 153.4, 149.1, 147.0, 141.0, 139.3, 130.87, 130.85, 129.2, 129.1, 127.8, 127.7, 125.8, 123.93, 123.90, 123.1, 110.0, 107.9, 103.9, 89.7, 89.3, 71.1, 70.8, 69.2, 68.6, 59.42, 59.35, 45.4. Note: the three amino protons were not observed, presumably due to chemical exchange. <sup>1</sup>H impurity peaks at 1.27 and 0.84 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively. The <sup>13</sup>C peak at 29.9 ppm is likely due to grease (CH<sub>2</sub>) impurity.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.1.8.  3-{1′-(3-Trimethyltinbenzyloxy)ethyl}17-[<i>N</i>-(3-benzylamineethynylphenyl)-6,7-bis(2-methoxy-ethoxy)-4-quinazolinamine]pyropheophorbide-<i>a</i> (<b>13</b>)</h4><div class="NLM_p last">To a solution of compound <b>5</b> (30 mg, 0.025 mmol) were added hexamethylditin (295.09 mg, 1.88 mmol) and PdCl<sub>2</sub> (PPh<sub>3</sub>)<sub>2</sub> (8.43 mg, 0.0120 mmol) in 12 mL of dry THF. The reaction mixture was stirred at room temperature under a N<sub>2</sub> atmosphere. It was then diluted with dichloromethane (40 mL), washed with water (3 × 50 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by a silica column using 4% methanol in dichloromethane to obtain pure compound <b>13</b> with 86% (26.57 mg) yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.77/9.74 (1H, s, 5-H), 9.10/9.07 (1H, s, 10-H), 8.75 (1H, br s, amine H), 8.69 (1H, s, pyrimidine H), 8.52 (1H, s, 20-H), 8.21 (1H, d, <i>J</i> = 8.3 Hz, phenyl H), 7.79 (1H, s, aromatic H), 7.65 (1H, m, phenyl H), 7.41–7.49 (3H, m, 3× phenyl H), 7.30–7.41 (4H, m, 4× phenyl H), 7.24 (1H, s, aromatic H), 7.22 (1H, br d, <i>J</i> ∼ 8 Hz, phenyl H), 7.06/7.04 (1H, dd, <i>J</i> = 1.6, 7.6 Hz, phenyl H), 6.93 (1H, br d, <i>J</i> = 7.4 Hz, phenyl H), 6.81 (1H, br s, amide H), 6.02/5.99 (1H, q, <i>J</i> = 6.8 Hz, 3<sup>1</sup>-H), 5.13 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-C<i>H</i>H), 4.81/4.79 (1H, d, <i>J</i> = 11.6 Hz, −OC<i>H</i>H-phenyl−), 4.65/4.64 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.64/4.62 (1H, d, <i>J</i> = 11.5 Hz, −OCH<i>H</i>-phenyl−), 4.53 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.41/4.40 (1H, dd, <i>J</i> = 6.4, 14.8 Hz, −NHC<i>H</i>H-phenyl−), 4.31 (1H, m, 17-H), 4.27 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.23 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.04 (1H, dd, <i>J</i> = 4.2, 14.7 Hz, −NHCH<i>H</i>-phenyl−), 3.83 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.63 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), ∼3.61 (2H, m, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.45 (3H, s, −OCH<sub>3</sub>), 3.37/3.34 (3H, s, ring-CH<sub>3</sub>), 3.234/3.230 (3H, s, −OCH<sub>3</sub>), 3.19/3.18 (3H, s, ring-CH<sub>3</sub>), 2.83 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.65 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.49 (3H, br s, 12-CH<sub>3</sub>), 2.32 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.162/2.156 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 2.02 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.76 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.65/1.63 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.62 (1H, br s, core NH), 0.22/0.20 (9H, s, Sn(CH<sub>3</sub>)<sub>3</sub>), −1.49 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.8, 173.0, 172.2, 160.2, 156.7, 155.7/155.6, 154.3, 153.6, 151.0, 149.1, 148.9, 147.5, 145.0, 142.6/142.5, 141.7/141.6, 139.5, 139.2/139.1, 138.5, 137.7/137.6, 137.5, 136.38/136.36, 135.90/135.87, 135.59/135.56, 135.3, 133.0/132.9, 130.7, 130.6, 129.5, 129.0, 128.5, 128.3/128.2, 128.1, 127.86/127.83, 127.81, 126.8, 124.3, 123.77/123.75, 123.5, 122.1, 109.8, 108.72/108.71, 105.8, 104.0, 103.0, 98.0/97.9, 92.7, 89.65/89.64, 89.0, 71.73/71.70, 71.5, 70.7, 70.5, 68.9, 68.3, 59.3, 59.1, 51.54/51.53, 49.8, 47.8, 43.2, 32.74/32.71, 31.03/31.00, 24.64/24.57, 22.9, 19.4, 17.4, 11.3, 11.13/11.09, 11.1, −9.60/–9.61. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 663 (0.622), 607 (0.119), 539 (0.122), 506 (0.119), 410 (1.314), 347 (0.664). MS (ESI) <i>m</i>/<i>z</i>: 1287.50 (M + H<sup>+</sup>). HRMS (ESI): calcd for C<sub>72</sub>H<sub>78</sub>O<sub>7</sub>N<sub>8</sub>Sn (M + H<sup>+</sup>) 1287.1876; found, 1287.1883. Note: <sup>1</sup>H impurity peaks at 1.27 and 0.89 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively. The <sup>13</sup>C peak at 29.7 ppm is likely due to grease (CH<sub>2</sub>) impurity.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.1.9.  HPLC Analysis of Iodoanalogue <b>5</b> and the Related Trimethyl-tin Derivative <b>13</b></h4><div class="NLM_p last">The solutions of <b>5</b> and <b>13</b> were prepared by dissolving 0.2 mg of individual compound in 25 μL of THF, and then, 500 μL of methanol was added and mixed. These solutions were then filtered through a 0.2 μm pore size regenerated cellulose 4 mm syringe filter. For analyzing the purity of these samples, a Waters 600 controller connected to a 996 photodiode array detector, a Delta 600-Multisolvent delivery system, and a Rheodyne injector (with a 20 μL loop) were used. The system was equipped with a Waters Symmetry C18 column of dimensions 4.6 × 250 mm<sup>2</sup> and 5 μm particle size. The mobile phase was 97% methanol/3% water at a flow rate of 1.0 mL/min. Each of the two compounds was isolated as an epimeric mixture, but the iodo-analogue <b>5</b> was eluted at 14.69 min, whereas the trimethyl tin derivative <b>13</b> showed two peaks (partially resolved), with retention times 18.38 and 19.23 min. The purity of the radioactive analogue <b>6</b> was also confirmed by the same HPLC parameters.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37">4.2.  Cell Lines</h3><div class="NLM_p last">UMUC3 (CRL-1749) and T24 (HTB-4) cells were acquired from ATCC. The cells were grown in McCoy supplemented with 10% FBS and 1% penicillin/streptomycin, <span class="smallcaps smallerCapital">l</span>-glutamate, and <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid buffer.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38">4.3.  Cytotoxicity Assay</h3><div class="NLM_p last">Cells were plated in 96-well plates at a concentration of 10k cells per well, 100 μL. After 24 h incubation time, to allow the cells to adhere to the plate, the photosensitizer was added to the plate in a 2-fold dilution pattern where the top concentration is 1 μM. The photosensitizer was allowed to incubate with the cells for 24 h before the cells were exposed to the optimal wavelength for HPPH in an aqueous environment, 665 nm. Cells were exposed to light for a total of 1.0 J/cm<sup>2</sup> at a dose rate of 3.2 mW/cm<sup>2</sup>. After 48 h of PDT, the cell viability was measured using an MTT assay. Briefly, 15 μL of MTT solution was added to each well and allowed to incubate for about 2 h. The medium was removed, and the insoluble Formazan was suspended in dimethyl sulfoxide. The plate is read at 570 nm. For the investigation on the impact of ABCG2 inhibition, cells were incubated with PSs as discussed above along with Gleevec at 5 μM concentration.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39">4.4.  Mechanistic Investigation Utilizing a Fluorescence Microscope</h3><div class="NLM_p last">Cells (100k) were plated into six-well plates and allowed to grow to 80% confluency. The cells were washed, and fresh medium was added. To investigate the impact of ABCG2 inhibition, 5 μM Gleevec was added to the cells with 500 nM each photosensitizer. The cells were incubated with the drugs for 24 h before being washed twice with PBS. Fresh medium was added to the cells. Hoechst 33342 was added to the plates to better visualize the cells. The plates were visualized utilizing a Zeiss fluorescence microscope. The images were analyzed in ImageJ, where the gray value of each fluorescent field was normalized to the number of cells in the field. For each group, experiments were done in triplicate. Each well was imaged in triplicate. To investigate EGFR affinity of the erlotinib-conjugated photosensitizer, free erlotinib was added at 3 μM concentration. For this experiment, the photosensitizer concentration was raised to 1 μM. The fluorescence images were recorded, and analysis was performed by following the method described above.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40">4.5.  Comparative ROS Measurements in Vitro</h3><div class="NLM_p last">UMUC3 cells (10k) were plated in 96-well plate. After 24 h, the PS <b>1</b>, <b>3</b>, or <b>5</b> was added at 1 μM. After 24 h incubation, 1 μM DCFDA was incubated with the cells for 20 min. The fluorescent intensity of DCFDA was measured utilizing Spectra Max at 492 nm excitation and 517 emission. The plates were then exposed to 665 nm light for a total of 1 J. Additionally, 0.05% H<sub>2</sub>O<sub>2</sub> was used as a control in one well. The fluorescence was measured again using the same parameters as above.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41">4.6.  Annexin V/PI Staining</h3><div class="NLM_p last">UMUC3 and T24 cells were treated with erlotinib conjugates <b>1</b>, <b>3</b>, and <b>5</b> followed by PDT for indicated time points. Cells were trypsinized and washed with ice-cold PBS once and suspended in 100 μL of annexin V binding buffer. Annexin V–fluorescein isothiocyanate (FITC) (5 μL) and 1 μL of PI (100 μg/mL) were added and incubated at room temperature. After 15 min incubation, 300 μL of annexin V binding buffer was added and analyzed using a BD flow cytometer (LSRII B) at FITC and phycoerythrin channels. Data were analyzed using BD FACSDiva software. Annexin V<sup>–</sup> and PI<sup>–</sup> cells were considered live cells; annexin V<sup>–</sup> and PI<sup>+</sup> cells were considered necrotic cells; and annexin V<sup>+</sup> cells were considered apoptotic cells.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42">4.7.  Western Blotting</h3><div class="NLM_p last">UMUC3 and T24 cells were treated with erlotinib conjugates <b>1</b>, <b>3</b>, and <b>5</b> followed by PDT for indicated time points. Cells were trypsinized and washed with ice-cold PBS once and lysed in radioimmunoprecipitation assay buffer supplemented with protease inhibitor cocktail (Sigma-Aldrich), 1 mM sodium orthovanadate, 5 mM sodium fluoride, and 1 mM dithiothreitol. The protein content was quantified by a micro bicinchoninic acid protein estimation kit (Thermo Scientific). Protein samples were resolved on 4–20% Criterion gels, transferred on nitrocellulose membranes (BioRad), and subjected to immunoblotting. Membranes were blocked in 5% fat-free dry milk (Santa Cruz) prepared in PBS-T (Tween 20) and incubated overnight in indicated primary antibodies (1:1000 dilution) at 4 °C with continuous shaking. After washing with PBS-T, membranes were incubated in horseradish peroxidase (HRP)-conjugated antimouse or antirabbit secondary antibody at room temperature for 1 h. After washing with PBS-T, proteins were detected with Clarity chemiluminescent reagent (BioRad) and X-ray films (ASI). Membranes were stripped with stripping buffer and probed with HRP-conjugated β-actin antibody to ensure equal loading of proteins.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43">4.8.  In Vivo Studies</h3><div class="NLM_p last">The experimental details for in vivo studies are presented in the <a class="ref internalNav" href="#sec2" aria-label="Section 2">Section 2</a> of the article. All of the animal studies presented in this study were approved by the Institutional Animal Care and Use Committee of the Roswell Park Comprehensive Cancer Center, Buffalo, NY.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44">4.9.  Instrumentation</h3><div class="NLM_p last">Measurements of fluorescence quantum yields were carried out on a Hamamatsu C9920<b>-</b>0X(PMA-12) U6039<b>-</b>05 fluorescence spectrofluorometer. Femtosecond laser flash photolysis was conducted using a Clark-MXR 2010 laser system and an optical detection system provided by Ultrafast Systems (Helios). The source for the pump and probe pulses was derived from the fundamental output of Clark laser system (775 nm, 1 mJ/pulse and fwhm = 150 fs) at a repetition rate of 1 kHz. A second harmonic generator introduced in the path of the laser beam provided 412 nm laser pulses for excitation. A 95% of the fundamental output of the laser was used to generate the second harmonic, whereas 5% of the deflected output was used for white light generation. Prior to generating the probe continuum, the laser pulse was fed to a delay line that provided an experimental time window of 1.6 ns with a maximum step resolution of 7 fs. The pump beam was attenuated at 5 μJ/pulse with a spot size of 2 mm diameter at the sample cell where it was merged with the white probe pulse in a close angle (<10°). The probe beam after passing through the 2 mm sample cell was focused on a 200 μm fiber-optic cable, which was connected to a charge-coupled device spectrograph (Ocean Optics, S2000-UV–vis for the visible region and Horiba, CP-140 for the NIR region) for recording the time-resolved spectra (450–800 and 800–1400 nm). Typically, 5000 excitation pulses were averaged to obtain the transient spectrum at a set delay time. The kinetic traces at appropriate wavelengths were assembled from the time-resolved spectral data. Nanosecond time-resolved transient absorption measurements were carried out using the laser system provided by UNISOKU Co., Ltd. Measurements of nanosecond transient absorption spectrum were performed according to the following procedure. A mixture solution in a quartz cell (1 cm × 1 cm) was excited by a Nd:YAG laser (Continuum SLII-10, 4-6 ns fwhm, λ<sub>ex</sub> = 355 nm, 80 mJ/pulse, 10 Hz). The photodynamics were monitored by continuous exposure to a xenon lamp for the visible region and a halogen lamp for the near-IR region as a probe light and a photomultiplier tube (Hamamatsu 2949) as a detector.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01927" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01927" class="ext-link">10.1021/acs.jmedchem.8b01927</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Copies of the NMR (proton and C-13) spectra of certain compounds (Figures S1–S14), variable-temperature NMR spectra of compound <b>5</b> (Figure S15), comparative photophysical properties of compounds <b>1</b>, <b>3</b>, and <b>5</b> (Figures S16–S20), and molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf">jm8b01927_si_001.pdf (2.18 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01927" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravindra K. Pandey</span> - <span class="hlFld-Affiliation affiliation">Photodynamic
Therapy Center, Cell Stress Biology, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9889-4860" title="Orcid link">http://orcid.org/0000-0002-9889-4860</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#01736077686f6573602f71606f65647841736e7276646d6d7160736a2f6e7366"><span class="__cf_email__" data-cfemail="d0a2b1a6b9beb4a2b1fea0b1beb4b5a990a2bfa3a7b5bcbca0b1a2bbfebfa2b7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravindra
R. Cheruku</span> - <span class="hlFld-Affiliation affiliation">Photodynamic
Therapy Center, Cell Stress Biology, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Cacaccio</span> - <span class="hlFld-Affiliation affiliation">Photodynamic
Therapy Center, Cell Stress Biology, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Farukh A. Durrani</span> - <span class="hlFld-Affiliation affiliation">Photodynamic
Therapy Center, Cell Stress Biology, 
    , , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Photolitec,
LLC, 73 High Street, Buffalo, New York 14226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter A. Tabaczynski</span> - <span class="hlFld-Affiliation affiliation">Photodynamic
Therapy Center, Cell Stress Biology, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramona Watson</span> - <span class="hlFld-Affiliation affiliation">Photodynamic
Therapy Center, Cell Stress Biology, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aimee Marko</span> - <span class="hlFld-Affiliation affiliation">Photolitec,
LLC, 73 High Street, Buffalo, New York 14226, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rahul Kumar</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and
Therapeutics, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed E. El-Khouly</span> - <span class="hlFld-Affiliation affiliation">Institute
of Basic and Applied Sciences, Egypt-Japan
University of Science and Technology, Qesm Borg Al Arab 21934, Egypt</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shunichi Fukuzumi</span> - <span class="hlFld-Affiliation affiliation">Institute
of Basic and Applied Sciences, Egypt-Japan
University of Science and Technology, Qesm Borg Al Arab 21934, Egypt</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Nano Science, Ewha Womans
University, Seoul 03760, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph R. Missert</span> - <span class="hlFld-Affiliation affiliation">Photodynamic
Therapy Center, Cell Stress Biology, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rutao Yao</span> - <span class="hlFld-Affiliation affiliation">Department
of Nuclear Medicine, SUNY, Buffalo, New York 14221, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Munawwar Sajjad</span> - <span class="hlFld-Affiliation affiliation">Department
of Nuclear Medicine, SUNY, Buffalo, New York 14221, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dhyan Chandra</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and
Therapeutics, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khurshid Guru</span> - <span class="hlFld-Affiliation affiliation">Department of Urology, , and , Roswell Park Comprehensive
Cancer Center, Buffalo, New York 14263, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Listed as an inventor in the patent application submitted to United States Patent office.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4786-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Mykhaylo Dukh of our research group for providing the starting material (iodinated photosensitizer <b>1</b>) to synthesize a series of erlotinib analogues. The authors are highly thankful to Photolitec, LLC, and Roswell Park Alliance Foundation (R.K.P. and K.G.) for the financial support. A partial support from the shared resources of the RPCI support grant (P30CA16056) is also highly appreciated.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">photosensitizers</p></td></tr><tr><td class="NLM_term">PDT</td><td class="NLM_def"><p class="first last">photodynamic therapy</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">DCFDA</td><td class="NLM_def"><p class="first last">2,7-dichlorofluorescein diacetate</p></td></tr><tr><td class="NLM_term">FDG</td><td class="NLM_def"><p class="first last">fluorodeoxyglucose</p></td></tr><tr><td class="NLM_term">NIR</td><td class="NLM_def"><p class="first last">near-infrared</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52578" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52578" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer Statistics, 2014</span>. <i>CA—Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.3322/caac.21208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3322%2Fcaac.21208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=24399786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=9-29&author=R.+Siegelauthor=J.+Maauthor=Z.+Zouauthor=A.+Jemal&title=Cancer+Statistics%2C+2014&doi=10.3322%2Fcaac.21208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2014</span></div><div class="casAuthors">Siegel Rebecca; Ma Jiemin; Zou Zhaohui; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics.  A total of 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014.  During the most recent 5 years for which there are data (2006-2010), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.4% per year in women.  The combined cancer death rate (deaths per 100,000 population) has been continuously declining for 2 decades, from a peak of 215.1 in 1991 to 171.8 in 2010.  This 20% decline translates to the avoidance of approximately 1,340,400 cancer deaths (952,700 among men and 387,700 among women) during this time period.  The magnitude of the decline in cancer death rates from 1991 to 2010 varies substantially by age, race, and sex, ranging from no decline among white women aged 80 years and older to a 55% decline among black men aged 40 years to 49 years.  Notably, black men experienced the largest drop within every 10-year age group.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-53QNNisGn5agfuraLLzSfW6udTcc2eYrnWviZNEza7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D&md5=2aa85d07bbfc7838e1d0e6bf94ce6c46</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21208%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520Statistics%252C%25202014%26jtitle%3DCA%25E2%2580%2594Cancer%2520J.%2520Clin.%26date%3D2014%26volume%3D64%26spage%3D9%26epage%3D29%26doi%3D10.3322%2Fcaac.21208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, W. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, A. S.</span></span> <span> </span><span class="NLM_article-title">Bladder Cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>374</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(09)60491-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2FS0140-6736%2809%2960491-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=19520422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos12ru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2009&pages=239-249&author=D.+S.+Kaufmanauthor=W.+U.+Shipleyauthor=A.+S.+Feldman&title=Bladder+Cancer&doi=10.1016%2FS0140-6736%2809%2960491-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Bladder cancer</span></div><div class="casAuthors">Kaufman, Donald S.; Shipley, William U.; Feldman, Adam S.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">9685</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Bladder cancer is a heterogeneous disease, with 70% of patients presenting with superficial tumors, which tend to recur but are generally not life threatening, and 30% presenting as muscle-invasive disease assocd. with a high risk of death from distant metastases.  The main presenting symptom of all bladder cancers is painless hematuria, and the diagnosis is established by urinary cytol. and transurethral tumor resection.  Intravesical treatment is used for carcinoma in situ and other high grade non-muscle-invasive tumors.  The std. of care for muscle-invasive disease is radical cystoprostatectomy, and several types of urinary diversions are offered to patients, with quality of life as an important consideration.  Bladder preservation with transurethral tumor resection, radiation, and chemotherapy can in some cases be equally curative.  Several chemotherapeutic agents have proven to be useful as neoadjuvant or adjuvant treatment and in patients with metastatic disease.  We discuss bladder preserving approaches, combination chemotherapy including new agents, targeted therapies, and advances in mol. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRtPGwwM2gPLVg90H21EOLACvtfcHk0ljVhPtHmK3pEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos12ru7g%253D&md5=fb7cc148fe8558cdfdf4fd496844e63b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2960491-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252960491-8%26sid%3Dliteratum%253Aachs%26aulast%3DKaufman%26aufirst%3DD.%2BS.%26aulast%3DShipley%26aufirst%3DW.%2BU.%26aulast%3DFeldman%26aufirst%3DA.%2BS.%26atitle%3DBladder%2520Cancer%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D239%26epage%3D249%26doi%3D10.1016%2FS0140-6736%2809%2960491-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">American Cancer Society</span>.  <i>Bladder Cancer; Survival Rates for Bladder
Cancer by Stage</i>, <span class="NLM_year">2016</span>. Available at <a href="http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-survival-rates" class="extLink">http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-survival-rates</a> (accessed Dec 10, 2014).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=American+Cancer+Society&title=Bladder+Cancer%3B+Survival+Rates+for+Bladder%0ACancer+by+Stage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DBladder%2520Cancer%253B%2520Survival%2520Rates%2520for%2520Bladder%250ACancer%2520by%2520Stage%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, H.
B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natale, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tangen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speights, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelzang, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trump, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deVere White, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarosdy, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, E. D.</span></span> <span> </span><span class="NLM_article-title">Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa022148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1056%2FNEJMoa022148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=12944571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVSnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=859-866&author=H.%0AB.+Grossmanauthor=R.+B.+Nataleauthor=C.+M.+Tangenauthor=V.+O.+Speightsauthor=N.+J.+Vogelzangauthor=D.+L.+Trumpauthor=R.+W.+deVere+Whiteauthor=M.+F.+Sarosdyauthor=D.+P.+Woodauthor=D.+Raghavanauthor=E.+D.+Crawford&title=Neoadjuvant+chemotherapy+plus+cystectomy+compared+with+cystectomy+alone+for+locally+advanced+bladder+cancer&doi=10.1056%2FNEJMoa022148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neoadjuvant chemotherapy plus cystectomy compared with cystectomy along for locally advanced bladder cancer</span></div><div class="casAuthors">Grossman, H. Barton; Natale, Ronald B.; Tangen, Catherine M.; Speights, V. O.; Vogelzang, Nicholas J.; Trump, Donald L.; de Vere White, Ralph W.; Sarosdy, Michael F.; Wood, David P., Jr.; Raghavan, Derek; Crawford, E. David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">859-866</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Despite aggressive local therapy, patients with locally advanced bladder cancer are at significant risk for metastases.  We evaluated the ability of neoadjuvant chemotherapy to improve the outcome in patients with locally advanced bladder cancer who were treated with radical cystectomy.  Methods: Patients were enrolled if they had muscle-invasive bladder cancer (stage T2 to T4a) and were to be treated with radical cystectomy.  They were stratified according to age (less than 65 yr vs. 65 yr or older) and stage (superficial muscle invasion vs. more extensive disease) and were randomly assigned to radical cystectomy alone or three cycles of methotrexate, vinblastine, doxorubicin, and cisplatin followed by radical cystectomy.  Results: We enrolled 317 patients over an 11-yr period, 10 of whom were found to be ineligible; thus, 154 were assigned to receive surgery alone and 153 to receive combination therapy.  According to an intention-to-treat anal., the median survival among patients assigned to surgery alone was 46 mo, as compared with 77 mo among patients assigned to combination therapy (P=0.06 by a two-sided stratified log-rank test).  In both groups, improved survival was assocd. with the absence of residual cancer in the cystectomy specimen.  Significantly more patients in the combination-therapy group had no residual disease than patients in the cystectomy group (38 % vs. 15 %, P<0.001).  Conclusions: As compared with radical cystectomy alone, the use of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin followed by radical cystectomy increases the likelihood of eliminating residual cancer in the cystectomy specimen and is assocd. with improved survival among patients with locally advanced bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVL6_8LWXPcbVg90H21EOLACvtfcHk0ljVhPtHmK3pEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVSnu7Y%253D&md5=fe61c6f5757118e63094654321ee12cd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa022148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa022148%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DH.%2BB.%26aulast%3DNatale%26aufirst%3DR.%2BB.%26aulast%3DTangen%26aufirst%3DC.%2BM.%26aulast%3DSpeights%26aufirst%3DV.%2BO.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3DTrump%26aufirst%3DD.%2BL.%26aulast%3DdeVere%2BWhite%26aufirst%3DR.%2BW.%26aulast%3DSarosdy%26aufirst%3DM.%2BF.%26aulast%3DWood%26aufirst%3DD.%2BP.%26aulast%3DRaghavan%26aufirst%3DD.%26aulast%3DCrawford%26aufirst%3DE.%2BD.%26atitle%3DNeoadjuvant%2520chemotherapy%2520plus%2520cystectomy%2520compared%2520with%2520cystectomy%2520alone%2520for%2520locally%2520advanced%2520bladder%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D859%26epage%3D866%26doi%3D10.1056%2FNEJMoa022148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trump, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study</span>. <i>BJU Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.1111/bju.13678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fbju.13678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=27743481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2srgsF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2017&pages=605-611&author=N.+Hinataauthor=A.+A.+Husseinauthor=S.+Georgeauthor=D.+L.+Trumpauthor=E.+G.+Levineauthor=K.+Omarauthor=P.+Dasguptaauthor=M.+S.+Khanauthor=A.+Hosseiniauthor=P.+Wiklundauthor=K.+A.+Guru&title=Impact+of+suboptimal+neoadjuvant+chemotherapy+on+peri-operative+outcomes+and+survival+after+robot-assisted+radical+cystectomy%3A+a+multicentre+multinational+study&doi=10.1111%2Fbju.13678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study</span></div><div class="casAuthors">Hinata Nobuyuki; Hussein Ahmed Aly; George Saby; Levine Ellis G; Guru Khurshid A; Hinata Nobuyuki; Hussein Ahmed Aly; Trump Donald L; Omar Kawa; Dasgupta Prokar; Khan Muhammad Shamim; Hosseini Abolfazl; Wiklund Peter</div><div class="citationInfo"><span class="NLM_cas:title">BJU international</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-611</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To evaluate the effect of suboptimal dosing on the outcomes of patients who received neoadjuvant chemotherapy (NAC) and robot-assisted radical cystectomy (RARC).  PATIENTS AND METHODS:  We retrospectively reviewed 336 consecutive patients with urothelial carcinoma of the bladder who were treated with NAC and RARC at three academic institutions.  Outcomes were compared among three groups: patients who received optimal NAC; patients who received suboptimal NAC; and those who did not receive NAC.  To adjust for potential baseline differences between the three groups, propensity-score-based matching was performed.  The suboptimal dose group was defined as those who received <3 cycles of cisplatin-based chemotherapy, received a decreased dosage, or those not treated with cisplatin.  Primary outcomes analysed were recurrence-free survival (RFS) and overall survival (OS).  Secondary outcomes were peri-operative complications and readmissions after RARC.  RESULTS:  After propensity-score matching, 69 patients in the cohort received optimal-dose NAC, 41 received suboptimal NAC and 69 did not receive NAC.  Complication rates and readmission rates did not differ significantly among the three groups.  On multivariable analysis, suboptimal NAC and no NAC were independent predictors of worse RFS (hazard ratio [HR] 2.5, 95% confidence interval [CI] 1.2-5.7, P = 0.01 and HR 2.4, 95% CI 1.28-5.16, P = 0.01) and worse OS (HR 4.5, 95% CI 1.6-15.0, P < 0.01 and HR 4.9, 95% CI 1.9-15.6, P < 0.01) in patients who received NAC and RARC.  Failure to achieve pathological complete response (ypT0N0) was also an independent predictor of worse RFS (HR 6.6, 95% CI 1.3-20.9; P = 0.02) and OS (HR 4.9, 95% CI 1.8-15.3; P = 0.02).  CONCLUSION:  Optimal NAC resulted in a better RFS and OS when compared with suboptimal or no NAC.  Suboptimal and no NAC were associated with worse OS and RFS.  These findings will facilitate improved patient counseling and treatment selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT02UKov-4BIGhHGZei4OW9fW6udTcc2eaSz1ADW7aR8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srgsF2htA%253D%253D&md5=7cf02baefce652fb20c17591cb25afd7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fbju.13678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbju.13678%26sid%3Dliteratum%253Aachs%26aulast%3DHinata%26aufirst%3DN.%26aulast%3DHussein%26aufirst%3DA.%2BA.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DTrump%26aufirst%3DD.%2BL.%26aulast%3DLevine%26aufirst%3DE.%2BG.%26aulast%3DOmar%26aufirst%3DK.%26aulast%3DDasgupta%26aufirst%3DP.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DHosseini%26aufirst%3DA.%26aulast%3DWiklund%26aufirst%3DP.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DImpact%2520of%2520suboptimal%2520neoadjuvant%2520chemotherapy%2520on%2520peri-operative%2520outcomes%2520and%2520survival%2520after%2520robot-assisted%2520radical%2520cystectomy%253A%2520a%2520multicentre%2520multinational%2520study%26jtitle%3DBJU%2520Int.%26date%3D2017%26volume%3D119%26spage%3D605%26epage%3D611%26doi%3D10.1111%2Fbju.13678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dibaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvshinoff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a quality assurance score for robot-assisted radical cystectomy: A 10-year Analysis</span>. <i>Urology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.urology.2016.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.urology.2016.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=27491964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2s3nvV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2016&pages=124-129&author=A.+A.+Husseinauthor=S.+Dibajauthor=N.+Hinataauthor=E.+Fieldauthor=K.+O%E2%80%99Learyauthor=B.+Kuvshinoffauthor=J.+L.+Mohlerauthor=G.+Wildingauthor=K.+A.+Guru&title=Development+and+validation+of+a+quality+assurance+score+for+robot-assisted+radical+cystectomy%3A+A+10-year+Analysis&doi=10.1016%2Fj.urology.2016.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis</span></div><div class="casAuthors">Hussein Ahmed A; Dibaj Shiva; Field Erinn; Mohler James L; Wilding Gregory; Hinata Nobuyuki; O'leary Kathleen; Kuvshinoff Boris; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">Urology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124-129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop quality assessment tool to evaluate surgical performance for robot-assisted radical cystectomy program.  METHODS:  A prospectively maintained quality assurance database of 425 consecutive robot-assisted radical cystectomies performed by a single surgeon between 2005 and 2015 was retrospectively reviewed.  Potentially modifiable factors, related to the management and perioperative care of patients, were used to evaluate patient care.  Criteria included the following: preoperative (administration of neoadjuvant chemotherapy); operative (operative time <6.5 hours and estimated blood loss <500 cc); pathologic (negative soft tissue surgical margins and lymph node yield ≥20); and postoperative (no high-grade complications, readmission, or noncancer-related mortality within 30 days).The Quality Cystectomy Score (QCS) was developed (1 star: achieving ≤2 criteria or mortality within 30 days; 2 stars: 3 or 4 criteria met; 3 stars: 5 or 6 criteria met; and 4 stars: 7 or all criteria met).  Univariate and multivariate Cox proportional hazard regression models were fitted to test for the association between QCS and survival outcomes.  RESULTS:  Most patients (85%) achieved at least 3 stars, and more patients achieved 4 stars with time.  High QCS was associated with better recurrence-free, cancer-specific, and overall survival (P values <.05).  None of the patients with 1-star were alive at 1 year.  Patients with 4 stars achieved the best survival rates (recurrence-free survival [62%], cancer-specific survival [70%], and overall survival [53%] at 5 years) (log rank P < .0001).  CONCLUSION:  Continuous assessment for quality improvement facilitated implementation and maintenance of robot-assisted program for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcToo6qAX0rnoJdYoSR9eyvsfW6udTcc2eaSz1ADW7aR8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3nvV2isQ%253D%253D&md5=a2edd80884ef1d34876229152f86ad89</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.urology.2016.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.urology.2016.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DA.%2BA.%26aulast%3DDibaj%26aufirst%3DS.%26aulast%3DHinata%26aufirst%3DN.%26aulast%3DField%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DK.%26aulast%3DKuvshinoff%26aufirst%3DB.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520quality%2520assurance%2520score%2520for%2520robot-assisted%2520radical%2520cystectomy%253A%2520A%252010-year%2520Analysis%26jtitle%3DUrology%26date%3D2016%26volume%3D97%26spage%3D124%26epage%3D129%26doi%3D10.1016%2Fj.urology.2016.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashmi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dibaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altartir, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boateng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Reoperations following robot-assisted radical cystectomy: A decade of experience</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">1368</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2015.10.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.juro.2015.10.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=26551296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC28vgt1equw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2016&pages=1368-1376&author=A.+A.+Husseinauthor=Z.+Hashmiauthor=S.+Dibajauthor=T.+Altartirauthor=T.+Fioricaauthor=J.+Wingauthor=M.+Durraniauthor=J.+Binkowskiauthor=L.+Boatengauthor=G.+Wildingauthor=K.+A.+Guru&title=Reoperations+following+robot-assisted+radical+cystectomy%3A+A+decade+of+experience&doi=10.1016%2Fj.juro.2015.10.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reoperations following Robot-Assisted Radical Cystectomy: A Decade of Experience</span></div><div class="casAuthors">Hussein Ahmed A; Hashmi Zishan; Dibaj Seyedeh; Altartir Tareq; Fiorica Thomas; Wing Joseph; Durrani Mohammad; Binkowski John; Boateng Lesley; Wilding Gregory; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1368-1376</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  There is a paucity of data regarding the operative management of complications after robot-assisted radical cystectomy.  We reviewed operative management of robot-assisted radical cystectomy specific complications during our 10-year experience with this procedure and assessed the feasibility, safety and outcomes of robot-assisted reoperations.  MATERIALS AND METHODS:  We retrospectively reviewed the records of all patients who underwent surgical interventions for robot-assisted radical cystectomy specific complications between 2005 and 2015.  Univariable and multivariable logistic regression models were fit to evaluate predictors of surgical intervention after robot-assisted radical cystectomy.  Kaplan-Meier curves were used to describe time to surgical interventions.  RESULTS:  A total of 92 patients (23%) underwent surgical intervention after robot-assisted radical cystectomy.  Mean followup was 27 months.  Average time to any surgical intervention after cystectomy was 14 months.  The reoperation rate was 5%, 2% and 16% at 30, 31 to 90 and greater than 90 days, respectively.  Using the Kaplan-Meier method surgical interventions occurred at a rate of 30% at 2 years and 46% at 5 years.  Interventions for ureteroileal complications were the most common (48 cases) followed by interventions for bowel obstruction, fistulas and abdominal wall related complications (11 cases).  Clavien 3 or greater complications and neoadjuvant chemotherapy were associated with surgical intervention.  CONCLUSIONS:  Even in experienced hands the long-term complications of robot-assisted radical cystectomy are notable.  Of our patients 23% required surgical interventions after the procedure.  Our initial experience with robot-assisted management of robot-assisted radical cystectomy complications appears safe and feasible, although the decision to proceed is determined primarily by surgeon experience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe_4IC_iyrYXthwrmtH4OBfW6udTcc2eaSz1ADW7aR8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vgt1equw%253D%253D&md5=bfa6613c8d7dfe552ac9baa20bc38756</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2015.10.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2015.10.171%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DA.%2BA.%26aulast%3DHashmi%26aufirst%3DZ.%26aulast%3DDibaj%26aufirst%3DS.%26aulast%3DAltartir%26aufirst%3DT.%26aulast%3DFiorica%26aufirst%3DT.%26aulast%3DWing%26aufirst%3DJ.%26aulast%3DDurrani%26aufirst%3DM.%26aulast%3DBinkowski%26aufirst%3DJ.%26aulast%3DBoateng%26aufirst%3DL.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DReoperations%2520following%2520robot-assisted%2520radical%2520cystectomy%253A%2520A%2520decade%2520of%2520experience%26jtitle%3DJ.%2520Urol.%26date%3D2016%26volume%3D195%26spage%3D1368%26epage%3D1376%26doi%3D10.1016%2Fj.juro.2015.10.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annerstedt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motttrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, B.</span></span> <span> </span><span class="NLM_article-title">Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy</span>. <i>Eur. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1016/j.eururo.2014.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.eururo.2014.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25560798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2MvjslWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=376-401&author=G.+Novaraauthor=J.+W.+Cattoauthor=T.+Wilsonauthor=M.+Annerstedtauthor=K.+Chanauthor=D.+G.+Murphyauthor=A.+Motttrieauthor=J.+O.+Peabodyauthor=E.+C.+Skinnerauthor=P.+N.+Wiklundauthor=K.+A.+Guruauthor=B.+Yuh&title=Systematic+review+and+cumulative+analysis+of+perioperative+outcomes+and+complications+after+robot-assisted+radical+cystectomy&doi=10.1016%2Fj.eururo.2014.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy</span></div><div class="casAuthors">Novara Giacomo; Catto James W F; Wilson Timothy; Chan Kevin; Yuh Bertram; Annerstedt Magnus; Murphy Declan G; Motttrie Alexander; Peabody James O; Skinner Eila C; Wiklund Peter N; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-401</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  Although open radical cystectomy (ORC) is still the standard approach, laparoscopic radical cystectomy (LRC) and robot-assisted radical cystectomy (RARC) have gained popularity.  OBJECTIVE:  To report a systematic literature review and cumulative analysis of perioperative outcomes and complications of RARC in comparison with ORC and LRC.  EVIDENCE ACQUISITION:  Medline, Scopus, and Web of Science databases were searched using a free-text protocol including the terms robot-assisted radical cystectomy or da Vinci radical cystectomy or robot* radical cystectomy.  RARC case series and studies comparing RARC with either ORC or LRC were collected.  Cumulative analysis was conducted.  EVIDENCE SYNTHESIS:  The searches retrieved 105 papers.  According to the different diversion type, overall mean operative time ranged from 360 to 420 min.  Similarly, mean blood loss ranged from 260 to 480 ml.  Mean in-hospital stay was about 9 d for all diversion types, with consistently high readmission rates.  In series reporting on RARC with either extracorporeal or intracorporeal conduit diversion, overall 90-d complication rates were 59% (high-grade complication: 15%).  In series reporting RARC with intracorporeal continent diversion, the overall 30-d complication rate was 45.7% (high-grade complication: 28%).  Reported mortality rates were ≤3% for all diversion types.  Comparing RARC and ORC, cumulative analyses demonstrated shorter operative time for ORC, whereas blood loss and in-hospital stay were better with RARC (all p values <0.003).  Moreover, 90-d complication rates of any-grade and 90-d grade 3 complication rates were lower for RARC (all p values <0.04), whereas high-grade complication and mortality rates were similar.  CONCLUSIONS:  RARC can be performed safely with acceptable perioperative outcome, although complications are common.  Cumulative analyses demonstrated that operative time was shorter with ORC, whereas RARC may provide some advantages in terms of blood loss and transfusion rates and, more limitedly, for postoperative complication rates over ORC and LRC.  PATIENT SUMMARY:  Although open radical cystectomy (RC) is still regarded as a standard treatment for muscle-invasive bladder cancer, laparoscopic and robot-assisted RC are becoming more popular.  Robotic RC can be safely performed with acceptably low risk of blood loss, transfusion, and intraoperative complications; however, as for open RC, the risk of postoperative complications is high, including a substantial risk of major complication and reoperation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRNsitfnFYflUIs6wFK5xJfW6udTcc2ea6-VsWHK7WVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvjslWlsA%253D%253D&md5=9d07eded21f33c84d2c6d015d205c9fe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2014.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2014.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DNovara%26aufirst%3DG.%26aulast%3DCatto%26aufirst%3DJ.%2BW.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DAnnerstedt%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DD.%2BG.%26aulast%3DMotttrie%26aufirst%3DA.%26aulast%3DPeabody%26aufirst%3DJ.%2BO.%26aulast%3DSkinner%26aufirst%3DE.%2BC.%26aulast%3DWiklund%26aufirst%3DP.%2BN.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26aulast%3DYuh%26aufirst%3DB.%26atitle%3DSystematic%2520review%2520and%2520cumulative%2520analysis%2520of%2520perioperative%2520outcomes%2520and%2520complications%2520after%2520robot-assisted%2520radical%2520cystectomy%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D67%26spage%3D376%26epage%3D401%26doi%3D10.1016%2Fj.eururo.2014.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherr, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Daghmin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dibaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richstone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaouk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rha, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium</span>. <i>Eur. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1016/j.eururo.2015.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.eururo.2015.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25985883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2MfltVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=721-728&author=S.+J.+Razaauthor=T.+Wilsonauthor=J.+O.+Peabodyauthor=P.+Wiklundauthor=D.+S.+Scherrauthor=A.+Al-Daghminauthor=S.+Dibajauthor=M.+S.+Khanauthor=P.+Dasguptaauthor=A.+Mottrieauthor=M.+Menonauthor=B.+Yuhauthor=L.+Richstoneauthor=M.+Saarauthor=M.+Stoeckleauthor=A.+Hosseiniauthor=J.+Kaoukauthor=J.+L.+Mohlerauthor=K.+H.+Rhaauthor=G.+Wildingauthor=K.+A.+Guru&title=Long-term+oncologic+outcomes+following+robot-assisted+radical+cystectomy%3A+results+from+the+International+Robotic+Cystectomy+Consortium&doi=10.1016%2Fj.eururo.2015.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium</span></div><div class="casAuthors">Raza Syed Johar; Al-Daghmin Ali; Dibaj Shiva; Mohler James L; Wilding Gregory; Wilson Timothy; Yuh Bertram; Peabody James O; Menon Mani; Wiklund Peter; Hosseini Abolfazl; Scherr Douglas S; Khan Muhammad Shamim; Dasgupta Prokar; Mottrie Alex; Richstone Lee; Saar Matthias; Stoeckle Michael; Kaouk Jihad; Rha Koon-Ho; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Long-term oncologic data on patients undergoing robot-assisted radical cystectomy (RARC) are limited and based largely on single-institution series.  OBJECTIVE:  Report survival outcomes of patients who underwent RARC ≥5 yr ago.  DESIGN, SETTING, AND PARTICIPANTS:  Retrospective review of the prospectively populated International Robotic Cystectomy Consortium multi-institutional database identified 743 patients with RARC performed ≥5 yr ago.  Clinical, pathologic, and survival data at the latest follow-up were collected.  Patients with palliative RARC were excluded.  Final analysis was performed on 702 patients from 11 institutions in 6 countries.  INTERVENTION:  RARC.  OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:  Outcomes of interest, recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were plotted using Kaplan-Meier survival curves.  A Cox proportional hazards model was used to identify factors that predicted outcomes.  RESULTS AND LIMITATIONS:  Pathologic organ-confined (OC) disease was found in 62% of patients.  Soft tissue surgical margins (SMs) were positive in 8%.  Median lymph node (LN) yield was 16, and 21% of patients had positive LNs.  Median follow-up was 67 mo (interquartile range: 18-84 mo).  Five-year RFS, CSS, and OS were 67%, 75%, and 50%, respectively.  Non-OC disease and SMs were associated with poorer RFS, CSS, and OS on multivariable analysis.  Age predicted poorer CSS and OS.  Adjuvant chemotherapy and positive SMs were predictors of RFS (hazard ratio: 3.20 and 2.16; p<0.001 and p<0.005, respectively).  Stratified survival curves demonstrated poorer outcomes for positive SM, LN, and non-OC disease.  Retrospective interrogation and lack of contemporaneous comparison groups that underwent open radical cystectomy were major limitations.  CONCLUSIONS:  The largest multi-institutional series to date reported long-term survival outcomes after RARC.  PATIENT SUMMARY:  Patients who underwent robot-assisted radical cystectomy for bladder cancer have acceptable long-term survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRL3xc9kwqF8VUIs6wFK5xJfW6udTcc2ea6-VsWHK7WVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfltVSqsg%253D%253D&md5=a8fd9b09fd080f175ccafb1a00181c2e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2015.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2015.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DRaza%26aufirst%3DS.%2BJ.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DPeabody%26aufirst%3DJ.%2BO.%26aulast%3DWiklund%26aufirst%3DP.%26aulast%3DScherr%26aufirst%3DD.%2BS.%26aulast%3DAl-Daghmin%26aufirst%3DA.%26aulast%3DDibaj%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DDasgupta%26aufirst%3DP.%26aulast%3DMottrie%26aufirst%3DA.%26aulast%3DMenon%26aufirst%3DM.%26aulast%3DYuh%26aufirst%3DB.%26aulast%3DRichstone%26aufirst%3DL.%26aulast%3DSaar%26aufirst%3DM.%26aulast%3DStoeckle%26aufirst%3DM.%26aulast%3DHosseini%26aufirst%3DA.%26aulast%3DKaouk%26aufirst%3DJ.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DRha%26aufirst%3DK.%2BH.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DLong-term%2520oncologic%2520outcomes%2520following%2520robot-assisted%2520radical%2520cystectomy%253A%2520results%2520from%2520the%2520International%2520Robotic%2520Cystectomy%2520Consortium%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D68%26spage%3D721%26epage%3D728%26doi%3D10.1016%2Fj.eururo.2015.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annerstedt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montorsi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redorta, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenzl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, J.</span></span> <span> </span><span class="NLM_article-title">Pasadena Consensus Panel. Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consenus Panel</span>. <i>Eur. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1016/j.eururo.2014.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.eururo.2014.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25582930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2MvmtVSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=363-375&author=T.+G.+Wilsonauthor=K.+Guruauthor=R.+C.+Rosenauthor=P.+Wiklundauthor=M.+Annerstedtauthor=B.+H.+Bochnerauthor=K.+G.+Chanauthor=F.+Montorsiauthor=A.+Mottrieauthor=D.+Murphyauthor=G.+Novaraauthor=J.+O.+Peabodyauthor=J.+P.+Redortaauthor=E.+C.+Skinnerauthor=G.+Thalmannauthor=A.+Stenzlauthor=B.+Yuhauthor=J.+Catto&title=Pasadena+Consensus+Panel.+Best+practices+in+robot-assisted+radical+cystectomy+and+urinary+reconstruction%3A+recommendations+of+the+Pasadena+Consenus+Panel&doi=10.1016%2Fj.eururo.2014.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel</span></div><div class="casAuthors">Wilson Timothy G; Guru Khurshid; Rosen Raymond C; Wiklund Peter; Annerstedt Magnus; Bochner Bernard H; Chan Kevin G; Yuh Bertram; Montorsi Francesco; Mottrie Alexandre; Murphy Declan; Novara Giacomo; Peabody James O; Palou Redorta Joan; Skinner Eila C; Thalmann George; Stenzl Arnulf; Catto James</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  Robot-assisted surgery is increasingly used for radical cystectomy (RC) and urinary reconstruction.  Sufficient data have accumulated to allow evidence-based consensus on key issues such as perioperative management, comparative effectiveness on surgical complications, and oncologic short- to midterm outcomes.  OBJECTIVE:  A 2-d conference of experts on RC and urinary reconstruction was organized in Pasadena, California, and the City of Hope Cancer Center in Duarte, California, to systematically review existing peer-reviewed literature on robot-assisted RC (RARC), extended lymphadenectomy, and urinary reconstruction.  No commercial support was obtained for the conference.  EVIDENCE ACQUISITION:  A systematic review of the literature was performed in agreement with the PRISMA statement.  EVIDENCE SYNTHESIS:  Systematic literature reviews and individual presentations were discussed, and consensus on all key issues was obtained.  Most operative, intermediate-term oncologic, functional, and complication outcomes are similar between open RC (ORC) and RARC.  RARC consistently results in less blood loss and a reduced need for transfusion during surgery.  RARC generally requires longer operative time than ORC, particularly with intracorporeal reconstruction.  Robotic assistance provides ergonomic value for surgeons.  Surgeon experience and institutional volume strongly predict favorable outcomes for either open or robotic techniques.  CONCLUSIONS:  RARC appears to be similar to ORC in terms of operative, pathologic, intermediate-term oncologic, complication, and most functional outcomes.  RARC consistently results in less blood loss and a reduced need for transfusion during surgery.  RARC can be more expensive than ORC, although high procedural volume may attenuate this difference.  PATIENT SUMMARY:  Robot-assisted radical cystectomy (RARC) is an alternative to open surgery for patients with bladder cancer who require removal of their bladder and reconstruction of their urinary tract.  RARC appears to be similar to open surgery for most important outcomes such as the rate of complications and intermediate-term cancer-specific survival.  Although RARC has some ergonomic advantages for surgeons and may result in less blood loss during surgery, it is more time consuming and may be more expensive than open surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLXSlQSB8SfpggzHGM8X5CfW6udTcc2ebtCjsTNl2OiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvmtVSkug%253D%253D&md5=10dc9a6d36fab4707a3c945273acaad8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2014.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2014.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BG.%26aulast%3DGuru%26aufirst%3DK.%26aulast%3DRosen%26aufirst%3DR.%2BC.%26aulast%3DWiklund%26aufirst%3DP.%26aulast%3DAnnerstedt%26aufirst%3DM.%26aulast%3DBochner%26aufirst%3DB.%2BH.%26aulast%3DChan%26aufirst%3DK.%2BG.%26aulast%3DMontorsi%26aufirst%3DF.%26aulast%3DMottrie%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DNovara%26aufirst%3DG.%26aulast%3DPeabody%26aufirst%3DJ.%2BO.%26aulast%3DRedorta%26aufirst%3DJ.%2BP.%26aulast%3DSkinner%26aufirst%3DE.%2BC.%26aulast%3DThalmann%26aufirst%3DG.%26aulast%3DStenzl%26aufirst%3DA.%26aulast%3DYuh%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DJ.%26atitle%3DPasadena%2520Consensus%2520Panel.%2520Best%2520practices%2520in%2520robot-assisted%2520radical%2520cystectomy%2520and%2520urinary%2520reconstruction%253A%2520recommendations%2520of%2520the%2520Pasadena%2520Consenus%2520Panel%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D67%26spage%3D363%26epage%3D375%26doi%3D10.1016%2Fj.eururo.2014.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, E. R.</span></span> <span> </span><span class="NLM_article-title">EGF receptor trafficking: consequences for signaling and cancer</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2013.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.tcb.2013.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=24295852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2gt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=26-34&author=A.+Tomasauthor=C.+E.+Futterauthor=E.+R.+Eden&title=EGF+receptor+trafficking%3A+consequences+for+signaling+and+cancer&doi=10.1016%2Fj.tcb.2013.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">EGF receptor trafficking: consequences for signaling and cancer</span></div><div class="casAuthors">Tomas, Alejandra; Futter, Clare E.; Eden, Emily R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-34</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ligand-stimulated epidermal growth factor receptor (EGFR) has been extensively studied in the anal. of mol. mechanisms regulating endocytic traffic and the role of that traffic in signal transduction.  Although such studies have largely focused on mitogenic signaling and dysregulated traffic in tumorigenesis, there is growing interest in the potential role of EGFR traffic in cell survival and the consequent response to cancer therapy.  Here we review recent advances in our understanding of mol. mechanisms regulating ligand-stimulated EGFR activation, internalization, and post-endocytic sorting.  The role of EGFR overexpression/mutation and new modulators of EGFR traffic in cancer and the response to cancer therapeutics are also discussed.  Finally, we speculate on the relationship between EGFR traffic and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLWxypVYs-bVg90H21EOLACvtfcHk0ljRzTxq8GHK5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2gt7zP&md5=850921a0c652f9401704f4152db482a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2013.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2013.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DTomas%26aufirst%3DA.%26aulast%3DFutter%26aufirst%3DC.%2BE.%26aulast%3DEden%26aufirst%3DE.%2BR.%26atitle%3DEGF%2520receptor%2520trafficking%253A%2520consequences%2520for%2520signaling%2520and%2520cancer%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26spage%3D26%26epage%3D34%26doi%3D10.1016%2Fj.tcb.2013.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yewale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baradia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vhora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, A.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor targeting in cancer: A review of trends and strategies</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">8690</span>– <span class="NLM_lpage">8707</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.07.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.biomaterials.2013.07.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23953842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=8690-8707&author=C.+Yewaleauthor=D.+Baradiaauthor=I.+Vhoraauthor=S.+Patilauthor=A.+Misra&title=Epidermal+growth+factor+receptor+targeting+in+cancer%3A+A+review+of+trends+and+strategies&doi=10.1016%2Fj.biomaterials.2013.07.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor targeting in cancer: A review of trends and strategies</span></div><div class="casAuthors">Yewale, Chetan; Baradia, Dipesh; Vhora, Imran; Patil, Sushilkumar; Misra, Ambikanandan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">8690-8707</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The epidermal growth factor receptor (EGFR) is a cell-surface receptor belonging to ErbB family of tyrosine kinase and it plays a vital role in the regulation of cell proliferation, survival and differentiation.  However; EGFR is aberrantly activated by various mechanisms like receptor overexpression, mutation, ligand-dependent receptor dimerization, ligand-independent activation and is assocd. with development of variety of tumors.  Therefore, specific EGFR inhibition is one of the key targets for cancer therapy.  Two major approaches have been developed and demonstrated benefits in clin. trials for targeting EGFR; monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs).  EGFR inhibitors like, cetuximab, panitumumab, etc. (mAbs) and gefitinib, erlotinib, lapatinib, etc. (TKIs) are now com. available for treatment of variety of cancers.  Recently, many other agents like peptides, nanobodies, affibodies and antisense oligonucleotide have also shown better efficacy in targeting and inhibiting EGFR.  Now a days, efforts are being focused to identify mol. markers that can predict patients more likely to respond to anti-EGFR therapy; to find out combinatorial approaches with EGFR inhibitors and to bring new therapeutic agents with clin. efficacy.  In this review we have outlined the role of EGFR in cancer, different types of EGFR inhibitors, preclin. and clin. status of EGFR inhibitors as well as summarized the recent efforts made in the field of mol. EGFR targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP89tYD6VDorVg90H21EOLACvtfcHk0ljRzTxq8GHK5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL&md5=e7ca806ebdfe6a6f48962cf3c8620468</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.07.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.07.100%26sid%3Dliteratum%253Aachs%26aulast%3DYewale%26aufirst%3DC.%26aulast%3DBaradia%26aufirst%3DD.%26aulast%3DVhora%26aufirst%3DI.%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520targeting%2520in%2520cancer%253A%2520A%2520review%2520of%2520trends%2520and%2520strategies%26jtitle%3DBiomaterials%26date%3D2013%26volume%3D34%26spage%3D8690%26epage%3D8707%26doi%3D10.1016%2Fj.biomaterials.2013.07.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vourganti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apolo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metwalli, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the epidermal growth factor receptor in bladder cancer</span>. <i>J. Carcinog. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>04</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2518</span>, <span class="refDoi"> DOI: 10.4172/2157-2518.1000143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.4172%2F2157-2518.1000143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=04&publication_year=2013&pages=2157-2518&author=M.+D.+Weintraubauthor=S.+Vourgantiauthor=Q.+Liauthor=A.+B.+Apoloauthor=A.+R.+Metwalliauthor=P.+K.+Agarwal&title=Targeting+the+epidermal+growth+factor+receptor+in+bladder+cancer&doi=10.4172%2F2157-2518.1000143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4172%2F2157-2518.1000143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2157-2518.1000143%26sid%3Dliteratum%253Aachs%26aulast%3DWeintraub%26aufirst%3DM.%2BD.%26aulast%3DVourganti%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DApolo%26aufirst%3DA.%2BB.%26aulast%3DMetwalli%26aufirst%3DA.%2BR.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26atitle%3DTargeting%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520in%2520bladder%2520cancer%26jtitle%3DJ.%2520Carcinog.%2520Mutagen.%26date%3D2013%26volume%3D04%26spage%3D2157%26epage%3D2518%26doi%3D10.4172%2F2157-2518.1000143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span> <span> </span><span class="NLM_article-title">Monoclonal antibodies targeting the epidermal growth factor receptor</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.2174/1389450053765842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.2174%2F1389450053765842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=15857288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlansb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=275-287&author=R.+Biancoauthor=G.+Danieleauthor=F.+Ciardielloauthor=G.+Tortora&title=Monoclonal+antibodies+targeting+the+epidermal+growth+factor+receptor&doi=10.2174%2F1389450053765842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies targeting the epidermal growth factor receptor</span></div><div class="casAuthors">Bianco, R.; Daniele, G.; Ciardiello, F.; Tortora, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-287</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The epidermal growth factor receptor (EGFR, HER1) autocrine pathway contributes to a no. of highly relevant processes in cancer development and progression, including cell proliferation, regulation of apoptotic cell death, angiogenesis and metastatic spread.  The crucial role that EGFR plays in human cancers has led to an extensive search for selective inhibitors of its signaling pathway.  The results of a large body of preclin. studies and clin. trials thus far conducted suggest that targeting the EGFR could bring a significant contribution to cancer therapy.  A variety of different approaches are currently being used to target the EGFR.  The most promising strategies in clin. development include monoclonal antibodies, to prevent ligand binding, and small mols. inhibitors of the tyrosine kinase enzymic activity, that inhibit autophosphorylation and downstream intracellular signaling.  Several blocking monoclonal antibodies against the EGFR have been developed.  Among these, IMC-225 is a chimeric human-mouse monoclonal IgG1 antibody that has been the first anti-EGFR targeted therapy to enter clin. evaluation in cancer patients in Phase II and III studies, alone or in combination with conventional radiotherapy and chemotherapy.  However, other antibodies against EGFR have demonstrated antitumor activity in several preclin. models of human cancer and are currently under investigation in the clin. setting, such as ICR62, ABX-EGF and EMD72000.  This review will focus on all the preclin. data available on monoclonal antibodies engineered against the EGF receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogab5NnAS547Vg90H21EOLACvtfcHk0liY4I1VGqazfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlansb0%253D&md5=8f85552acb124d817863a3e0b0b3b0dc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1389450053765842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450053765842%26sid%3Dliteratum%253Aachs%26aulast%3DBianco%26aufirst%3DR.%26aulast%3DDaniele%26aufirst%3DG.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DTortora%26aufirst%3DG.%26atitle%3DMonoclonal%2520antibodies%2520targeting%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2005%26volume%3D6%26spage%3D275%26epage%3D287%26doi%3D10.2174%2F1389450053765842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartore-Bianchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichelatti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolantonio, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dosso, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzucchelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frattini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span> <span> </span><span class="NLM_article-title">PIK3CA mutations in colorectal cancer associated with clinical resistance to EGFR-targeted monoclonal antibodies</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1851</span>– <span class="NLM_lpage">1857</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-2466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1158%2F0008-5472.CAN-08-2466" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=1851-1857&author=A.+Sartore-Bianchiauthor=M.+Martiniauthor=F.+Molinariauthor=S.+Veroneseauthor=M.+Nichelattiauthor=S.+Artaleauthor=F.+D.+Nicolantonioauthor=P.+Salettiauthor=S.+D.+Dossoauthor=L.+Mazzucchelliauthor=M.+Frattiniauthor=S.+Sienaauthor=A.+Bardelli&title=PIK3CA+mutations+in+colorectal+cancer+associated+with+clinical+resistance+to+EGFR-targeted+monoclonal+antibodies&doi=10.1158%2F0008-5472.CAN-08-2466"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2466%26sid%3Dliteratum%253Aachs%26aulast%3DSartore-Bianchi%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DF.%26aulast%3DVeronese%26aufirst%3DS.%26aulast%3DNichelatti%26aufirst%3DM.%26aulast%3DArtale%26aufirst%3DS.%26aulast%3DNicolantonio%26aufirst%3DF.%2BD.%26aulast%3DSaletti%26aufirst%3DP.%26aulast%3DDosso%26aufirst%3DS.%2BD.%26aulast%3DMazzucchelli%26aufirst%3DL.%26aulast%3DFrattini%26aufirst%3DM.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DPIK3CA%2520mutations%2520in%2520colorectal%2520cancer%2520associated%2520with%2520clinical%2520resistance%2520to%2520EGFR-targeted%2520monoclonal%2520antibodies%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D1851%26epage%3D1857%26doi%3D10.1158%2F0008-5472.CAN-08-2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janmaat, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span> <span> </span><span class="NLM_article-title">Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.8-6-576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1634%2Ftheoncologist.8-6-576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=14657536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSqs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=576-586&author=M.+L.+Janmaatauthor=G.+Giaccone&title=Small-molecule+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitors&doi=10.1634%2Ftheoncologist.8-6-576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">small-molecule epidermal growth factor receptor tyrosine kinase inhibitors</span></div><div class="casAuthors">Janmaat, Maarten L.; Giaccone, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576-586</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  The growth and proliferation of cells are usually tightly regulated processes that are activated by stimuli from their environment.  Epidermal growth factor (EGF)-related peptides represent a class of mols. that can trigger cell proliferation, among several cellular processes, such as differentiation, migration, and survival.  Binding of EGF-like peptides to the EGF receptor (EGFR) at the cell surface leads to a cascade of intracellular reactions that transduce signals to the nucleus, resulting in particular gene expression patterns.  However, in many tumor cells, the regulation of EGFR activity is lost, due to increased or aberrant expression of the receptor or its ligands, and this contributes to many processes important for tumor growth, including cell proliferation, survival, angiogenesis, invasion, and metastasis.  Many strategies have been developed that specifically target the EGFR and inhibit its activity.  Of these, small-mol. tyrosine kinase inhibitors represent one of the most promising classes of anticancer agents.  Here, we describe the status of small-mol. EGFR tyrosine kinase inhibitors in preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQzJhkHxRx57Vg90H21EOLACvtfcHk0liY4I1VGqazfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSqs7rJ&md5=3ea6c899e55d7997d24d994fc83f3013</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.8-6-576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.8-6-576%26sid%3Dliteratum%253Aachs%26aulast%3DJanmaat%26aufirst%3DM.%2BL.%26aulast%3DGiaccone%26aufirst%3DG.%26atitle%3DSmall-molecule%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DOncologist%26date%3D2003%26volume%3D8%26spage%3D576%26epage%3D586%26doi%3D10.1634%2Ftheoncologist.8-6-576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blayney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Pheophorbide-a is a specific probe for ABCG2 function and inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1242</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1158%2F0008-5472.CAN-03-3298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1242-1246&author=R.+W.+Robeyauthor=K.+Steadmanauthor=O.+Polgarauthor=K.+Morisakiauthor=M.+Blayneyauthor=P.+Mistryauthor=S.+E.+Bates&title=Pheophorbide-a+is+a+specific+probe+for+ABCG2+function+and+inhibition&doi=10.1158%2F0008-5472.CAN-03-3298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-3298%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DSteadman%26aufirst%3DK.%26aulast%3DPolgar%26aufirst%3DO.%26aulast%3DMorisaki%26aufirst%3DK.%26aulast%3DBlayney%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DPheophorbide-a%2520is%2520a%2520specific%2520probe%2520for%2520ABCG2%2520function%2520and%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1242%26epage%3D1246%26doi%3D10.1158%2F0008-5472.CAN-03-3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span> <span> </span><span class="NLM_article-title">The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy in inhibiting ABCG2</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2463</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-1599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1158%2F1078-0432.CCR-06-1599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=17438106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1enu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2463-2470&author=W.+Liuauthor=M.+R.+Baerauthor=M.+J.+Bowmanauthor=P.+Peraauthor=X.+Zhengauthor=J.+Morganauthor=R.+K.+Pandeyauthor=A.+R.+Oseroff&title=The+tyrosine+kinase+inhibitor+imatinib+mesylate+enhances+the+efficacy+of+photodynamic+therapy+in+inhibiting+ABCG2&doi=10.1158%2F1078-0432.CCR-06-1599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2</span></div><div class="casAuthors">Liu, Weiguo; Baer, Maria R.; Bowman, Mary Jo; Pera, Paula; Zheng, Xiang; Morgan, Janet; Pandey, Ravindra A.; Oseroff, Allan R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2463-2470</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The ATP-binding cassette protein ABCG2 (breast cancer resistance protein) effluxes some of the photosensitizers used in photodynamic therapy (PDT) and, thus, may confer resistance to this treatment modality.  Tyrosine kinase inhibitors (TKI) can block the function of ABCG2.  Therefore, we tested the effects of the TKI imatinib mesylate (Gleevec) on photosensitizer accumulation and in vitro and in vivo PDT efficacy.  Exptl. Design: Energy-dependent photosensitizer efflux and imatinib mesylate's effects on intracellular accumulation of clin. used second- and first-generation photosensitizers were studied by flow cytometry in murine and human cells with and without ABCG2 expression.  Effects of ABCG2 inhibition on PDT were examd. in vitro using cell viability assays and in vivo measuring photosensitizer accumulation and time to regrowth in a RIF-1 tumor model.  RESULTS: Energy-dependent efflux of 2-(1-hexyloxethyl)-2-devinyl pyropheophorbide-a (HPPH, Photochlor), endogenous protoporphyrin IX (PpIX) synthesized from 5-aminolevulenic acid, and the benzoporphyrin deriv. monoacid ring A (BPD-MA, Verteporfin) was shown in ABCG2+ cell lines, but the first-generation multimeric photosensitizer porfimer sodium (Photofrin) and a novel deriv. of HPPH conjugated to galactose were minimally transported.  Imatinib mesylate increased accumulation of HPPH, PpIX, and BPD-MA from 1.3- to 6-fold in ABCG2+ cells, but not in ABCG2- cells, and enhanced PDT efficacy both in vitro and in vivo.  CONCLUSIONS: Second-generation clin. photosensitizers are transported out of cells by ABCG2, and this effect can be abrogated by coadministration of imatinib mesylate.  By increasing intracellular photosensitizer levels in ABCG2+ tumors, imatinib mesylate or other ABCG2 transport inhibitors may enhance efficacy and selectivity of clin. PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFAA8XTpfO_bVg90H21EOLACvtfcHk0liY4I1VGqazfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1enu7c%253D&md5=b9f644cc459248c414ba29aeb0b82ac8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1599%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26atitle%3DThe%2520tyrosine%2520kinase%2520inhibitor%2520imatinib%2520mesylate%2520enhances%2520the%2520efficacy%2520of%2520photodynamic%2520therapy%2520in%2520inhibiting%2520ABCG2%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D2463%26epage%3D2470%26doi%3D10.1158%2F1078-0432.CCR-06-1599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Substrate affinity of photosensitizers derived from chlorophyll-<i>a</i>: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/mp100154j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100154j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1789-1804&author=J.+Morganauthor=J.+D.+Jacksonauthor=X.+Zhengauthor=S.+K.+Pandeyauthor=R.+K.+Pandey&title=Substrate+affinity+of+photosensitizers+derived+from+chlorophyll-a%3A+The+ABCG2+transporter+affects+the+phototoxic+response+of+side+population+stem+cell-like+cancer+cells+to+photodynamic+therapy&doi=10.1021%2Fmp100154j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Affinity of Photosensitizers Derived from Chlorophyll-a: The ABCG2 Transporter Affects the Phototoxic Response of Side Population Stem Cell-like Cancer Cells to Photodynamic Therapy</span></div><div class="casAuthors">Morgan, Janet; Jackson, Jennifer D.; Zheng, Xiang; Pandey, Suresh K.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1804</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photosensitizers (PS) synthesized with the aim of optimizing photodynamic therapy (PDT) of tumors do not always fulfill their potential when tested in vitro and in vivo in different tumor models.  The ATP-dependent transporter ABCG2, a multidrug resistant pump expressed at variable levels in cancerous cells, can bind and efflux a wide range of structurally different classes of compds. including several PS used preclinically and clin. such as porphyrins and chlorins.  ABCG2 may lower intracellular levels of substrate PS below the threshold for cell death in tumors treated by PDT, leaving resistant cells to repopulate the tumor.  To det. some of the structural factors that affect substrate affinity of PS for ABCG2, we used an ABCG2-expressing cell line (HEK 293 482R) and its nonexpressing counterpart, and tyrosine kinase ABCG2 inhibitors in a simple flow cytometric assay to identify PS effluxed by the ABCG2 pump.  We tested a series of conjugates of substrate PS with different groups attached at different positions on the tetrapyrrole macrocycle to examine whether a change in affinity for the pump occurred and whether such changes depended on the position or the structure/type of the attached group.  PS without substitutions including pyropheophorbides and purpurinimides were generally substrates for ABCG2, but carbohydrate groups conjugated at positions 8, 12, 13, and 17 but not at position 3 abrogated ABCG2 affinity regardless of structure or linking moiety.  At position 3, affinity was retained with the addn. of iodobenzene, alkyl chains and monosaccharides, but not with disaccharides.  This suggests that structural characteristics at position 3 may offer important contributions to requirements for binding to ABCG2.  We examd. several tumor cell lines for ABCG2 activity, and found that although some cell lines had negligible ABCG2 activity in bulk, they contained a small ABCG2-expressing side population (SP) thought to contain cells which are responsible for initiating tumor regrowth.  We examd. the relevance of the SP to PDT resistance with ABCG2 substrates in vitro and in vivo in the murine mammary tumor 4T1.  We show for the first time in vivo that the substrate PS HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a) but not the nonsubstrate PS HPPH-Gal (a galactose conjugate of HPPH) selectively preserved the SP which was primarily responsible for regrowth in vitro.  The SP could be targeted by addn. of imatinib mesylate, a tyrosine kinase inhibitor which inhibits the ATPase activity of ABCG2, and prevents efflux of substrates.  A PDT resistant SP may be responsible for recurrences obsd. both preclinically and clin.  To prevent ABCG2 mediated resistance, choosing nonsubstrate PS or administering an ABCG2 inhibitor alongside a substrate PS might be advantageous when treating ABCG2-expressing tumors with PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSGTD8kwyhrVg90H21EOLACvtfcHk0li_StPACk2aqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM&md5=668a1009391c86ad4b55abd75c67e7ff</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fmp100154j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100154j%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DJ.%2BD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DSubstrate%2520affinity%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%253A%2520The%2520ABCG2%2520transporter%2520affects%2520the%2520phototoxic%2520response%2520of%2520side%2520population%2520stem%2520cell-like%2520cancer%2520cells%2520to%2520photodynamic%2520therapy%26jtitle%3DMol.%2520Pharm.%26date%3D2010%26volume%3D7%26spage%3D1789%26epage%3D1804%26doi%3D10.1021%2Fmp100154j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spring, B. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span> <span> </span><span class="NLM_article-title">The role of photodynamic therapy in overcoming cancer drug resistance</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1476</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1039/C4PP00495G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2FC4PP00495G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25856800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=1476-1491&author=B.+Q.+Springauthor=I.+Rizviauthor=N.+Xuauthor=T.+Hasan&title=The+role+of+photodynamic+therapy+in+overcoming+cancer+drug+resistance&doi=10.1039%2FC4PP00495G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The role of photodynamic therapy in overcoming cancer drug resistance</span></div><div class="casAuthors">Spring, Bryan Q.; Rizvi, Imran; Xu, Nan; Hasan, Tayyaba</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1476-1491</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Many modalities of cancer therapy induce mechanisms of treatment resistance and escape pathways during chronic treatments, including photodynamic therapy (PDT).  It is conceivable that resistance induced by one treatment might be overcome by another treatment.  Emerging evidence suggests that the unique mechanisms of tumor cell and microenvironment damage produced by PDT could be utilized to overcome cancer drug resistance, to mitigate the compensatory induction of survival pathways and even to re-sensitize resistant cells to std. therapies.  Approaches that capture the unique features of PDT, therefore, offer promising factors for increasing the efficacy of a broad range of therapeutic modalities.  Here, we highlight key preclin. findings utilizing PDT to overcome classical drug resistance or escape pathways and thus enhance the efficacy of many pharmaceuticals, possibly explaining the clin. observations of the PDT response to otherwise treatment-resistant diseases.  With the development of nanotechnol., it is possible that light activation may be used not only to damage and sensitize tumors but also to enable controlled drug release to inhibit escape pathways that may lead to resistance or cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqaooNTs325bVg90H21EOLACvtfcHk0lhbWW59jCm25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCqsrw%253D&md5=ead7f9e6cfccef2ea4705c668a59e081</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC4PP00495G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4PP00495G%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DB.%2BQ.%26aulast%3DRizvi%26aufirst%3DI.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DHasan%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520photodynamic%2520therapy%2520in%2520overcoming%2520cancer%2520drug%2520resistance%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2015%26volume%3D14%26spage%3D1476%26epage%3D1491%26doi%3D10.1039%2FC4PP00495G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagiya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurabayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furihata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, S.</span></span> <span> </span><span class="NLM_article-title">Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulenic acid (ALA)-induced tumor-specific protoporphyrin IX accumulation in bladder cancer</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1016/j.pdpdt.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.pdpdt.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23993855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlGltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=288-295&author=Y.+Hagiyaauthor=H.+Fukuharaauthor=K.+Matsumotoauthor=Y.+Endoauthor=M.+Nakajimaauthor=T.+Tanakaauthor=I.+Okuraauthor=A.+Kurabayashiauthor=M.+Furihataauthor=K.+Inoueauthor=T.+Shuinauthor=S.+Ogura&title=Expression+levels+of+PEPT1+and+ABCG2+play+key+roles+in+5-aminolevulenic+acid+%28ALA%29-induced+tumor-specific+protoporphyrin+IX+accumulation+in+bladder+cancer&doi=10.1016%2Fj.pdpdt.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer</span></div><div class="casAuthors">Hagiya, Yuichiro; Fukuhara, Hideo; Matsumoto, Kentaro; Endo, Yoshio; Nakajima, Motowo; Tanaka, Tohru; Okura, Ichiro; Kurabayashi, Atsushi; Furihata, Mutsuo; Inoue, Keiji; Shuin, Taro; Ogura, Shun-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-295</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A detection method widely used of late in cancer surgery is 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD), which relies on the tumor-specific accumulation of photosensitizing protoporphyrin IX (PpIX) after the administration of ALA.  In this regard, we recently reported that peptide transporter PEPT1 and human ATP-binding cassette transporter ABCG2 are key players in regulating intracellular PpIX levels.  In the present study, we re-evaluated in vivo the expression of genes involved in the porphyrin biosynthesis pathway.  Using quant. real-time (qRT)-PCR, we measured the mRNA levels in a clin. specimen of bladder cancer from a patient who had been subjected to ALA-PDD.We confirmed that PEPT1 and ABCG2 are major contributors to the regulation of.  We confirmed that PEPT1 and ABCG2 are major contributors to the regulation of tumor-specific PpIX accumulation.  QRT-PCR anal. revealed a predominantly high level of PEPT1 mRNA and a very low level of ABCG2 mRNA in the bladder cancer, corresponding to the roles of these genes in vitro.  These findings were further confirmed by immunohistochem. studies with PEPT1- and ABCG2-specific antibodies.  The induction of PEPT1 gene and the suppression of ABCG2 gene expression are among the key mol. mechanisms underlying tumor-specific PpIX accumulation after the administration of ALA in bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhcBz8tBp6H7Vg90H21EOLACvtfcHk0lhbWW59jCm25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlGltr4%253D&md5=7f46eb5ae350654f805595a31d78c195</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DHagiya%26aufirst%3DY.%26aulast%3DFukuhara%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DOkura%26aufirst%3DI.%26aulast%3DKurabayashi%26aufirst%3DA.%26aulast%3DFurihata%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DShuin%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DS.%26atitle%3DExpression%2520levels%2520of%2520PEPT1%2520and%2520ABCG2%2520play%2520key%2520roles%2520in%25205-aminolevulenic%2520acid%2520%2528ALA%2529-induced%2520tumor-specific%2520protoporphyrin%2520IX%2520accumulation%2520in%2520bladder%2520cancer%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2013%26volume%3D10%26spage%3D288%26epage%3D295%26doi%3D10.1016%2Fj.pdpdt.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hepburn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeratterapillay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Sherif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, H. D.</span></span> <span> </span><span class="NLM_article-title">Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e50690</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0050690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1371%2Fjournal.pone.0050690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23226356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A.+C.+Hepburnauthor=R.+Veeratterapillayauthor=S.+C.+Williamsonauthor=A.+El-Sherifauthor=N.+Sahayauthor=H.+D.+Thomas&title=Side+population+in+human+non-muscle+invasive+bladder+cancer+enriches+for+cancer+stem+cells+that+are+maintained+by+MAPK+signaling&doi=10.1371%2Fjournal.pone.0050690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling</span></div><div class="casAuthors">Hepburn, Anastasia C.; Veeratterapillay, Rajan; Williamson, Stuart C.; El-Sherif, Amira; Sahay, Neha; Thomas, Huw D.; Mantilla, Alejandra; Pickard, Robert S.; Robson, Craig N.; Heer, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e50690</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Side population (SP) and ABC transporter expression enrich for stem cells in numerous tissues.  We explored if this phenotype characterised human bladder cancer stem cells (CSCs) and attempted to identify regulatory mechanisms.  Focusing on non-muscle invasive bladder cancer (NMIBC), multiple human cell lines were used to characterize SP and ABC transporter expression.  In vitro and in vivo phenotypic and functional assessments of CSC behavior were undertaken.  Expression of putative CSC marker ABCG2 was assessed in clin. NMIBC samples (n = 148), and a role for MAPK signalling, a central mechanism of bladder tumorigenesis, was investigated.  Results showed that the ABCG2 transporter was predominantly expressed and was up-regulated in the SP fraction by 3-fold (ABCG2hi) relative to the non-SP (NSP) fraction (ABCG2low).  ABCG2hi SP cells displayed enrichment of stem cell markers (Nanog, Notch1 and SOX2) and a three-fold increase in colony forming efficiency (CFE) in comparison to ABCG2low NSP cells.  In vivo, ABCG2hi SP cells enriched for tumor growth compared with ABCG2low NSP cells, consistent with CSCs.  PERK was constitutively active in ABCG2hi SP cells and MEK inhibition also inhibited the ABCG2hi SP phenotype and significantly suppressed CFE.  Furthermore, on examg. clin. NMIBC samples, ABCG2 expression correlated with increased recurrence and decreased progression free survival.  Addnl., pERK expression also correlated with decreased progression free survival, while a pos. correlation was further demonstrated between ABCG2 and pERK expression.  In conclusion, we confirm ABCG2hi SP enriches for CSCs in human NMIBC and MAPK/ERK pathway is a suitable therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhXFmNaVX6e7Vg90H21EOLACvtfcHk0lhbWW59jCm25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqtrfN&md5=c93d2c038599d5a44c857ac2ce55d901</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0050690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0050690%26sid%3Dliteratum%253Aachs%26aulast%3DHepburn%26aufirst%3DA.%2BC.%26aulast%3DVeeratterapillay%26aufirst%3DR.%26aulast%3DWilliamson%26aufirst%3DS.%2BC.%26aulast%3DEl-Sherif%26aufirst%3DA.%26aulast%3DSahay%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26atitle%3DSide%2520population%2520in%2520human%2520non-muscle%2520invasive%2520bladder%2520cancer%2520enriches%2520for%2520cancer%2520stem%2520cells%2520that%2520are%2520maintained%2520by%2520MAPK%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0050690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, M. A.</span></span> <span> </span><span class="NLM_article-title">Treatment options in non-muscle invasive bladder cancer after BCG failure</span>. <i>Indian J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.4103/0970-1591.166475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.4103%2F0970-1591.166475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=26604442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC28rgsFOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=312-319&author=N.+A.+Brooksauthor=M.+A.+O%E2%80%99Donnell&title=Treatment+options+in+non-muscle+invasive+bladder+cancer+after+BCG+failure&doi=10.4103%2F0970-1591.166475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options in non-muscle-invasive bladder cancer after BCG failure</span></div><div class="casAuthors">Brooks Nathan A; O'Donnell Michael A</div><div class="citationInfo"><span class="NLM_cas:title">Indian journal of urology : IJU : journal of the Urological Society of India</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-9</span>
        ISSN:<span class="NLM_cas:issn">0970-1591</span>.
    </div><div class="casAbstract">Bladder cancer is the ninth-most prevalent cancer worldwide.  Most patients with urothelial cell carcinoma of the bladder present with non-muscle-invasive disease and are treated with bacillus Calmette-Guerin (BCG) intravesical therapy.  Many of these patients experience disease recurrence after BCG failure.  Radical cystectomy is the recommended treatment for high-risk patients failing BCG.  However, many patients are unfit for or unwilling to undergo this procedure.  We searched the published literature on the treatment of non-muscle-invasive bladder cancer (NMIBC) after BCG failure.  We review current evidence regarding intravesical therapy with gemcitabine, mitomycin combined with thermo-chemotherapy, docetaxel, nab-paclitaxel, photodynamic therapy (PDT), BCG with interferon (IFN), and combination sequentially administered chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRoa-Gbph8Lhcr74wzj5o5fW6udTcc2eaddq_JnJJ5j7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgsFOksg%253D%253D&md5=92b81293c28623f01e835a27cfc4bc69</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4103%2F0970-1591.166475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0970-1591.166475%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DN.%2BA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BA.%26atitle%3DTreatment%2520options%2520in%2520non-muscle%2520invasive%2520bladder%2520cancer%2520after%2520BCG%2520failure%26jtitle%3DIndian%2520J.%2520Urol.%26date%3D2015%26volume%3D31%26spage%3D312%26epage%3D319%26doi%3D10.4103%2F0970-1591.166475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azar, F. S.</span>, <span class="NLM_string-name">Intes, X.</span></span>, Eds.;  <i>Translational Multimodality Optical Imaging</i>; <span class="NLM_publisher-name">Artech House</span>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=F.+S.+Azar&author=X.+Intes&title=Translational+Multimodality+Optical+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAzar%26aufirst%3DF.%2BS.%26btitle%3DTranslational%2520Multimodality%2520Optical%2520Imaging%26pub%3DArtech%2520House%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1039/B915149B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2FB915149B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=20694259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=340-362&author=M.+Ethirajanauthor=Y.+Chenauthor=P.+Joshiauthor=R.+K.+Pandey&title=The+role+of+porphyrin+chemistry+in+tumor+imaging+and+photodynamic+therapy&doi=10.1039%2FB915149B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span></div><div class="casAuthors">Ethirajan, Manivannan; Chen, Yihui; Joshi, Penny; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">340-362</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In recent years several review articles and books have been published on the use of porphyrin-based compds. in photodynamic therapy (PDT).  This crit. review is focused on (i) the basic concept of PDT, (ii) advantages of long-wavelength absorbing photosensitizers (PS), (iii) a brief discussion on recent advances in developing PDT agents, and (iv) the various synthetic strategies designed at the Roswell Park Cancer Institute, Buffalo, for developing highly effective long-wavelength PDT agents and their utility in constructing the conjugates with tumor-imaging and therapeutic potential (Theranostics).  The clin. status of certain selected PDT agents is also summarized (205 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaO6TvgtDibVg90H21EOLACvtfcHk0lgtr6GiChaOWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF&md5=b462478255e32db5d073a892c64e2d52</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FB915149B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB915149B%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520porphyrin%2520chemistry%2520in%2520tumor%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D340%26epage%3D362%26doi%3D10.1039%2FB915149B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumlin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoudia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic therapy</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1996.tb02442.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.1996.tb02442.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=194-204&author=R.+K.+Pandeyauthor=A.+B.+Sumlinauthor=S.+Constantineauthor=M.+Aoudiaauthor=W.+R.+Potterauthor=D.+A.+Bellnierauthor=B.+W.+Hendersonauthor=M.+A.+Rodgersauthor=K.+M.+Smithauthor=T.+J.+Dougherty&title=Alkyl+ether+analogs+of+chlorophyll-a+derivatives%3A+Part+1.+Synthesis%2C+photophysical+properties+and+photodynamic+therapy&doi=10.1111%2Fj.1751-1097.1996.tb02442.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1996.tb02442.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1996.tb02442.x%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DSumlin%26aufirst%3DA.%2BB.%26aulast%3DConstantine%26aufirst%3DS.%26aulast%3DAoudia%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DW.%2BR.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DRodgers%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAlkyl%2520ether%2520analogs%2520of%2520chlorophyll-a%2520derivatives%253A%2520Part%25201.%2520Synthesis%252C%2520photophysical%2520properties%2520and%2520photodynamic%2520therapy%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1996%26volume%3D64%26spage%3D194%26epage%3D204%26doi%3D10.1111%2Fj.1751-1097.1996.tb02442.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weishaupt, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">An <i>in vivo</i> quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4000</span>– <span class="NLM_lpage">4007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=9307285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4000-4007&author=B.+W.+Hendersonauthor=D.+A.+Bellnierauthor=W.+R.+Grecoauthor=A.+Sharmaauthor=R.+K.+Pandeyauthor=L.+A.+Vaughanauthor=K.+R.+Weishauptauthor=T.+J.+Dougherty&title=An+in+vivo+quantitative+structure-activity+relationship+for+a+congeneric+series+of+pyropheophorbide+derivatives+as+photosensitizers+for+photodynamic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Henderson, Barbara W.; Bellnier, David A.; Greco, William R.; Sharma, Amarnath; Pandey, Ravindra K.; Vaughan, Lurine A.; Weishaupt, Kenneth R.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4000-4007</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An in vivo quant. structure-activity relationship (QSAR) study was carried out on a congeneric series of pyropheophorbide photosensitizers to identify structural features crit. for their antitumor activity in photodynamic therapy (PDT).  The structural elements evaluated in this study include the length and shape (alkyl, alkenyl, cyclic, and secondary analogs) of the ether side chain.  C3H mice, harboring the radiation-induced fibrosarcoma tumor model, were used to study three biol. response endpoints: tumor growth delay, tumor cell lethality, and vascular perfusion.  All three endpoints revealed highly similar QSAR patterns that constituted a function of the alkyl ether chain length and drug lipophilicity, which is defined as the log of the octanol:water partition coeff. (log P).  When the illumination of tumor, tumor cells, or cutaneous vasculature occurred 24 h after sensitizer administration, activities were minimal with analogs of log P ≤ 5, increased dramatically between log P of 5-6, and peaked between log P of 5.6-6.6.  Activities declined gradually with higher log P.  The lack of activity of the least-lipophilic analogs was explained in large part by their poor biodistribution characteristics, which yielded negligible tumor and plasma drug levels at the time of treatment with light.  The progressively lower potencies of the most lipophilic analogs cannot be explained through the overall tumor and plasma pharmacokinetics of photosensitizer because tumor and plasma concns. progressively increased with lipophilicity.  When compensated for differences in tumor photosensitizer concn., the 1-hexyl deriv. (optimal lipophilicity) was 5-fold more potent than the 1-dodecyl deriv. (more lipophilic) and 3-fold more potent than the 1-pentyl analog (less lipophilic), indicating that, in addn. to the overall tumor pharmacokinetics, pharmacodynamic factors may influence PDT activity.  Drug lipophilicity was highly predictive for photodynamic activity.  QSAR modeling revealed that direct antitumor effects and vascular PDT effects may be governed by common mechanisms, and that the mere assocn. of high levels of photosensitizer in the tumor tissue is not sufficient for optimal PDT efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8jr9wz9QNVbVg90H21EOLACvtfcHk0lgtr6GiChaOWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D&md5=a1b891da5bee6c012242bc129ea28636</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DVaughan%26aufirst%3DL.%2BA.%26aulast%3DWeishaupt%26aufirst%3DK.%2BR.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAn%2520in%2520vivo%2520quantitative%2520structure-activity%2520relationship%2520for%2520a%2520congeneric%2520series%2520of%2520pyropheophorbide%2520derivatives%2520as%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4000%26epage%3D4007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation of cRGD peptide to chlorophyll-a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.1021/mp200018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1186-1197&author=A.+Srivatsanauthor=E.+Ethirajanauthor=S.+K.+Pandeyauthor=S.+Dubeyauthor=X.+Zhengauthor=T.-H.+Liuauthor=M.+Shibataauthor=J.+Missertauthor=J.+Morganauthor=R.+K.+Pandey&title=Conjugation+of+cRGD+peptide+to+chlorophyll-a+based+photosensitizer+%28HPPH%29+alters+its+pharmacokinetics+with+enhanced+tumor-imaging+and+photosensitizing+%28PDT%29+efficacy&doi=10.1021%2Fmp200018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of cRGD Peptide to Chlorophyll a Based Photosensitizer (HPPH) Alters Its Pharmacokinetics with Enhanced Tumor-Imaging and Photosensitizing (PDT) Efficacy</span></div><div class="casAuthors">Srivatsan, Avinash; Ethirajan, Manivannan; Pandey, Suresh K.; Dubey, Shipra; Zheng, Xiang; Liu, Ting-Hsiu; Shibata, Masayuki; Missert, Joseph; Morgan, Janet; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1186-1197</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The αvβ3 integrin receptor plays an important role in human metastasis and tumor-induced angiogenesis.  Cyclic Arg-Gly-Asp (cRGD) peptide represents a selective αvβ3 integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.  For developing photosensitizers with enhanced PDT efficacy, we here report the synthesis of a series of bifunctional agents in which the 3-(1'-hexyloxyethyl)-3-devinylpyropheophorbide a (HPPH), a chlorophyll-based photosensitizer, was conjugated to cRGD and the related analogs.  The cell uptake and in vitro PDT efficacy of the conjugates were studied in αvβ3 integrin overexpressing U87 and 4T1 cell lines whereas the in vivo PDT efficacy and fluorescence-imaging potential of the conjugates were compared with the corresponding nonconjugated photosensitizer HPPH in 4T1 tumors.  Compared to HPPH, the HPPH-cRGD conjugate in which the arginine and aspartic acid moieties were available for binding to two subunits of αvβ3 integrin showed faster clearance, enhanced tumor imaging and enhanced PDT efficacy at 2-4 h postinjection.  Mol. modeling studies also confirmed that the presence of the HPPH moiety in HPPH-cRGD conjugate does not interfere with specific recognition of cRGD by αvβ3 integrin.  Compared to U87 and 4T1 cells the HPPH-cRGD showed significantly low photosensitizing efficacy in A431 (αvβ3 neg.) tumor cells, suggesting possible target specificity of the conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnvNJrWfkErVg90H21EOLACvtfcHk0ljUeOIecfu6_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D&md5=19b20682aed1fe3f7acef8a4b7348f11</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fmp200018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200018y%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DEthirajan%26aufirst%3DE.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DDubey%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DT.-H.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMissert%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DConjugation%2520of%2520cRGD%2520peptide%2520to%2520chlorophyll-a%2520based%2520photosensitizer%2520%2528HPPH%2529%2520alters%2520its%2520pharmacokinetics%2520with%2520enhanced%2520tumor-imaging%2520and%2520photosensitizing%2520%2528PDT%2529%2520efficacy%26jtitle%3DMol.%2520Pharm.%26date%3D2011%26volume%3D8%26spage%3D1186%26epage%3D1197%26doi%3D10.1021%2Fmp200018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Conjugation of HPPH to carbohydrates changes its subcellular biodistribution and enhances photodynamic activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4306</span>– <span class="NLM_lpage">4318</span>, <span class="refDoi"> DOI: 10.1021/jm9001617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9001617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4306-4318&author=X.+Zhengauthor=J.+Morganauthor=S.+K.+Pandeyauthor=Y.+Chenauthor=E.+Tracyauthor=H.+Baumannauthor=J.+R.+Missertauthor=C.+Batt&title=Conjugation+of+HPPH+to+carbohydrates+changes+its+subcellular+biodistribution+and+enhances+photodynamic+activity+in+vivo&doi=10.1021%2Fjm9001617"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Fjm9001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9001617%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTracy%26aufirst%3DE.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DBatt%26aufirst%3DC.%26atitle%3DConjugation%2520of%2520HPPH%2520to%2520carbohydrates%2520changes%2520its%2520subcellular%2520biodistribution%2520and%2520enhances%2520photodynamic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4306%26epage%3D4318%26doi%3D10.1021%2Fjm9001617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.2011.00992.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.2011.00992.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1405-1418&author=E.+C.+Tracyauthor=M.+J.+Bowmanauthor=R.+K.+Pandeyauthor=B.+W.+Hendersonauthor=H.+Baumann&title=Cell-type+selective+phototoxicity+achieved+with+chlorophyll-a+derived+photosensitizers+in+a+co-culture+system+of+primary+human+tumor+and+normal+lung+cells&doi=10.1111%2Fj.1751-1097.2011.00992.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2011.00992.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2011.00992.x%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DCell-type%2520selective%2520phototoxicity%2520achieved%2520with%2520chlorophyll-a%2520derived%2520photosensitizers%2520in%2520a%2520co-culture%2520system%2520of%2520primary%2520human%2520tumor%2520and%2520normal%2520lung%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2011%26spage%3D1405%26epage%3D1418%26doi%3D10.1111%2Fj.1751-1097.2011.00992.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Purpurinide carbohydrate conjugates: effect of the position of the carbohydrate moiety in photosensitizing efficacy</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1021/mp060135x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp060135x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Witbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=448-464&author=S.+K.+Pandeyauthor=X.+Zhengauthor=J.+Morganauthor=J.+R.+Missertauthor=T.+H.+Liuauthor=M.+Shibataauthor=D.+A.+Bellnierauthor=A.+R.+Oseroffauthor=B.+W.+Hendersonauthor=T.+J.+Doughertyauthor=R.+K.+Pandey&title=Purpurinide+carbohydrate+conjugates%3A+effect+of+the+position+of+the+carbohydrate+moiety+in+photosensitizing+efficacy&doi=10.1021%2Fmp060135x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Purpurinimide Carbohydrate Conjugates: Effect of the Position of the Carbohydrate Moiety in Photosensitizing Efficacy</span></div><div class="casAuthors">Pandey, Suresh K.; Zheng, Xiang; Morgan, Janet; Missert, Joseph R.; Liu, Ting-Hsiu; Shibata, Masayuki; Bellnier, David A.; Oseroff, Allan R.; Henderson, Barbara W.; Dougherty, Thomas J.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">448-464</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A lactose moiety was regioselectively introduced at various positions of N-hexyl-mesopurpurinimide (a class of chlorin contg. a fused six-membered imide ring system, λmax: 700 nm) to investigate the effect of its presence and position on photosensitizing efficacy.  The resulting novel structures produced a significant difference in in vitro and in vivo efficacy.  Among the positional isomers in which the lactose moiety was introduced at positions 3, 8, and 12, the 3-lactose purpurin-18-N-hexylimide produced the best efficacy.  Compared to these analogs, the lactose moiety joined with an amide bond at position 172, and with an N-benzyl group bearing a -C≡C- linkage at position 132 showed reduced in vitro/in vivo photosensitivity.  A noticeable difference between lactose conjugates in cell uptake (RIF tumor cells) was obsd. at 3 and 24 h postincubation.  Replacing the lactose (Galβ1 → 4Glc) with β-galactose and glucose moieties at position 3 of purpurinimide produced an increase in both cell uptake and in in vitro efficacy, but with reduced in vivo efficacy.  Sites of intracellular localization differed among photosensitizers with and without carbohydrate moieties.  Mol. modeling shows favorable interactions of 3- and 12-lactose-purpurinimide analogs with both galectin-1 and galectin-3, but clear contributions were not found for the conjugate contg. lactose moiety at position 8.  In a comparative ELISA study of the lactose conjugates with free lactose, all carbohydrate-purpurinimides showed binding to both galectins with a significant variation between the batches of galectins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-ZX2fTBfe7Vg90H21EOLACvtfcHk0ljUeOIecfu6_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Witbw%253D&md5=df0dfb54a62c282b3f726d92e37ed822</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fmp060135x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060135x%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DT.%2BH.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DPurpurinide%2520carbohydrate%2520conjugates%253A%2520effect%2520of%2520the%2520position%2520of%2520the%2520carbohydrate%2520moiety%2520in%2520photosensitizing%2520efficacy%26jtitle%3DMol.%2520Pharm.%26date%3D2007%26volume%3D4%26spage%3D448%26epage%3D464%26doi%3D10.1021%2Fmp060135x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryshuk, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouzeid, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charamisinau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabi, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Multimodality agents for tumor imaging (PET, Fluorescence) and photodynamic therapy, A possible “See and Treat” approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6286</span>– <span class="NLM_lpage">6295</span>, <span class="refDoi"> DOI: 10.1021/jm050427m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050427m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6286-6295&author=S.+K.+Pandeyauthor=A.+L.+Gryshukauthor=M.+Sajjadauthor=X.+Zhengauthor=Y.+Chenauthor=M.+M.+Abouzeidauthor=J.+Morganauthor=I.+Charamisinauauthor=H.+A.+Nabiauthor=A.+Oseroffauthor=R.+K.+Pandey&title=Multimodality+agents+for+tumor+imaging+%28PET%2C+Fluorescence%29+and+photodynamic+therapy%2C+A+possible+%E2%80%9CSee+and+Treat%E2%80%9D+approach&doi=10.1021%2Fjm050427m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm050427m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050427m%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DGryshuk%26aufirst%3DA.%2BL.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAbouzeid%26aufirst%3DM.%2BM.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DCharamisinau%26aufirst%3DI.%26aulast%3DNabi%26aufirst%3DH.%2BA.%26aulast%3DOseroff%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DMultimodality%2520agents%2520for%2520tumor%2520imaging%2520%2528PET%252C%2520Fluorescence%2529%2520and%2520photodynamic%2520therapy%252C%2520A%2520possible%2520%25E2%2580%259CSee%2520and%2520Treat%25E2%2580%259D%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6286%26epage%3D6295%26doi%3D10.1021%2Fjm050427m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3603</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.bmc.2015.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25936263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3603-3617&author=A.+Srivatsanauthor=P.+Peraauthor=P.+Joshiauthor=Y.+Wangauthor=J.+R.+Missertauthor=E.+C.+Tracyauthor=W.+A.+Tabaczynskiauthor=R.+Yaoauthor=M.+Sajjadauthor=H.+Baumannauthor=R.+K.+Pandey&title=Effect+of+chirality+on+cellular+uptake%2C+imaging+and+photodynamic+therapy+of+photosensitizers+derived+from+chlorophyll-a&doi=10.1016%2Fj.bmc.2015.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span></div><div class="casAuthors">Srivatsan, Avinash; Pera, Paula; Joshi, Penny; Wang, Yanfang; Missert, Joseph R.; Tracy, Erin C.; Tabaczynski, Walter A.; Yao, Rutao; Sajjad, Munawwar; Baumann, Heinz; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3603-3617</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously shown that the 124I-analog of Me 3-(1'-m-iodobenzyloxy) ethyl-3-devinyl-pyropheophorbide-a derived as racemic mixt. from chlorophyll-a can be used for PET (positron emission tomog.)-imaging in animal tumor models.  On the other hand, as a non-radioactive analog, it showed excellent fluorescence and photodynamic therapy (PDT) efficacy.  Thus, a single agent in a mixt. of radioactive (124I-) and non-radioactive (127I) material can be used for both dual-imaging and PDT of cancer.  Before advancing to Phase I human clin. trials, we evaluated the activity of the individual isomers as well as the impact of a chiral center at position-31 in directing in vitro/in vivo cellular uptake, intracellular localization, epithelial tumor cell-specific retention, fluorescence/PET imaging, and photosensitizing ability.  The results indicate that both isomers (racemates), either as Me ester or carboxylic acid, were equally effective.  However, the Me ester analogs, due to subcellular deposition into vesicular structures, were preferentially retained.  All derivs. contg. carboxylic acid at the position-172 were noted to be substrate for the ABCG2 (a member of the ATP binding cassette transporters) protein explaining their low retention in lung tumor cells expressing this transporter.  The compds. in which the chirality at position-3 has been substituted by a non-chiral functionality showed reduced cellular uptake, retention and lower PDT efficacy in mice bearing murine Colon26 tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc4VikWQsT3LVg90H21EOLACvtfcHk0lhxmv6qsmuq3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D&md5=ce58e5a8ae06afe14296a0de6b87d24f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DEffect%2520of%2520chirality%2520on%2520cellular%2520uptake%252C%2520imaging%2520and%2520photodynamic%2520therapy%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3603%26epage%3D3617%26doi%3D10.1016%2Fj.bmc.2015.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinchilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najera, C.</span></span> <span> </span><span class="NLM_article-title">The Sonogashira reaction: A booming methodology in synthetic organic chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1021/cr050992x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr050992x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=874-922&author=R.+Chinchillaauthor=C.+Najera&title=The+Sonogashira+reaction%3A+A+booming+methodology+in+synthetic+organic+chemistry&doi=10.1021%2Fcr050992x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Sonogashira reaction: a booming methodology in synthetic organic chemistry</span></div><div class="casAuthors">Chinchilla, Rafael; Najera, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-922</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The palladium-catalyzed sp2-sp coupling reaction between aryl or alkenyl halides or triflates and terminal alkynes, with or without the presence of copper(I) cocatalyst, was reviewed.  The mechanism of Sonogashira reaction was discussed, and the catalysts and reaction conditions were explored as well.  In addn., the application of Sonogashira cross-coupling reaction was also introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ8ePd8RdbSrVg90H21EOLACvtfcHk0lhxmv6qsmuq3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D&md5=91f627efbf940c60809c2acfe597d3b7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr050992x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr050992x%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DNajera%26aufirst%3DC.%26atitle%3DThe%2520Sonogashira%2520reaction%253A%2520A%2520booming%2520methodology%2520in%2520synthetic%2520organic%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2007%26volume%3D107%26spage%3D874%26epage%3D922%26doi%3D10.1021%2Fcr050992x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canteenwala, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khouly, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritzker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, L. Y.</span></span> <span> </span><span class="NLM_article-title">Efficiency of singlet oxygen production from self-assembled nanospheres of molecular micelle-like photosensitizers FC<sub>4</sub>S</span>. <i>J. Mater. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1857</span>– <span class="NLM_lpage">1864</span>, <span class="refDoi"> DOI: 10.1039/b500369e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2Fb500369e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsl2ntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1857-1864&author=C.+Yuauthor=T.+Canteenwalaauthor=M.+E.+El-Khoulyauthor=Y.+Arakiauthor=K.+Pritzkerauthor=O.+Itoauthor=B.+C.+Wilsonauthor=L.+Y.+Chiang&title=Efficiency+of+singlet+oxygen+production+from+self-assembled+nanospheres+of+molecular+micelle-like+photosensitizers+FC4S&doi=10.1039%2Fb500369e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficiency of singlet oxygen production from self-assembled nanospheres of molecular micelle-like photosensitizers FC4S</span></div><div class="casAuthors">Yu, Chi; Canteenwala, Taizoon; El-Khouly, Mohamed E.; Araki, Yasuyuki; Pritzker, Kenneth; Ito, Osamu; Wilson, Brian C.; Chiang, Long Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1857-1864</span>CODEN:
                <span class="NLM_cas:coden">JMACEP</span>;
        ISSN:<span class="NLM_cas:issn">0959-9428</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Direct detection of singlet oxygen (1O2) prodn. under irradn. of mol. micelle-like hexa(sulfo-n-butyl)[60]fullerene (FC4S) self-assembled nanospheres at 500-600 nm was obtained by the measurement of its near-IR luminescence at 1270 nm.  This photocatalytic effect makes FC4S a potential alternative sensitizer to TiO2 and feasible for use in the visible region in addn. to its intrinsic high UV efficiency.  Despite having a relatively low optical absorption of FC4S at 600 nm, appreciable 1O2 signal was detected comparable to that of hematoporphyrin derivs. Photofrin at the same molar concn., but less than sulfonated aluminum phthalocyanine, AlS4Pc.  The quantum yield of FC4S for the generation of 1O2 in H2O was roughly estd. to be 0.36 using the relative correlation to that of C60/γ-CD.  The abs. value is not available.  These results demonstrated efficient triplet energy transfer from 3FC4S* to mol. oxygen in the nanosphere structure.  The authors also confirmed certain retention between photocatalytic characteristics of underivatized C60 with that of FC4S, a C60 hexaadduct contg. a single covalent bond between each addend and the fullerene cage, in contrast to other Bingel-type hexamalonate adducts of C60 in the literature with a low 1O2 yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdGy-c_VE357Vg90H21EOLACvtfcHk0liFs2_-J-FsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsl2ntbs%253D&md5=1139a88463d2e6d499bb4451bcbdfb9b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fb500369e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb500369e%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%26aulast%3DCanteenwala%26aufirst%3DT.%26aulast%3DEl-Khouly%26aufirst%3DM.%2BE.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DPritzker%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DO.%26aulast%3DWilson%26aufirst%3DB.%2BC.%26aulast%3DChiang%26aufirst%3DL.%2BY.%26atitle%3DEfficiency%2520of%2520singlet%2520oxygen%2520production%2520from%2520self-assembled%2520nanospheres%2520of%2520molecular%2520micelle-like%2520photosensitizers%2520FC4S%26jtitle%3DJ.%2520Mater.%2520Chem.%26date%3D2005%26volume%3D15%26spage%3D1857%26epage%3D1864%26doi%3D10.1039%2Fb500369e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Khouly, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmawar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, O.</span></span> <span> </span><span class="NLM_article-title">Photoinduced processes in a tricomponent molecule consisting of diphenylaminofluorene-dicyanoethylene-methano[60]fullerene</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">884</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1021/jp055324u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp055324u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2006&pages=884-891&author=M.+E.+El-Khoulyauthor=P.+Padmawarauthor=Y.+Arakiauthor=S.+Vermaauthor=L.+Y.+Chiangauthor=O.+Ito&title=Photoinduced+processes+in+a+tricomponent+molecule+consisting+of+diphenylaminofluorene-dicyanoethylene-methano%5B60%5Dfullerene&doi=10.1021%2Fjp055324u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjp055324u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp055324u%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Khouly%26aufirst%3DM.%2BE.%26aulast%3DPadmawar%26aufirst%3DP.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DChiang%26aufirst%3DL.%2BY.%26aulast%3DIto%26aufirst%3DO.%26atitle%3DPhotoinduced%2520processes%2520in%2520a%2520tricomponent%2520molecule%2520consisting%2520of%2520diphenylaminofluorene-dicyanoethylene-methano%255B60%255Dfullerene%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2006%26volume%3D110%26spage%3D884%26epage%3D891%26doi%3D10.1021%2Fjp055324u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redmond, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamlin, J. N.</span></span> <span> </span><span class="NLM_article-title">Comparison of singlet oxygen yields from relevant biological molecules</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1999.tb08240.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.1999.tb08240.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1999&pages=391-475&author=R.+W.+Redmondauthor=J.+N.+Gamlin&title=Comparison+of+singlet+oxygen+yields+from+relevant+biological+molecules&doi=10.1111%2Fj.1751-1097.1999.tb08240.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1999.tb08240.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1999.tb08240.x%26sid%3Dliteratum%253Aachs%26aulast%3DRedmond%26aufirst%3DR.%2BW.%26aulast%3DGamlin%26aufirst%3DJ.%2BN.%26atitle%3DComparison%2520of%2520singlet%2520oxygen%2520yields%2520from%2520relevant%2520biological%2520molecules%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1999%26volume%3D70%26spage%3D391%26epage%3D475%26doi%3D10.1111%2Fj.1751-1097.1999.tb08240.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiggino, K. P.</span></span> <span> </span><span class="NLM_article-title">Singlet oxygen quantum yields of potential porphyrin-based photosensitizers for photodynamic therapy</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1039/b705853e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2Fb705853e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=17721599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsV2ku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=995-1002&author=S.+Mathaiauthor=T.+A.+Smithauthor=K.+P.+Ghiggino&title=Singlet+oxygen+quantum+yields+of+potential+porphyrin-based+photosensitizers+for+photodynamic+therapy&doi=10.1039%2Fb705853e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Singlet oxygen quantum yields of potential porphyrin-based photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Mathai, Sean; Smith, Trevor A.; Ghiggino, Kenneth P.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">995-1002</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The singlet oxygen formation quantum yield (ΦΔ) for solns. of the di-cation, free-base and metalated forms of hematoporphyrin deriv. (HpD), hematoporphyrin IX (Hp9) and a boronated protoporphyrin (BOPP) are reported using the method of direct detection of the characteristic phosphorescence following polychromatic excitation.  Values of ΦΔ for the free-base form of all the porphyrins and the di-cation forms of Hp9 and HpD are in the range of 0.44 to 0.85 in the solvents investigated.  Incorporation of zinc ions into the macrocycle reduces ΦΔ for all three porphyrins.  BOPP facilitates the coordination of certain transition metals (Mn, Co and Cu) compared to Hp9 and HpD and results in a dramatic decrease in ΦΔ.  The exptl. data suggest the introduction of low energy charge transfer states assocd. with the disruption of the planarity of the macrocyclic ring provides alternative non-radiative deactivation pathways.  In BOPP, this non-planarity is augmented by the large closo-carborane peripheral substituent groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BcKi3TkwyrVg90H21EOLACvtfcHk0liFs2_-J-FsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsV2ku78%253D&md5=4b3b0187ddc05fc8439ca2cceaa57aac</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2Fb705853e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705853e%26sid%3Dliteratum%253Aachs%26aulast%3DMathai%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BA.%26aulast%3DGhiggino%26aufirst%3DK.%2BP.%26atitle%3DSinglet%2520oxygen%2520quantum%2520yields%2520of%2520potential%2520porphyrin-based%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2007%26volume%3D6%26spage%3D995%26epage%3D1002%26doi%3D10.1039%2Fb705853e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitto-Barry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, N. P. E.</span></span> <span> </span><span class="NLM_article-title">Pluronic block-copolymers in medicine: from chemical and biological versatility to rationalization and clinical advances</span>. <i>Polym. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3291</span>– <span class="NLM_lpage">3297</span>, <span class="refDoi"> DOI: 10.1039/c4py00039k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2Fc4py00039k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlGhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3291-3297&author=A.+Pitto-Barryauthor=N.+P.+E.+Barry&title=Pluronic+block-copolymers+in+medicine%3A+from+chemical+and+biological+versatility+to+rationalization+and+clinical+advances&doi=10.1039%2Fc4py00039k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pluronic block-copolymers in medicine: from chemical and biological versatility to rationalization and clinical advances</span></div><div class="casAuthors">Pitto-Barry, Anais; Barry, Nicolas P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Polymer Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3291-3297</span>CODEN:
                <span class="NLM_cas:coden">PCOHC2</span>;
        ISSN:<span class="NLM_cas:issn">1759-9962</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This mini-review highlights the latest advances in the chem. and biol. of Pluronic triblock copolymers.  We focus on their applications in medicine, as drug delivery carriers, biol. response modifiers, and pharmaceutical ingredients.  Examples of drug delivery systems and formulations currently in clin. use, clin. trials or preclin. development are highlighted.  We also discuss the role that Pluronic copolymers may play in the innovative design of new nanomedicines in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTea63E_th9LVg90H21EOLACvtfcHk0liFs2_-J-FsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlGhu7s%253D&md5=aecdecc33b3222f426d22044fdf7b25f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2Fc4py00039k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4py00039k%26sid%3Dliteratum%253Aachs%26aulast%3DPitto-Barry%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DN.%2BP.%2BE.%26atitle%3DPluronic%2520block-copolymers%2520in%2520medicine%253A%2520from%2520chemical%2520and%2520biological%2520versatility%2520to%2520rationalization%2520and%2520clinical%2520advances%26jtitle%3DPolym.%2520Chem.%26date%3D2014%26volume%3D5%26spage%3D3291%26epage%3D3297%26doi%3D10.1039%2Fc4py00039k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riss, T. L.</span>; <span class="NLM_string-name">Moravec, R. A.</span>; <span class="NLM_string-name">Niles, A. L.</span>; <span class="NLM_string-name">Duellman, S.</span>; <span class="NLM_string-name">Benink, H. A.</span>; <span class="NLM_string-name">Worzella, T. J.</span>; <span class="NLM_string-name">Minor, L.</span></span> <span> </span><span class="NLM_article-title">Cell Viability Assay</span>. In  <i>Assay Guidance Manual</i> [Online]; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span>, <span class="NLM_string-name">Coussens, N. P.</span>, <span class="NLM_string-name">Brimacombe, K.</span>, <span class="NLM_string-name">Grossman, A.</span>, <span class="NLM_string-name">Arkin, M.</span>, <span class="NLM_string-name">Auld, D.</span>, <span class="NLM_string-name">Austin, C.</span>, <span class="NLM_string-name">Baell, J.</span>, <span class="NLM_string-name">Bejcek, B.</span>, <span class="NLM_string-name">Caaveiro, J. M. M.</span>, <span class="NLM_string-name">Chung, T. D. Y.</span>, <span class="NLM_string-name">Dahlin, J. L.</span>, <span class="NLM_string-name">Devanaryan, V.</span>, <span class="NLM_string-name">Foley, T. L.</span>, <span class="NLM_string-name">Glicksman, M.</span>, <span class="NLM_string-name">Hall, M. D.</span>, <span class="NLM_string-name">Haas, J. V.</span>, <span class="NLM_string-name">Inglese, J.</span>, <span class="NLM_string-name">Iversen, P. W.</span>, <span class="NLM_string-name">Kahl, S. D.</span>, <span class="NLM_string-name">Kales, S. C.</span>, <span class="NLM_string-name">Lal-Nag, M.</span>, <span class="NLM_string-name">Li, Z.</span>, <span class="NLM_string-name">McGee, J.</span>, <span class="NLM_string-name">McManus, O.</span>, <span class="NLM_string-name">Riss, T.</span>, <span class="NLM_string-name">Trask, O. J.,  Jr.</span>, <span class="NLM_string-name">Weidner, J. R.</span>, <span class="NLM_string-name">Wildey, M. J.</span>, <span class="NLM_string-name">Xia, M.</span>, <span class="NLM_string-name">Xu, X.</span></span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2004–2013</span> (updated July 1, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004%E2%80%932013&author=T.+L.+Riss&author=R.+A.+Moravec&author=A.+L.+Niles&author=S.+Duellman&author=H.+A.+Benink&author=T.+J.+Worzella&author=L.+Minorauthor=G.+S.+Sittampalam&author=N.+P.+Coussens&author=K.+Brimacombe&author=A.+Grossman&author=M.+Arkin&author=D.+Auld&author=C.+Austin&author=J.+Baell&author=B.+Bejcek&author=J.+M.+M.+Caaveiro&author=T.+D.+Y.+Chung&author=J.+L.+Dahlin&author=V.+Devanaryan&author=T.+L.+Foley&author=M.+Glicksman&author=M.+D.+Hall&author=J.+V.+Haas&author=J.+Inglese&author=P.+W.+Iversen&author=S.+D.+Kahl&author=S.+C.+Kales&author=M.+Lal-Nag&author=Z.+Li&author=J.+McGee&author=O.+McManus&author=T.+Riss&author=O.+J.+Trask&author=J.+R.+Weidner&author=M.+J.+Wildey&author=M.+Xia&author=X.+Xu&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DT.%2BL.%26atitle%3DCell%2520Viability%2520Assay%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004%25E2%2580%25932013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohulchanskyy, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Structural and epimeric isomers of HPPH: Effects on uptake and photodynamic therapy</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=933-946&author=C.+Saenzauthor=R.+R.+Cherukuauthor=T.+Y.+Ohulchanskyyauthor=P.+Joshiauthor=W.+A.+Tabaczynskiauthor=J.+R.+Missertauthor=Y.+Chenauthor=P.+Peraauthor=E.+Tracyauthor=A.+Markoauthor=D.+Rohrbachauthor=U.+Sunarauthor=H.+Baumannauthor=R.+K.+Pandey&title=Structural+and+epimeric+isomers+of+HPPH%3A+Effects+on+uptake+and+photodynamic+therapy&doi=10.1021%2Facschembio.7b00023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00023%26sid%3Dliteratum%253Aachs%26aulast%3DSaenz%26aufirst%3DC.%26aulast%3DCheruku%26aufirst%3DR.%2BR.%26aulast%3DOhulchanskyy%26aufirst%3DT.%2BY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DTracy%26aufirst%3DE.%26aulast%3DMarko%26aufirst%3DA.%26aulast%3DRohrbach%26aufirst%3DD.%26aulast%3DSunar%26aufirst%3DU.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DStructural%2520and%2520epimeric%2520isomers%2520of%2520HPPH%253A%2520Effects%2520on%2520uptake%2520and%2520photodynamic%2520therapy%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D933%26epage%3D946%26doi%3D10.1021%2Facschembio.7b00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span> <span> </span><span class="NLM_article-title">The role of subcellular localization in initiation of apoptosis by photodynamic therapy</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1997.tb08581.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.1997.tb08581.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1997&pages=422-426&author=D.+Kesselauthor=Y.+Luoauthor=Y.+Dengauthor=C.+K.+Chang&title=The+role+of+subcellular+localization+in+initiation+of+apoptosis+by+photodynamic+therapy&doi=10.1111%2Fj.1751-1097.1997.tb08581.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1997.tb08581.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1997.tb08581.x%26sid%3Dliteratum%253Aachs%26aulast%3DKessel%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DC.%2BK.%26atitle%3DThe%2520role%2520of%2520subcellular%2520localization%2520in%2520initiation%2520of%2520apoptosis%2520by%2520photodynamic%2520therapy%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1997%26volume%3D65%26spage%3D422%26epage%3D426%26doi%3D10.1111%2Fj.1751-1097.1997.tb08581.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ongarora, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. d. G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolli, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. P.</span></span> <span> </span><span class="NLM_article-title">Intracellular targeting specificity of novel Phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e20786</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0020786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1371%2Fjournal.pone.0020786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=21673971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFaltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=S.+Duttaauthor=B.+G.+Ongaroraauthor=H.+Liauthor=M.+d.+G.+H.+Vicenteauthor=B.+K.+Kolliauthor=K.+P.+Chang&title=Intracellular+targeting+specificity+of+novel+Phthalocyanines+assessed+in+a+host-parasite+model+for+developing+potential+photodynamic+medicine&doi=10.1371%2Fjournal.pone.0020786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine</span></div><div class="casAuthors">Dutta, Sujoy; Ongarora, Benson G.; Li, Hairong; Vicente, Maria da Graca H.; Kolli, Bala K.; Chang, Kwang Poo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e20786</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Photodynamic therapy, unlikely to elicit drug-resistance, deserves attention as a strategy to counter this outstanding problem common to the chemotherapy of all diseases.  Previously, we have broadened the applicability of this modality to photodynamic vaccination by exploiting the unusual properties of the trypanosomatid protozoa, Leishmania, i.e., their innate ability of homing to the phagolysosomes of the antigen-presenting cells and their selective photolysis therein, using transgenic mutants endogenously inducible for porphyrin accumulation.  Here, we extended the utility of this host-parasite model for in vitro photodynamic therapy and vaccination by exploring exogenously supplied photosensitizers.  Seventeen novel phthalocyanines (Pcs) were screened in vitro for their photolytic activity against cultured Leishmania.  Pcs rendered cationic and sol. (csPcs) for cellular uptake were phototoxic to both parasite and host cells, i.e., macrophages and dendritic cells.  The csPcs that targeted to mitochondria were more photolytic than those restricted to the endocytic compartments.  Treatment of infected cells with endocytic csPcs resulted in their accumulation in Leishmania-contg. phagolysosomes, indicative of reaching their target for photodynamic therapy, although their parasite vs. host specificity is limited to a narrow range of csPc concns.  In contrast, Leishmania pre-loaded with csPc were selectively photolyzed intracellularly, leaving host cells viable.  Pre-illumination of such csPc-loaded Leishmania did not hinder their infectivity, but ensured their intracellular lysis.  Ovalbumin (OVA) so delivered by photo-inactivated OVA transfectants to mouse macrophages and dendritic cells were co-presented with MHC Class I mols. by these antigen-presenting cells to activate OVA epitope-specific CD8+T cells.  The in vitro evidence presented here demonstrates for the first time not only the potential of endocytic csPcs for effective photodynamic therapy against Leishmania but also their utility in photo-inactivation of Leishmania to produce a safe carrier to express and deliver a defined antigen with enhanced cell-mediated immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreL85hHqtEK7Vg90H21EOLACvtfcHk0ljFaXd6vwF8YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFaltbs%253D&md5=ea20cdc239078e3abd0aa3ecc2fee2cf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0020786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0020786%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DS.%26aulast%3DOngarora%26aufirst%3DB.%2BG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DVicente%26aufirst%3DM.%2Bd.%2BG.%2BH.%26aulast%3DKolli%26aufirst%3DB.%2BK.%26aulast%3DChang%26aufirst%3DK.%2BP.%26atitle%3DIntracellular%2520targeting%2520specificity%2520of%2520novel%2520Phthalocyanines%2520assessed%2520in%2520a%2520host-parasite%2520model%2520for%2520developing%2520potential%2520photodynamic%2520medicine%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0020786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demidova, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms in photodynamic therapy: part one – photosensitizers, photochemistry and cellular localization</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/S1572-1000(05)00007-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2FS1572-1000%2805%2900007-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25048432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=279-293&author=A.+P.+Castanoauthor=T.+N.+Demidovaauthor=M.+R.+Hamblin&title=Mechanisms+in+photodynamic+therapy%3A+part+one+%E2%80%93+photosensitizers%2C+photochemistry+and+cellular+localization&doi=10.1016%2FS1572-1000%2805%2900007-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization</span></div><div class="casAuthors">Castano, Ana P.; Demidova, Tatiana N.; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-293</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of non-toxic dyes or photosensitizers (PS) in combination with harmless visible light that is known as photodynamic therapy (PDT) has been known for over a hundred years, but is only now becoming widely used.  Originally developed as a tumor therapy, some of its most successful applications are for non-malignant disease.  In a series of three reviews we will discuss the mechanisms that operate in the field of PDT.  Part one discusses the recent explosion in discovery and chem. synthesis of new PS.  Some guidelines on how to choose an ideal PS for a particular application are presented.  The photochem. and photophysics of PS and the two pathways known as Type I (radicals and reactive oxygen species) and Type II (singlet oxygen) photochem. processes are discussed.  To carry out PDT effectively in vivo, it is necessary to ensure sufficient light reaches all the diseased tissue.  This involves understanding how light travels within various tissues and the relative effects of absorption and scattering.  The fact that most of the PS are also fluorescent allows various optical imaging and monitoring strategies to be combined with PDT.  The most important factor governing the outcome of PDT is how the PS interacts with cells in the target tissue or tumor, and the key aspect of this interaction is the subcellular localization of the PS.  Examples of PS that localize in mitochondria, lysosomes, endoplasmic reticulum, Golgi app. and plasma membranes are given.  Finally the use of 5-aminolevulinic acid as a natural precursor of the heme biosynthetic pathway, stimulates accumulation of the PS protoporphyrin IX is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNeTzOpZvourVg90H21EOLACvtfcHk0ljEGOGqvEU2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wls7s%253D&md5=77884008762c9f15aa23f5e6338c4567</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS1572-1000%2805%2900007-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1572-1000%252805%252900007-4%26sid%3Dliteratum%253Aachs%26aulast%3DCastano%26aufirst%3DA.%2BP.%26aulast%3DDemidova%26aufirst%3DT.%2BN.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DMechanisms%2520in%2520photodynamic%2520therapy%253A%2520part%2520one%2520%25E2%2580%2593%2520photosensitizers%252C%2520photochemistry%2520and%2520cellular%2520localization%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2004%26volume%3D1%26spage%3D279%26epage%3D293%26doi%3D10.1016%2FS1572-1000%2805%2900007-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Treda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ksiazkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzela, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banaszczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peciak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoczynska-Fidelus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieske, P.</span></span> <span> </span><span class="NLM_article-title">EGFR activation leads to cell death independent of P13K/ART/mTOR in an AD293 cell line</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0155230</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0155230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1371%2Fjournal.pone.0155230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=27153109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWlu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=C.+Tredaauthor=M.+Popedaauthor=M.+Ksiazkiewiczauthor=D.+P.+Grzelaauthor=M.+P.+Walczakauthor=M.+Banaszczykauthor=J.+Peciakauthor=F.+Stoczynska-Fidelusauthor=P.+Rieske&title=EGFR+activation+leads+to+cell+death+independent+of+P13K%2FART%2FmTOR+in+an+AD293+cell+line&doi=10.1371%2Fjournal.pone.0155230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR activation leads to cell death independent of PI3K/AKT/mTOR in an AD293 cell line</span></div><div class="casAuthors">Treda, Cezary; Popeda, Marta; Ksiazkiewicz, Magdalena; Grzela, Dawid P.; Walczak, Maciej P.; Banaszczyk, Mateusz; Peciak, Joanna; Stoczynska-Fidelus, Ewelina; Rieske, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0155230/1-e0155230/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The Epidermal Growth Factor Receptor (EGFR) and its mutations contribute in various ways to tumorigenesis and biol. of human cancers.  They are assocd. with tumor proliferation, progression, drug resistance and the process of apoptosis.  There are also reports that overexpression and activation of wild-type EGFR may lead to cell apoptosis.  To study this phenomenon, we overexpressed in an AD293 cell line two most frequently obsd. forms of the EGFR receptor: wild-type and the constitutively active mutant-EGFR variant III (EGFRvIII).  Then, we compared the effect of EGF stimulation on cell viability and downstream EGFR signaling.  AD293 cells overexpressing wild-type EGFR, despite a significant proliferation increase in serum supplemented medium, underwent apoptosis after EGF stimulation in serum free conditions.  EGFRvIII expressing cells, however, were unaffected by either serum starvation or EGF treatment.  The effect of EGF was completely neutralized by tyrosine kinase inhibitors (TKIs), indicating the specificity of this observation.  Moreover, apoptosis was not prevented by inhibiting EGFR downstream proteins (PI3K, AKT and mTOR).  Here we showed another EGFR function, dependent on environmental factors, which could be employed in therapy and drug design.  We also proposed a new tool for EGFR inhibitor anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2gWMQiOGB0LVg90H21EOLACvtfcHk0ljEGOGqvEU2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWlu7%252FK&md5=21e9bd48f28be44f6e6c88fc1a5f3c93</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0155230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0155230%26sid%3Dliteratum%253Aachs%26aulast%3DTreda%26aufirst%3DC.%26aulast%3DPopeda%26aufirst%3DM.%26aulast%3DKsiazkiewicz%26aufirst%3DM.%26aulast%3DGrzela%26aufirst%3DD.%2BP.%26aulast%3DWalczak%26aufirst%3DM.%2BP.%26aulast%3DBanaszczyk%26aufirst%3DM.%26aulast%3DPeciak%26aufirst%3DJ.%26aulast%3DStoczynska-Fidelus%26aufirst%3DF.%26aulast%3DRieske%26aufirst%3DP.%26atitle%3DEGFR%2520activation%2520leads%2520to%2520cell%2520death%2520independent%2520of%2520P13K%252FART%252FmTOR%2520in%2520an%2520AD293%2520cell%2520line%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0155230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceresa, B. P.</span></span> <span> </span><span class="NLM_article-title">EGFR-mediated apoptosis via STAT3</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2017.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.yexcr.2017.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=28433699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2017&pages=93-103&author=N.+M.+Jacksonauthor=B.+P.+Ceresa&title=EGFR-mediated+apoptosis+via+STAT3&doi=10.1016%2Fj.yexcr.2017.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR-mediated apoptosis via STAT3</span></div><div class="casAuthors">Jackson, Nicole M.; Ceresa, Brian P.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-103</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Epidermal Growth Factor Receptor (EGFR) is a cell surface receptor with primary implications in cell growth in both normal and malignant tissue.  Paradoxically, cell lines that hyperexpress the EGFR have been documented to undergo receptor-mediated apoptosis.  The underlying mechanism by which EGF-induced apoptosis occurs however remains inexplicit.  In an attempt to identify this mechanism, we assessed downstream effectors of EGFR in MDA-MB-468 cells during conditions of EGF-induced apoptosis.  The effector assessment revealed STAT3 as a potential mediator of EGF-induced apoptosis.  Alternative strategies for activating STAT3, independent of EGFR stimulation, resulted in the induction of the apoptotic pathways.  A redn. in STAT3 expression via RNAi resulted in a significant attenuation of EGF-induced PARP cleavage.  Our findings support STAT3 as a pos. mediator of EGF-induced apoptosis in MDA-MB-468 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEOtRHTfrSyLVg90H21EOLACvtfcHk0ljEGOGqvEU2qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms1ChsL4%253D&md5=2dec72022d91ca27731dcd389eeb9678</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2017.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2017.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DN.%2BM.%26aulast%3DCeresa%26aufirst%3DB.%2BP.%26atitle%3DEGFR-mediated%2520apoptosis%2520via%2520STAT3%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D356%26spage%3D93%26epage%3D103%26doi%3D10.1016%2Fj.yexcr.2017.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lainey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouteloup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thepot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tailler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adres, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehrer, S.</span></span> <span> </span><span class="NLM_article-title">Erlotinib antagonizes efflux via ABC transporters and decreases P-Gp cell surface expression by inhibiting SRC kinase and mTOR pathways in acute myeloid leukemia (AML)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">2564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=2564&author=E.+Laineyauthor=M.+Sebertauthor=C.+Bouteloupauthor=C.+Leroyauthor=S.+Thepotauthor=M.+Taillerauthor=L.+Adresauthor=C.+Gardinauthor=G.+Kroemerauthor=P.+Fenauxauthor=S.+Boehrer&title=Erlotinib+antagonizes+efflux+via+ABC+transporters+and+decreases+P-Gp+cell+surface+expression+by+inhibiting+SRC+kinase+and+mTOR+pathways+in+acute+myeloid+leukemia+%28AML%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLainey%26aufirst%3DE.%26aulast%3DSebert%26aufirst%3DM.%26aulast%3DBouteloup%26aufirst%3DC.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DThepot%26aufirst%3DS.%26aulast%3DTailler%26aufirst%3DM.%26aulast%3DAdres%26aufirst%3DL.%26aulast%3DGardin%26aufirst%3DC.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DBoehrer%26aufirst%3DS.%26atitle%3DErlotinib%2520antagonizes%2520efflux%2520via%2520ABC%2520transporters%2520and%2520decreases%2520P-Gp%2520cell%2520surface%2520expression%2520by%2520inhibiting%2520SRC%2520kinase%2520and%2520mTOR%2520pathways%2520in%2520acute%2520myeloid%2520leukemia%2520%2528AML%2529%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D2564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaroslasvsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharkwal, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Cell death pathways in photodynamic therapy of cancer</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">2516</span>– <span class="NLM_lpage">2539</span>, <span class="refDoi"> DOI: 10.3390/cancers3022516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3390%2Fcancers3022516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23914299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Siu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=2516-2539&author=P.+Mrozauthor=A.+Yaroslasvskyauthor=C.+B.+Kharkwalauthor=M.+R.+Hamblin&title=Cell+death+pathways+in+photodynamic+therapy+of+cancer&doi=10.3390%2Fcancers3022516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death pathways in photodynamic therapy of cancer</span></div><div class="casAuthors">Mroz, Pawel; Yaroslavsky, Anastasia; Kharkwal, Gitika B.; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2516-2539</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is an emerging cancer therapy that uses the combination of non-toxic dyes or photosensitizers (PS) and harmless visible light to produce reactive oxygen species and destroy tumors.  The PS can be localized in various organelles such as mitochondria, lysosomes, endoplasmic reticulum, Golgi app. and plasma membranes and this sub-cellular location governs much of the signaling that occurs after PDT.  There is an acute stress response that leads to changes in calcium and lipid metab. and causes the prodn. of cytokines and stress response mediators.  Enzymes (particularly protein kinases) are activated and transcription factors are expressed.  Many of the cellular responses center on mitochondria and frequently lead to induction of apoptosis by the mitochondrial pathway involving caspase activation and release of cytochrome c.  Certain specific proteins (such as Bcl-2) are damaged by PDT-induced oxidn. thereby increasing apoptosis, and a build-up of oxidized proteins leads to an ER-stress response that may be increased by proteasome inhibition.  Autophagy plays a role in either inhibiting or enhancing cell death after PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorIEK_ZSI_MrVg90H21EOLACvtfcHk0lh9wHmD4kGXRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Siu7k%253D&md5=cc2393bfb173611c589ac1fcb0b1a377</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fcancers3022516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers3022516%26sid%3Dliteratum%253Aachs%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DYaroslasvsky%26aufirst%3DA.%26aulast%3DKharkwal%26aufirst%3DC.%2BB.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DCell%2520death%2520pathways%2520in%2520photodynamic%2520therapy%2520of%2520cancer%26jtitle%3DCancers%26date%3D2011%26volume%3D3%26spage%3D2516%26epage%3D2539%26doi%3D10.3390%2Fcancers3022516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, H. I.</span></span> <span> </span><span class="NLM_article-title">Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages</span>. <i>JNCI, J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1093/jnci/82.1.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1093%2Fjnci%2F82.1.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=2293654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADyaK3c%252FnvF2qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=34-38&author=S.+Evansauthor=W.+Mathewsauthor=R.+Perryauthor=D.+Frakerauthor=J.+Nortonauthor=H.+I.+Pass&title=Effect+of+photodynamic+therapy+on+tumor+necrosis+factor+production+by+murine+macrophages&doi=10.1093%2Fjnci%2F82.1.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages</span></div><div class="casAuthors">Evans S; Matthews W; Perry R; Fraker D; Norton J; Pass H I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-9</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">Photodynamic therapy (PDT) involves the treatment of tumors in the presence of sensitizer, light, and oxygen, causing energy-dependent cytotoxicity.  A vascular effect that causes hemorrhagic tumor necrosis has been described with PDT, but its basis remains undefined.  To investigate the possible role of tumor necrosis factor (TNF) production in the generation of such a vascular effect and/or a direct tumor effect, we treated thioglycollate-elicited murine macrophages with PDT, and we measured the possible production of TNF using the L929 assay.  An energy-dependent production of TNF by macrophage treated with PDT, stimulated or unstimulated with endotoxin, was demonstrated, and TNF production was inhibited at the highest treatment energy levels.  These data represent the first description of cytokine production by PDT-treated macrophages, and may serve as another mechanism of PDT cytotoxicity in vivo, either directly by TNF-mediated tumor necrosis, or indirectly by vascular effects on tumor vessels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJKuxtnmxDaz0SWnHPWbmmfW6udTcc2ebvds0qIdi1r7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c%252FnvF2qtQ%253D%253D&md5=0b6d1f995898eb8d58d06bf86c109700</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.1.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.1.34%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DW.%26aulast%3DPerry%26aufirst%3DR.%26aulast%3DFraker%26aufirst%3DD.%26aulast%3DNorton%26aufirst%3DJ.%26aulast%3DPass%26aufirst%3DH.%2BI.%26atitle%3DEffect%2520of%2520photodynamic%2520therapy%2520on%2520tumor%2520necrosis%2520factor%2520production%2520by%2520murine%2520macrophages%26jtitle%3DJNCI%252C%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D34%26epage%3D38%26doi%3D10.1093%2Fjnci%2F82.1.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogue, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demidenko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoopes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">J Hasan, T.</span></span> <span> </span><span class="NLM_article-title">Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=15701861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=720-727&author=B.+Chenauthor=B.+W.+Pogueauthor=X.+O.+Zhouauthor=J.+A.+Haraauthor=N.+Solbanauthor=E.+Demidenkoauthor=P.+Hoopesauthor=T.+J+Hasan&title=Effect+of+tumor+host+microenvironment+on+photodynamic+therapy+in+a+rat+prostate+tumor+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model</span></div><div class="casAuthors">Chen, Bin; Pogue, Brian W.; Zhou, Xiaodong; O'Hara, Julia A.; Solban, Nicolas; Demidenko, Eugene; Hoopes, P. Jack; Hasan, Tayyaba</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor host microenvironment plays an important role in tumor growth, metastasis, and response to cancer therapy.  In this study, the influence of tumor host environment on tumor pathophysiol., photosensitizer distribution, and photodynamic therapy (PDT) treatment effect was examd. in the metastatic at lymph node and lung (MatLyLu) rat prostate tumor.  MatLyLu tumors implanted in different host environment [i.e., orthotopically (in the prostate) or s.c.] were compared for difference in vessel d., av. vessel size, vascular permeability, tumor vascular endothelial growth factor prodn., and tumor oxygenation.  Uptake of photosensitizer verteporfin in tumors in both sites was detd. by fluorescence microscopy.  To compare tumor response to PDT, both orthotopic and s.c. MatLyLu tumors were given the same doses of verteporfin and laser light treatment, and PDT-induced tumor necrotic area was measured histol.  Orthotopic MatLyLu tumors were found to grow faster, have higher vessel d. and more permeable vasculature, have higher vascular endothelial growth factor protein levels, and have lower tumor hypoxic fraction than the s.c. tumors.  Uptake of photosensitizer verteporfin in the orthotopic tumor was higher than in the s.c. tumors at 15 min after injection (1 mg/kg, i.v.), and became similar at 3 h after injection.  For the vascular targeting PDT treatment (0.25 mg/kg verteporfin, 50 J/cm2 at 50 mW/cm2, 15 min drug-light interval), there was no significant difference in PDT-induced tumor necrotic area between the orthotopic and s.c. tumors, with 85% to 90% necrosis in both types of tumors.  However, tumor necrosis induced by the cellular targeting PDT (1 mg/kg verteporfin, 50 J/cm2 at 50 mW/cm2, 3 h drug-light interval) was significantly different in the orthotopic (64%) vs. the s.c. (29%) tumors.  Tumor host environment can significantly affect photosensitizer verteporfin distribution and PDT treatment effect.  Verteporfin-PDT regimen targeting tumor cells is more sensitive to such influence than the vascular targeting PDT.  Our study showed the importance of tumor host environment in detg. tumor physiol. properties and tumor response to PDT.  To obtain clin. relevant information, orthotopic tumor model should be used in the exptl. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmbZaxKsndpLVg90H21EOLACvtfcHk0lh9wHmD4kGXRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWgur8%253D&md5=b87295498c9898412d8f164d765c01f7</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPogue%26aufirst%3DB.%2BW.%26aulast%3DZhou%26aufirst%3DX.%2BO.%26aulast%3DHara%26aufirst%3DJ.%2BA.%26aulast%3DSolban%26aufirst%3DN.%26aulast%3DDemidenko%26aufirst%3DE.%26aulast%3DHoopes%26aufirst%3DP.%26aulast%3DJ%2BHasan%26aufirst%3DT.%26atitle%3DEffect%2520of%2520tumor%2520host%2520microenvironment%2520on%2520photodynamic%2520therapy%2520in%2520a%2520rat%2520prostate%2520tumor%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D720%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yotnda, P.</span></span> <span> </span><span class="NLM_article-title">Production and detection of the reactive oxygen species (ROS) in cancers</span>. <i>J. Vis. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>, <span class="NLM_elocation-id">e3357</span> <span class="refDoi"> DOI: 10.3791/3357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3791%2F3357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=22127014" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Wuauthor=P.+Yotnda&title=Production+and+detection+of+the+reactive+oxygen+species+%28ROS%29+in+cancers&doi=10.3791%2F3357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3791%2F3357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F3357%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DYotnda%26aufirst%3DP.%26atitle%3DProduction%2520and%2520detection%2520of%2520the%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520cancers%26jtitle%3DJ.%2520Vis.%2520Exp.%26date%3D2011%26doi%3D10.3791%2F3357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belhocine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaepen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaigne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muylle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgegis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierickx, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamen, P.</span></span> <span> </span><span class="NLM_article-title">[<sup>18</sup>] FFDG PET in Oncology: The best and the worst (Review)</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1249</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.3892/ijo.28.5.1249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3892%2Fijo.28.5.1249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=16596242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BD287ptVeisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=1249-1261&author=T.+Belhocineauthor=K.+Spaepenauthor=M.+Dusartauthor=C.+Castaigneauthor=K.+Muylleauthor=P.+Bourgeoisauthor=D.+Bourgegisauthor=L.+Dierickxauthor=P.+Flamen&title=%5B18%5D+FFDG+PET+in+Oncology%3A+The+best+and+the+worst+%28Review%29&doi=10.3892%2Fijo.28.5.1249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">18FDG PET in oncology: the best and the worst (Review)</span></div><div class="casAuthors">Belhocine Tarik; Spaepen Karoline; Dusart Michelle; Castaigne Catherine; Muylle Kristof; Bourgeois Pierre; Bourgeois Daniel; Dierickx Lawrence; Flamen Patrick</div><div class="citationInfo"><span class="NLM_cas:title">International journal of oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1249-61</span>
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    </div><div class="casAbstract">The clinical added-value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18FDG PET) in the management of oncology patients is increasingly documented.  In the present review, we discuss both the benefits and the limitations of 18FDG PET in different cancers.  Considering the literature data and our own experience, we also indicate the best clinical approach to optimize the use of metabolic imaging in oncology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAVO1tTumrTlMGsG_HTXYFfW6udTcc2eYjrXTRv--_QLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287ptVeisg%253D%253D&md5=163e338b0781f09f2b70f4a9925bc9fc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3892%2Fijo.28.5.1249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.28.5.1249%26sid%3Dliteratum%253Aachs%26aulast%3DBelhocine%26aufirst%3DT.%26aulast%3DSpaepen%26aufirst%3DK.%26aulast%3DDusart%26aufirst%3DM.%26aulast%3DCastaigne%26aufirst%3DC.%26aulast%3DMuylle%26aufirst%3DK.%26aulast%3DBourgeois%26aufirst%3DP.%26aulast%3DBourgegis%26aufirst%3DD.%26aulast%3DDierickx%26aufirst%3DL.%26aulast%3DFlamen%26aufirst%3DP.%26atitle%3D%255B18%255D%2520FFDG%2520PET%2520in%2520Oncology%253A%2520The%2520best%2520and%2520the%2520worst%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D28%26spage%3D1249%26epage%3D1261%26doi%3D10.3892%2Fijo.28.5.1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47a','cit47b'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ravindra R. Cheruku, Joseph Cacaccio, Farukh A. Durrani, Walter A. Tabaczynski, Ramona Watson, Kevin Siters, Joseph R. Missert, Erin C. Tracy, Mykhaylo Dukh, Khurshid Guru, Richard C. Koya, Pawel Kalinski, Heinz Baumann, <span class="NLM_string-name hlFld-ContribAuthor">Ravindra K. Pandey</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 741-767. <a href="https://doi.org/10.1021/acs.jmedchem.0c01735" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01735%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BTumor%252BSpecificity%25252C%252Band%252BPhotosensitizing%252BEfficacy%252Bof%252BErlotinib-Conjugated%252BChlorins%252Band%252BBacteriochlorins%25253A%252BIdentification%252Bof%252Ba%252BHighly%252BEffective%252BCandidate%252Bfor%252BPhotodynamic%252BTherapy%252Bof%252BCancer%26aulast%3DCheruku%26aufirst%3DRavindra%2BR.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D02102020%26date%3D05012021%26volume%3D64%26issue%3D1%26spage%3D741%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vasilii F. Otvagin, Natalia S. Kuzmina, Lubov V. Krylova, Arthur B. Volovetsky, Alexander V. Nyuchev, Andrei E. Gavryushin, Ivan N. Meshkov, Yulia G. Gorbunova, Yuliya V. Romanenko, Oscar I. Koifman, Irina V. Balalaeva, <span class="NLM_string-name hlFld-ContribAuthor">Alexey Yu Fedorov</span>. </span><span class="cited-content_cbyCitation_article-title">Water-Soluble Chlorin/Arylaminoquinazoline Conjugate for Photodynamic and Targeted Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11182-11193. <a href="https://doi.org/10.1021/acs.jmedchem.9b01294" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01294%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWater-Soluble%252BChlorin%25252FArylaminoquinazoline%252BConjugate%252Bfor%252BPhotodynamic%252Band%252BTargeted%252BTherapy%26aulast%3DOtvagin%26aufirst%3DVasilii%2BF.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08082019%26date%3D13122019%26date%3D29112019%26volume%3D62%26issue%3D24%26spage%3D11182%26epage%3D11193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shin  Ogasawara</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Takahashi</span>, <span class="hlFld-ContribAuthor ">Yuichi  Kitagawa</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Tamiaki</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Highly Fluorescent Cationic Chlorophyll-
              a
              Derivatives Possessing a
              p
              -Aminopyridinio Group at the 3
              1
              -Position. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Chemical Society of Japan</span><span> <strong>2021,</strong> <em>94 </em>
                                    (4)
                                     , 1201-1203. <a href="https://doi.org/10.1246/bcsj.20210009" title="DOI URL">https://doi.org/10.1246/bcsj.20210009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/bcsj.20210009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fbcsj.20210009%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Chemical%2520Society%2520of%2520Japan%26atitle%3DSynthesis%252Bof%252BHighly%252BFluorescent%252BCationic%252BChlorophyll-%252Ba%252BDerivatives%252BPossessing%252Ba%252Bp%252B-Aminopyridinio%252BGroup%252Bat%252Bthe%252B3%252B1%252B-Position%26aulast%3DOgasawara%26aufirst%3DShin%26date%3D2021%26volume%3D94%26issue%3D4%26spage%3D1201%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nichole E. M.  Kaufman</span>, <span class="hlFld-ContribAuthor ">Simran  Dhingra</span>, <span class="hlFld-ContribAuthor ">Seetharama D.  Jois</span>, <span class="hlFld-ContribAuthor ">Maria da Graça H.  Vicente</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1076. <a href="https://doi.org/10.3390/molecules26041076" title="DOI URL">https://doi.org/10.3390/molecules26041076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041076%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BTargeting%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252Band%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252B%252528VEGFR%252529%26aulast%3DKaufman%26aufirst%3DNichole%2BE.%2BM.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Peng  Li</span>, <span class="hlFld-ContribAuthor ">Chia-Jui  Yen</span>, <span class="hlFld-ContribAuthor ">Bo-Sheng  Wu</span>, <span class="hlFld-ContribAuthor ">Tak-Wah  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     , 69. <a href="https://doi.org/10.3390/biomedicines9010069" title="DOI URL">https://doi.org/10.3390/biomedicines9010069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9010069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9010069%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DRecent%252BAdvances%252Bin%252BPhotodynamic%252BTherapy%252Bfor%252BDeep-Seated%252BTumors%252Bwith%252Bthe%252BAid%252Bof%252BNanomedicine%26aulast%3DLi%26aufirst%3DWei-Peng%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1%26spage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Muhammad  Usama</span>, <span class="hlFld-ContribAuthor ">Bosheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Kevin  Burgess</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent kinase inhibitors as probes in cancer. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>36 </em><a href="https://doi.org/10.1039/D1CS00017A" title="DOI URL">https://doi.org/10.1039/D1CS00017A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CS00017A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CS00017A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DFluorescent%252Bkinase%252Binhibitors%252Bas%252Bprobes%252Bin%252Bcancer%26aulast%3DUsama%26aufirst%3DSyed%2BMuhammad%26date%3D2021%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shin‐ichi  Sasaki</span>, <span class="hlFld-ContribAuthor ">Yuki  Hashimoto</span>, <span class="hlFld-ContribAuthor ">Yusuke  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Tamiaki</span>, <span class="hlFld-ContribAuthor ">Shengnan  Duan</span>, <span class="hlFld-ContribAuthor ">Xiao‐Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Saga</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Toshitaka  Ikeuchi</span>, <span class="hlFld-ContribAuthor ">Nobue  Shishioh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of C3/C13‐Substituted Semi‐Synthetic Bacteriochlorophyll‐
              a
              Derivatives and Their Properties as Functional Dyes. </span><span class="cited-content_cbyCitation_journal-name">ChemPhotoChem</span><span> <strong>2020,</strong> <em>4 </em>
                                    (12)
                                     , 5399-5407. <a href="https://doi.org/10.1002/cptc.202000169" title="DOI URL">https://doi.org/10.1002/cptc.202000169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cptc.202000169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcptc.202000169%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhotoChem%26atitle%3DSynthesis%252Bof%252BC3%25252FC13%2525E2%252580%252590Substituted%252BSemi%2525E2%252580%252590Synthetic%252BBacteriochlorophyll%2525E2%252580%252590%252Ba%252BDerivatives%252Band%252BTheir%252BProperties%252Bas%252BFunctional%252BDyes%26aulast%3DSasaki%26aufirst%3DShin%25E2%2580%2590ichi%26date%3D2020%26date%3D2020%26volume%3D4%26issue%3D12%26spage%3D5399%26epage%3D5407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Prasad</span>, <span class="hlFld-ContribAuthor ">N.K.  Jain</span>, <span class="hlFld-ContribAuthor ">J.  Conde</span>, <span class="hlFld-ContribAuthor ">R.  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Localized nanotheranostics: recent developments in cancer nanomedicine. </span><span class="cited-content_cbyCitation_journal-name">Materials Today Advances</span><span> <strong>2020,</strong> <em>8 </em>, 100087. <a href="https://doi.org/10.1016/j.mtadv.2020.100087" title="DOI URL">https://doi.org/10.1016/j.mtadv.2020.100087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mtadv.2020.100087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mtadv.2020.100087%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%2520Advances%26atitle%3DLocalized%252Bnanotheranostics%25253A%252Brecent%252Bdevelopments%252Bin%252Bcancer%252Bnanomedicine%26aulast%3DPrasad%26aufirst%3DR.%26date%3D2020%26volume%3D8%26spage%3D100087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yixin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongyang  Zhao</span>, <span class="hlFld-ContribAuthor ">Gang  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Linlin  Cao</span>, <span class="hlFld-ContribAuthor ">Jin  Sun</span>, <span class="hlFld-ContribAuthor ">Qikun  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhonggui  He</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1382-1396. <a href="https://doi.org/10.1016/j.apsb.2020.01.004" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DRecent%252Bprogress%252Bof%252Bhypoxia-modulated%252Bmultifunctional%252Bnanomedicines%252Bto%252Benhance%252Bphotodynamic%252Btherapy%25253A%252Bopportunities%25252C%252Bchallenges%25252C%252Band%252Bfuture%252Bdevelopment%26aulast%3DSun%26aufirst%3DYixin%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1382%26epage%3D1396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Hua  Gao</span>, <span class="hlFld-ContribAuthor ">Xue-Xue  Zhu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Dan  Wu</span>, <span class="hlFld-ContribAuthor ">Dan-Ye  Chen</span>, <span class="hlFld-ContribAuthor ">Yi-Jia  Yan</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Wu</span>, <span class="hlFld-ContribAuthor ">Donal F.  O’Shea</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel chlorophyll a derivatives as potent photosensitizers for photodynamic therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111959. <a href="https://doi.org/10.1016/j.ejmech.2019.111959" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111959%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bchlorophyll%252Ba%252Bderivatives%252Bas%252Bpotent%252Bphotosensitizers%252Bfor%252Bphotodynamic%252Btherapy%26aulast%3DGao%26aufirst%3DYing-Hua%26date%3D2020%26volume%3D187%26spage%3D111959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-jing  Hou</span>, <span class="hlFld-ContribAuthor ">Xin-xin  Yang</span>, <span class="hlFld-ContribAuthor ">Rui-qi  Liu</span>, <span class="hlFld-ContribAuthor ">Di  Zhao</span>, <span class="hlFld-ContribAuthor ">Che-nxu  Guo</span>, <span class="hlFld-ContribAuthor ">An-chao  Zhu</span>, <span class="hlFld-ContribAuthor ">Mei-na  Wen</span>, <span class="hlFld-ContribAuthor ">Zhao  Liu</span>, <span class="hlFld-ContribAuthor ">Guo-fan  Qu</span>, <span class="hlFld-ContribAuthor ">Hong-xue  Meng</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles</p>. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Nanomedicine</span><span> <strong>2020,</strong> <em>Volume 15 </em>, 6827-6838. <a href="https://doi.org/10.2147/IJN.S269321" title="DOI URL">https://doi.org/10.2147/IJN.S269321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/IJN.S269321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FIJN.S269321%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Nanomedicine%26atitle%3D%25253Cp%25253EPathological%252BMechanism%252Bof%252BPhotodynamic%252BTherapy%252Band%252BPhotothermal%252BTherapy%252BBased%252Bon%252BNanoparticles%25253C%25252Fp%25253E%26aulast%3DHou%26aufirst%3DYun-jing%26date%3D2020%26date%3D2020%26volume%3DVolume%252015%26spage%3D6827%26epage%3D6838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structures of Parent Compounds (Radioactive and Nonradioactive) Derived from Chlorophyll <i>a</i> and the Synthesis of the Corresponding Erlotinib Conjugates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) <sup>1</sup>H NMR spectral regions of <b>1</b>, <b>3</b>, and <b>5</b> show significant chemical shift differences for specific protons. In <b>5</b>, protons in the vicinity of the photosensitizer moiety’s C-ring (10-H, 13<sup>2</sup>-CH<i>H</i>, and 12-CH<sub>3</sub>) are significantly shielded with respect to the corresponding protons of <b>1</b> and <b>3</b>. Also, 5-H of the erlotinib moiety of <b>3</b> exhibits a substantial shielding compared with the 5-H chemical shift observed in <b>5</b>. These observations suggest structural differences that are dependent on the erlotinib orientation in the conjugates (see the text for details). (B) <sup>1</sup>H NMR spectra of <b>5</b> at 28 °C (bottom) and 55 °C (top). At elevated temperature, the chemical shifts of the 10-H (open triangle), 13<sup>1</sup>-CH<i>H</i> (filled triangle), and 12-CH<sub>3</sub> (arrow) proton signals exhibit a marked deshielding toward the positions observed for the corresponding protons of <b>1</b> and <b>3</b>. This behavior is consistent with the breaking of π–π stacking interactions that may be responsible for the unusual shieldings observed for these protons in <b>5</b>. (See the figure in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf" class="ext-link">Supporting Information</a> for additional spectra taken at other temperatures.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Photophysical properties of photosensitizers with and without the erlotinib moiety. (A) Absorption and fluorescence spectra of <b>1</b>, <b>3</b>, and <b>5</b> in toluene. The fluorescence spectra were recorded using excitation light of 610 nm. Inset: fluorescence decay profile of <b>1</b> in toluene; λ<sub>ex</sub> = 420 nm. (B) (Left) differential absorption spectra obtained upon femtosecond flash photolysis (λ<sub>ex</sub><b>=</b> 390 nm) of <b>1</b> in deaerated toluene at the indicated time intervals. The inset shows the singlet state at 670 nm. (Right) nanosecond transient absorption spectra at the indicated time intervals of <b>3</b> in Ar-saturated toluene solution. The inset shows the decay profile of the triplet <b>3</b> in Ar-saturated and oxygen-saturated solutions. (C) Emission spectra of the singlet oxygen produced by the examined chlorin derivatives <b>1</b>, <b>3</b>, and <b>5</b> and the standard C<sub>60</sub> in toluene; λ<sub>ex</sub> = 470 nm. Inset: decay profile of the generated singlet oxygen in the microsecond time scale.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Impact of solvents on absorption and fluorescence spectra of photosensitizers with and without the erlotinib moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparative <i>in vitro</i> photosensitizing efficacy of the photosensitizers formulated in Tween 80 and Pluronic-127. (A) Comparative <i>in vitro</i> photosensitizing efficacy of PS <b>1</b> formulated in Tween 80 and Pluronic-127 at the same drug concentrations in UMUC3 and T24 tumor cells, light dose: 1.0 J/cm<sup>2</sup>. The plates that receive no light are used as an internal control to determine any latent toxicity of the compound from either the structure or the formulation used. (B) Comparative <i>in vitro</i> photosensitizing efficacy of (a) PS <b>3</b> in T24, (b) PS <b>3</b> in the UMUC3, (c) PS <b>5</b> in T24, and (d) PS <b>5</b> in UMUC3 cell lines, formulated in Tween 80 and Pluronic-127 at the same PS concentrations. Light dose: 1.0 J/cm<sup>2</sup>. The IC<sub>50</sub> values of the PSs in micromolar concentrations are presented in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparative uptake and intracellular localization (mitochondria vs lysosomes) of PSs <b>1</b>, <b>3</b>, and <b>5</b> formulated either in Tween 80 or Pluronic F-127 in UMUC3 and T24 cells. The uptake of PSs in Tween (A) and Pluronic F-127 (B) after 24 h incubation and the fluorescence was measured using a CARY fluorimeter. The degree of fluorescence in each cell was directly compared as a measure of uptake. The fluorescence of each cell was measured using an image stream. Simultaneously, cells were stained with lysosphere green and MitoTracker red to determine the subcellular localization specificity of the PSs: (C) PSs <b>1</b>, <b>3</b>, and <b>5</b> Tween 80 formulation in UMUC3, (D) PSs <b>1</b>, <b>3</b>, and <b>5</b> Tween formulation in T24, (E) PSs <b>1</b>, <b>3</b>, and <b>5</b> Pluronic formulation in UMUC3, and (F) PSs <b>1</b>, <b>3</b>, and <b>5</b> Pluronic formulation in the T24 cell line. The higher bright detail similarity score to a particular site reflects a stronger overlap of the PS fluorescence to that site, either lysosomes or the mitochondria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparative EGFR signal inhibition efficacy of erlotinib, PS <b>1</b>, and the corresponding erlotinib conjugates <b>3</b> and <b>5</b> in bladder cancer cell lines UMUC3 and T24, known for high and low expression levels of EGFR. (A) PS–erlotinib conjugates were treated at 1 μM concentration for 24 h followed by PDT. (B) UMUC3 cells were treated with PS–erlotinib conjugates at 100 nM concentration for 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Erlotinib conjugates induce robust apoptotic and necrotic cell death upon PDT. UMUC3 and T24 cells were treated with different erlotinib conjugates (1.0 μM) with and without PDT. Cell death was quantified using the trypan blue assay (A, B). Necrotic (C, D) and apoptotic (E, F) cell death was quantified using annexin V/propidium iodide (PI) labeling. Live cells and apoptotic cell death were quantified in UMUC3 and T24 cells treated with erlotinib conjugates (100 nM) with and without PDT (G, H).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. ABCG2 substrate specificity of PS with and without erlotinib in UMUC3 and T24 cells. (A, B) Uptake of PSs <b>1</b> and <b>5</b> with and without the addition of Gleevec (small-molecule inhibitor known to inhibit ABCG2 function) in UMUC3 and T24 cells. Cells were incubated with 500 nm of the photosensitizers with or without the addition of Gleevec at 1 μM concentration. (C–F) Effect of Gleevec on the toxicity of PS <b>1</b> and PS <b>5</b> at 48 h post incubation (light dose: I J).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Erlotinib competition with PSs <b>1</b>, <b>3</b>, and <b>5</b> in UMUC3 and T24 cells. UMUC3 (A) or T24 (B) cells were incubated with the photosensitizer at 1 μM or erlotinib at 3 μM for 4 h. The cells were washed with warmed PBS three times and then imaged using a Zeiss fluorescence microscope.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Comparative uptake of PSs <b>1</b>, <b>3</b>, and <b>5</b> (formulated either in Tween or Pluronic) in tumor, liver, and skin (SCID mice bearing UMUC3 and T24 tumors) at a dose of 0.47 μmol/kg)) at variable time points (λ<sub>ex</sub>: 675 nm, λ<sub>em</sub>: 720), using the IVIS optical imaging system. (b) Comparative <i>in vivo</i> PDT efficacy (long-term antitumor activity) of PSs with and without erlotinib conjugates. (A): PS <b>1</b> (non-erlotinib PS), (B): PS <b>3</b>, erlotinib moiety is attached at position-3 of the PS (C): PS <b>5</b>, erlotinib moiety is attached at position-15 of the PS. PS <b>1</b>, <b>3</b>, and <b>5</b> were individually injected (dose: 0.47 μmol/Kg) to SCID mice bearing UMUC3 tumors at the flank. Mice were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post injection (optimal uptake time), and tumor regrowth was monitored daily. These results suggest that the position of the erlotinib moiety in the PS makes a remarkable difference in long-term tumor cure. (c) Comparative tumor necrosis of mice injected with (A) PS <b>3</b> (effective PDT agent), and (B) PS <b>5</b> that showed limited efficacy at 72 h post light exposure. Mice were treated under similar drug and light doses. Dug dose: 0.47 μmol/kg, light dose: 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>, and the tumors were exposed to light (665 nm) at 24 h post injection of the PS.  CR = Complete response (tumore cure).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparative DCFDA fluorescence before and after exposure to 665 nm light. Plates were exposed to a total of 1 J of light (665 nm) at a rate of 3.2 mW/cm<sup>2.</sup>. The fluorescence value of cells with no DCFDA (background) was subtracted from that before and after PDT. 0.05% H<sub>2</sub>O<sub>2</sub> (30% stock was diluted to 0.18%, and then, 20 μL of it was added to each well) was added to four wells as a control before the plates were exposed to light. Photosensitizers were formulated in Tween 80.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/medium/jm-2018-01927k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A) PET images of SCID mice bearing UMUC3 tumors using <sup>124</sup>I-6 and <sup>18</sup>F-FDG. The images were analyzed using Amide Medical Imaging software. Boxes indicate the volume of interest (VOI) in the coronal plane. Separate scale bars for <sup>18</sup>F-FDG and <sup>124</sup> I-6 images are indicated on the right. The maximum threshold for color distribution was set to 10% in the <sup>18</sup>F-FDG images and 50% in the <sup>124</sup>I-6 images. In each panel, the top row of mice shows <sup>18</sup>F-FDG uptake in the bladder, brain, chest, and muscles, whereas tumor uptake is difficult to visualize. Tumors are well-visualized by <sup>124</sup>I-6 at all time points, and uptake is primarily in the tumor and liver. <sup>124</sup>I-6 is retained in the tumor longer than in other parts of the body. (B) Relative uptake values (RUVs) were calculated as maximum tumor uptake divided by average whole-body uptake. <sup>18</sup>F-FDG (left) and <sup>124</sup>I-6 (right) RUVs indicate almost twice the specific uptake of <sup>124</sup>I-6 at 24 h as compared to that of <sup>18</sup>F-FDG. For II<sup>124</sup>I-6, the RUVs continue to rise at longer time points as it is retained well in the tumor and less in the rest of the body.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01927/20190308/images/large/jm-2018-01927k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01927&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60335" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60335" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer Statistics, 2014</span>. <i>CA—Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.3322/caac.21208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3322%2Fcaac.21208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=24399786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2014&pages=9-29&author=R.+Siegelauthor=J.+Maauthor=Z.+Zouauthor=A.+Jemal&title=Cancer+Statistics%2C+2014&doi=10.3322%2Fcaac.21208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2014</span></div><div class="casAuthors">Siegel Rebecca; Ma Jiemin; Zou Zhaohui; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics.  A total of 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014.  During the most recent 5 years for which there are data (2006-2010), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.4% per year in women.  The combined cancer death rate (deaths per 100,000 population) has been continuously declining for 2 decades, from a peak of 215.1 in 1991 to 171.8 in 2010.  This 20% decline translates to the avoidance of approximately 1,340,400 cancer deaths (952,700 among men and 387,700 among women) during this time period.  The magnitude of the decline in cancer death rates from 1991 to 2010 varies substantially by age, race, and sex, ranging from no decline among white women aged 80 years and older to a 55% decline among black men aged 40 years to 49 years.  Notably, black men experienced the largest drop within every 10-year age group.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-53QNNisGn5agfuraLLzSfW6udTcc2eZUzIony5QHYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjtVOlsw%253D%253D&md5=2aa85d07bbfc7838e1d0e6bf94ce6c46</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21208%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520Statistics%252C%25202014%26jtitle%3DCA%25E2%2580%2594Cancer%2520J.%2520Clin.%26date%3D2014%26volume%3D64%26spage%3D9%26epage%3D29%26doi%3D10.3322%2Fcaac.21208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipley, W. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, A. S.</span></span> <span> </span><span class="NLM_article-title">Bladder Cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>374</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(09)60491-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2FS0140-6736%2809%2960491-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=19520422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos12ru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2009&pages=239-249&author=D.+S.+Kaufmanauthor=W.+U.+Shipleyauthor=A.+S.+Feldman&title=Bladder+Cancer&doi=10.1016%2FS0140-6736%2809%2960491-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Bladder cancer</span></div><div class="casAuthors">Kaufman, Donald S.; Shipley, William U.; Feldman, Adam S.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">9685</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Bladder cancer is a heterogeneous disease, with 70% of patients presenting with superficial tumors, which tend to recur but are generally not life threatening, and 30% presenting as muscle-invasive disease assocd. with a high risk of death from distant metastases.  The main presenting symptom of all bladder cancers is painless hematuria, and the diagnosis is established by urinary cytol. and transurethral tumor resection.  Intravesical treatment is used for carcinoma in situ and other high grade non-muscle-invasive tumors.  The std. of care for muscle-invasive disease is radical cystoprostatectomy, and several types of urinary diversions are offered to patients, with quality of life as an important consideration.  Bladder preservation with transurethral tumor resection, radiation, and chemotherapy can in some cases be equally curative.  Several chemotherapeutic agents have proven to be useful as neoadjuvant or adjuvant treatment and in patients with metastatic disease.  We discuss bladder preserving approaches, combination chemotherapy including new agents, targeted therapies, and advances in mol. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRtPGwwM2gPLVg90H21EOLACvtfcHk0lhgJHhggEHWZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos12ru7g%253D&md5=fb7cc148fe8558cdfdf4fd496844e63b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2960491-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252960491-8%26sid%3Dliteratum%253Aachs%26aulast%3DKaufman%26aufirst%3DD.%2BS.%26aulast%3DShipley%26aufirst%3DW.%2BU.%26aulast%3DFeldman%26aufirst%3DA.%2BS.%26atitle%3DBladder%2520Cancer%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D239%26epage%3D249%26doi%3D10.1016%2FS0140-6736%2809%2960491-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">American Cancer Society</span>.  <i>Bladder Cancer; Survival Rates for Bladder
Cancer by Stage</i>, <span class="NLM_year">2016</span>. Available at <a href="http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-survival-rates" class="extLink">http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-survival-rates</a> (accessed Dec 10, 2014).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=American+Cancer+Society&title=Bladder+Cancer%3B+Survival+Rates+for+Bladder%0ACancer+by+Stage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DBladder%2520Cancer%253B%2520Survival%2520Rates%2520for%2520Bladder%250ACancer%2520by%2520Stage%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, H.
B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natale, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tangen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speights, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelzang, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trump, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deVere White, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarosdy, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghavan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, E. D.</span></span> <span> </span><span class="NLM_article-title">Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa022148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1056%2FNEJMoa022148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=12944571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVSnu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=859-866&author=H.%0AB.+Grossmanauthor=R.+B.+Nataleauthor=C.+M.+Tangenauthor=V.+O.+Speightsauthor=N.+J.+Vogelzangauthor=D.+L.+Trumpauthor=R.+W.+deVere+Whiteauthor=M.+F.+Sarosdyauthor=D.+P.+Woodauthor=D.+Raghavanauthor=E.+D.+Crawford&title=Neoadjuvant+chemotherapy+plus+cystectomy+compared+with+cystectomy+alone+for+locally+advanced+bladder+cancer&doi=10.1056%2FNEJMoa022148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neoadjuvant chemotherapy plus cystectomy compared with cystectomy along for locally advanced bladder cancer</span></div><div class="casAuthors">Grossman, H. Barton; Natale, Ronald B.; Tangen, Catherine M.; Speights, V. O.; Vogelzang, Nicholas J.; Trump, Donald L.; de Vere White, Ralph W.; Sarosdy, Michael F.; Wood, David P., Jr.; Raghavan, Derek; Crawford, E. David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">859-866</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Despite aggressive local therapy, patients with locally advanced bladder cancer are at significant risk for metastases.  We evaluated the ability of neoadjuvant chemotherapy to improve the outcome in patients with locally advanced bladder cancer who were treated with radical cystectomy.  Methods: Patients were enrolled if they had muscle-invasive bladder cancer (stage T2 to T4a) and were to be treated with radical cystectomy.  They were stratified according to age (less than 65 yr vs. 65 yr or older) and stage (superficial muscle invasion vs. more extensive disease) and were randomly assigned to radical cystectomy alone or three cycles of methotrexate, vinblastine, doxorubicin, and cisplatin followed by radical cystectomy.  Results: We enrolled 317 patients over an 11-yr period, 10 of whom were found to be ineligible; thus, 154 were assigned to receive surgery alone and 153 to receive combination therapy.  According to an intention-to-treat anal., the median survival among patients assigned to surgery alone was 46 mo, as compared with 77 mo among patients assigned to combination therapy (P=0.06 by a two-sided stratified log-rank test).  In both groups, improved survival was assocd. with the absence of residual cancer in the cystectomy specimen.  Significantly more patients in the combination-therapy group had no residual disease than patients in the cystectomy group (38 % vs. 15 %, P<0.001).  Conclusions: As compared with radical cystectomy alone, the use of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin followed by radical cystectomy increases the likelihood of eliminating residual cancer in the cystectomy specimen and is assocd. with improved survival among patients with locally advanced bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVL6_8LWXPcbVg90H21EOLACvtfcHk0lhgJHhggEHWZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVSnu7Y%253D&md5=fe61c6f5757118e63094654321ee12cd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa022148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa022148%26sid%3Dliteratum%253Aachs%26aulast%3DGrossman%26aufirst%3DH.%2BB.%26aulast%3DNatale%26aufirst%3DR.%2BB.%26aulast%3DTangen%26aufirst%3DC.%2BM.%26aulast%3DSpeights%26aufirst%3DV.%2BO.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3DTrump%26aufirst%3DD.%2BL.%26aulast%3DdeVere%2BWhite%26aufirst%3DR.%2BW.%26aulast%3DSarosdy%26aufirst%3DM.%2BF.%26aulast%3DWood%26aufirst%3DD.%2BP.%26aulast%3DRaghavan%26aufirst%3DD.%26aulast%3DCrawford%26aufirst%3DE.%2BD.%26atitle%3DNeoadjuvant%2520chemotherapy%2520plus%2520cystectomy%2520compared%2520with%2520cystectomy%2520alone%2520for%2520locally%2520advanced%2520bladder%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D859%26epage%3D866%26doi%3D10.1056%2FNEJMoa022148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trump, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study</span>. <i>BJU Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.1111/bju.13678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fbju.13678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=27743481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2srgsF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2017&pages=605-611&author=N.+Hinataauthor=A.+A.+Husseinauthor=S.+Georgeauthor=D.+L.+Trumpauthor=E.+G.+Levineauthor=K.+Omarauthor=P.+Dasguptaauthor=M.+S.+Khanauthor=A.+Hosseiniauthor=P.+Wiklundauthor=K.+A.+Guru&title=Impact+of+suboptimal+neoadjuvant+chemotherapy+on+peri-operative+outcomes+and+survival+after+robot-assisted+radical+cystectomy%3A+a+multicentre+multinational+study&doi=10.1111%2Fbju.13678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study</span></div><div class="casAuthors">Hinata Nobuyuki; Hussein Ahmed Aly; George Saby; Levine Ellis G; Guru Khurshid A; Hinata Nobuyuki; Hussein Ahmed Aly; Trump Donald L; Omar Kawa; Dasgupta Prokar; Khan Muhammad Shamim; Hosseini Abolfazl; Wiklund Peter</div><div class="citationInfo"><span class="NLM_cas:title">BJU international</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-611</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To evaluate the effect of suboptimal dosing on the outcomes of patients who received neoadjuvant chemotherapy (NAC) and robot-assisted radical cystectomy (RARC).  PATIENTS AND METHODS:  We retrospectively reviewed 336 consecutive patients with urothelial carcinoma of the bladder who were treated with NAC and RARC at three academic institutions.  Outcomes were compared among three groups: patients who received optimal NAC; patients who received suboptimal NAC; and those who did not receive NAC.  To adjust for potential baseline differences between the three groups, propensity-score-based matching was performed.  The suboptimal dose group was defined as those who received <3 cycles of cisplatin-based chemotherapy, received a decreased dosage, or those not treated with cisplatin.  Primary outcomes analysed were recurrence-free survival (RFS) and overall survival (OS).  Secondary outcomes were peri-operative complications and readmissions after RARC.  RESULTS:  After propensity-score matching, 69 patients in the cohort received optimal-dose NAC, 41 received suboptimal NAC and 69 did not receive NAC.  Complication rates and readmission rates did not differ significantly among the three groups.  On multivariable analysis, suboptimal NAC and no NAC were independent predictors of worse RFS (hazard ratio [HR] 2.5, 95% confidence interval [CI] 1.2-5.7, P = 0.01 and HR 2.4, 95% CI 1.28-5.16, P = 0.01) and worse OS (HR 4.5, 95% CI 1.6-15.0, P < 0.01 and HR 4.9, 95% CI 1.9-15.6, P < 0.01) in patients who received NAC and RARC.  Failure to achieve pathological complete response (ypT0N0) was also an independent predictor of worse RFS (HR 6.6, 95% CI 1.3-20.9; P = 0.02) and OS (HR 4.9, 95% CI 1.8-15.3; P = 0.02).  CONCLUSION:  Optimal NAC resulted in a better RFS and OS when compared with suboptimal or no NAC.  Suboptimal and no NAC were associated with worse OS and RFS.  These findings will facilitate improved patient counseling and treatment selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT02UKov-4BIGhHGZei4OW9fW6udTcc2ebE_QxicjEYpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srgsF2htA%253D%253D&md5=7cf02baefce652fb20c17591cb25afd7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fbju.13678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbju.13678%26sid%3Dliteratum%253Aachs%26aulast%3DHinata%26aufirst%3DN.%26aulast%3DHussein%26aufirst%3DA.%2BA.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DTrump%26aufirst%3DD.%2BL.%26aulast%3DLevine%26aufirst%3DE.%2BG.%26aulast%3DOmar%26aufirst%3DK.%26aulast%3DDasgupta%26aufirst%3DP.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DHosseini%26aufirst%3DA.%26aulast%3DWiklund%26aufirst%3DP.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DImpact%2520of%2520suboptimal%2520neoadjuvant%2520chemotherapy%2520on%2520peri-operative%2520outcomes%2520and%2520survival%2520after%2520robot-assisted%2520radical%2520cystectomy%253A%2520a%2520multicentre%2520multinational%2520study%26jtitle%3DBJU%2520Int.%26date%3D2017%26volume%3D119%26spage%3D605%26epage%3D611%26doi%3D10.1111%2Fbju.13678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dibaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvshinoff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a quality assurance score for robot-assisted radical cystectomy: A 10-year Analysis</span>. <i>Urology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">124</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1016/j.urology.2016.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.urology.2016.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=27491964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2s3nvV2isQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2016&pages=124-129&author=A.+A.+Husseinauthor=S.+Dibajauthor=N.+Hinataauthor=E.+Fieldauthor=K.+O%E2%80%99Learyauthor=B.+Kuvshinoffauthor=J.+L.+Mohlerauthor=G.+Wildingauthor=K.+A.+Guru&title=Development+and+validation+of+a+quality+assurance+score+for+robot-assisted+radical+cystectomy%3A+A+10-year+Analysis&doi=10.1016%2Fj.urology.2016.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis</span></div><div class="casAuthors">Hussein Ahmed A; Dibaj Shiva; Field Erinn; Mohler James L; Wilding Gregory; Hinata Nobuyuki; O'leary Kathleen; Kuvshinoff Boris; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">Urology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124-129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop quality assessment tool to evaluate surgical performance for robot-assisted radical cystectomy program.  METHODS:  A prospectively maintained quality assurance database of 425 consecutive robot-assisted radical cystectomies performed by a single surgeon between 2005 and 2015 was retrospectively reviewed.  Potentially modifiable factors, related to the management and perioperative care of patients, were used to evaluate patient care.  Criteria included the following: preoperative (administration of neoadjuvant chemotherapy); operative (operative time <6.5 hours and estimated blood loss <500 cc); pathologic (negative soft tissue surgical margins and lymph node yield ≥20); and postoperative (no high-grade complications, readmission, or noncancer-related mortality within 30 days).The Quality Cystectomy Score (QCS) was developed (1 star: achieving ≤2 criteria or mortality within 30 days; 2 stars: 3 or 4 criteria met; 3 stars: 5 or 6 criteria met; and 4 stars: 7 or all criteria met).  Univariate and multivariate Cox proportional hazard regression models were fitted to test for the association between QCS and survival outcomes.  RESULTS:  Most patients (85%) achieved at least 3 stars, and more patients achieved 4 stars with time.  High QCS was associated with better recurrence-free, cancer-specific, and overall survival (P values <.05).  None of the patients with 1-star were alive at 1 year.  Patients with 4 stars achieved the best survival rates (recurrence-free survival [62%], cancer-specific survival [70%], and overall survival [53%] at 5 years) (log rank P < .0001).  CONCLUSION:  Continuous assessment for quality improvement facilitated implementation and maintenance of robot-assisted program for bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcToo6qAX0rnoJdYoSR9eyvsfW6udTcc2eYKHex8OzGbzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3nvV2isQ%253D%253D&md5=a2edd80884ef1d34876229152f86ad89</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.urology.2016.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.urology.2016.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DA.%2BA.%26aulast%3DDibaj%26aufirst%3DS.%26aulast%3DHinata%26aufirst%3DN.%26aulast%3DField%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DK.%26aulast%3DKuvshinoff%26aufirst%3DB.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520quality%2520assurance%2520score%2520for%2520robot-assisted%2520radical%2520cystectomy%253A%2520A%252010-year%2520Analysis%26jtitle%3DUrology%26date%3D2016%26volume%3D97%26spage%3D124%26epage%3D129%26doi%3D10.1016%2Fj.urology.2016.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashmi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dibaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altartir, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boateng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Reoperations following robot-assisted radical cystectomy: A decade of experience</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">1368</span>– <span class="NLM_lpage">1376</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2015.10.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.juro.2015.10.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=26551296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC28vgt1equw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2016&pages=1368-1376&author=A.+A.+Husseinauthor=Z.+Hashmiauthor=S.+Dibajauthor=T.+Altartirauthor=T.+Fioricaauthor=J.+Wingauthor=M.+Durraniauthor=J.+Binkowskiauthor=L.+Boatengauthor=G.+Wildingauthor=K.+A.+Guru&title=Reoperations+following+robot-assisted+radical+cystectomy%3A+A+decade+of+experience&doi=10.1016%2Fj.juro.2015.10.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Reoperations following Robot-Assisted Radical Cystectomy: A Decade of Experience</span></div><div class="casAuthors">Hussein Ahmed A; Hashmi Zishan; Dibaj Seyedeh; Altartir Tareq; Fiorica Thomas; Wing Joseph; Durrani Mohammad; Binkowski John; Boateng Lesley; Wilding Gregory; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1368-1376</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  There is a paucity of data regarding the operative management of complications after robot-assisted radical cystectomy.  We reviewed operative management of robot-assisted radical cystectomy specific complications during our 10-year experience with this procedure and assessed the feasibility, safety and outcomes of robot-assisted reoperations.  MATERIALS AND METHODS:  We retrospectively reviewed the records of all patients who underwent surgical interventions for robot-assisted radical cystectomy specific complications between 2005 and 2015.  Univariable and multivariable logistic regression models were fit to evaluate predictors of surgical intervention after robot-assisted radical cystectomy.  Kaplan-Meier curves were used to describe time to surgical interventions.  RESULTS:  A total of 92 patients (23%) underwent surgical intervention after robot-assisted radical cystectomy.  Mean followup was 27 months.  Average time to any surgical intervention after cystectomy was 14 months.  The reoperation rate was 5%, 2% and 16% at 30, 31 to 90 and greater than 90 days, respectively.  Using the Kaplan-Meier method surgical interventions occurred at a rate of 30% at 2 years and 46% at 5 years.  Interventions for ureteroileal complications were the most common (48 cases) followed by interventions for bowel obstruction, fistulas and abdominal wall related complications (11 cases).  Clavien 3 or greater complications and neoadjuvant chemotherapy were associated with surgical intervention.  CONCLUSIONS:  Even in experienced hands the long-term complications of robot-assisted radical cystectomy are notable.  Of our patients 23% required surgical interventions after the procedure.  Our initial experience with robot-assisted management of robot-assisted radical cystectomy complications appears safe and feasible, although the decision to proceed is determined primarily by surgeon experience.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe_4IC_iyrYXthwrmtH4OBfW6udTcc2eYKHex8OzGbzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vgt1equw%253D%253D&md5=bfa6613c8d7dfe552ac9baa20bc38756</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2015.10.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2015.10.171%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DA.%2BA.%26aulast%3DHashmi%26aufirst%3DZ.%26aulast%3DDibaj%26aufirst%3DS.%26aulast%3DAltartir%26aufirst%3DT.%26aulast%3DFiorica%26aufirst%3DT.%26aulast%3DWing%26aufirst%3DJ.%26aulast%3DDurrani%26aufirst%3DM.%26aulast%3DBinkowski%26aufirst%3DJ.%26aulast%3DBoateng%26aufirst%3DL.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DReoperations%2520following%2520robot-assisted%2520radical%2520cystectomy%253A%2520A%2520decade%2520of%2520experience%26jtitle%3DJ.%2520Urol.%26date%3D2016%26volume%3D195%26spage%3D1368%26epage%3D1376%26doi%3D10.1016%2Fj.juro.2015.10.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annerstedt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motttrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, B.</span></span> <span> </span><span class="NLM_article-title">Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy</span>. <i>Eur. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1016/j.eururo.2014.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.eururo.2014.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25560798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2MvjslWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=376-401&author=G.+Novaraauthor=J.+W.+Cattoauthor=T.+Wilsonauthor=M.+Annerstedtauthor=K.+Chanauthor=D.+G.+Murphyauthor=A.+Motttrieauthor=J.+O.+Peabodyauthor=E.+C.+Skinnerauthor=P.+N.+Wiklundauthor=K.+A.+Guruauthor=B.+Yuh&title=Systematic+review+and+cumulative+analysis+of+perioperative+outcomes+and+complications+after+robot-assisted+radical+cystectomy&doi=10.1016%2Fj.eururo.2014.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy</span></div><div class="casAuthors">Novara Giacomo; Catto James W F; Wilson Timothy; Chan Kevin; Yuh Bertram; Annerstedt Magnus; Murphy Declan G; Motttrie Alexander; Peabody James O; Skinner Eila C; Wiklund Peter N; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-401</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  Although open radical cystectomy (ORC) is still the standard approach, laparoscopic radical cystectomy (LRC) and robot-assisted radical cystectomy (RARC) have gained popularity.  OBJECTIVE:  To report a systematic literature review and cumulative analysis of perioperative outcomes and complications of RARC in comparison with ORC and LRC.  EVIDENCE ACQUISITION:  Medline, Scopus, and Web of Science databases were searched using a free-text protocol including the terms robot-assisted radical cystectomy or da Vinci radical cystectomy or robot* radical cystectomy.  RARC case series and studies comparing RARC with either ORC or LRC were collected.  Cumulative analysis was conducted.  EVIDENCE SYNTHESIS:  The searches retrieved 105 papers.  According to the different diversion type, overall mean operative time ranged from 360 to 420 min.  Similarly, mean blood loss ranged from 260 to 480 ml.  Mean in-hospital stay was about 9 d for all diversion types, with consistently high readmission rates.  In series reporting on RARC with either extracorporeal or intracorporeal conduit diversion, overall 90-d complication rates were 59% (high-grade complication: 15%).  In series reporting RARC with intracorporeal continent diversion, the overall 30-d complication rate was 45.7% (high-grade complication: 28%).  Reported mortality rates were ≤3% for all diversion types.  Comparing RARC and ORC, cumulative analyses demonstrated shorter operative time for ORC, whereas blood loss and in-hospital stay were better with RARC (all p values <0.003).  Moreover, 90-d complication rates of any-grade and 90-d grade 3 complication rates were lower for RARC (all p values <0.04), whereas high-grade complication and mortality rates were similar.  CONCLUSIONS:  RARC can be performed safely with acceptable perioperative outcome, although complications are common.  Cumulative analyses demonstrated that operative time was shorter with ORC, whereas RARC may provide some advantages in terms of blood loss and transfusion rates and, more limitedly, for postoperative complication rates over ORC and LRC.  PATIENT SUMMARY:  Although open radical cystectomy (RC) is still regarded as a standard treatment for muscle-invasive bladder cancer, laparoscopic and robot-assisted RC are becoming more popular.  Robotic RC can be safely performed with acceptably low risk of blood loss, transfusion, and intraoperative complications; however, as for open RC, the risk of postoperative complications is high, including a substantial risk of major complication and reoperation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRNsitfnFYflUIs6wFK5xJfW6udTcc2eY1vuenvOci6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvjslWlsA%253D%253D&md5=9d07eded21f33c84d2c6d015d205c9fe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2014.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2014.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DNovara%26aufirst%3DG.%26aulast%3DCatto%26aufirst%3DJ.%2BW.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DAnnerstedt%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DD.%2BG.%26aulast%3DMotttrie%26aufirst%3DA.%26aulast%3DPeabody%26aufirst%3DJ.%2BO.%26aulast%3DSkinner%26aufirst%3DE.%2BC.%26aulast%3DWiklund%26aufirst%3DP.%2BN.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26aulast%3DYuh%26aufirst%3DB.%26atitle%3DSystematic%2520review%2520and%2520cumulative%2520analysis%2520of%2520perioperative%2520outcomes%2520and%2520complications%2520after%2520robot-assisted%2520radical%2520cystectomy%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D67%26spage%3D376%26epage%3D401%26doi%3D10.1016%2Fj.eururo.2014.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherr, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Daghmin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dibaj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richstone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeckle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaouk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rha, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K. A.</span></span> <span> </span><span class="NLM_article-title">Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium</span>. <i>Eur. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1016/j.eururo.2015.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.eururo.2015.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25985883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2MfltVSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=721-728&author=S.+J.+Razaauthor=T.+Wilsonauthor=J.+O.+Peabodyauthor=P.+Wiklundauthor=D.+S.+Scherrauthor=A.+Al-Daghminauthor=S.+Dibajauthor=M.+S.+Khanauthor=P.+Dasguptaauthor=A.+Mottrieauthor=M.+Menonauthor=B.+Yuhauthor=L.+Richstoneauthor=M.+Saarauthor=M.+Stoeckleauthor=A.+Hosseiniauthor=J.+Kaoukauthor=J.+L.+Mohlerauthor=K.+H.+Rhaauthor=G.+Wildingauthor=K.+A.+Guru&title=Long-term+oncologic+outcomes+following+robot-assisted+radical+cystectomy%3A+results+from+the+International+Robotic+Cystectomy+Consortium&doi=10.1016%2Fj.eururo.2015.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium</span></div><div class="casAuthors">Raza Syed Johar; Al-Daghmin Ali; Dibaj Shiva; Mohler James L; Wilding Gregory; Wilson Timothy; Yuh Bertram; Peabody James O; Menon Mani; Wiklund Peter; Hosseini Abolfazl; Scherr Douglas S; Khan Muhammad Shamim; Dasgupta Prokar; Mottrie Alex; Richstone Lee; Saar Matthias; Stoeckle Michael; Kaouk Jihad; Rha Koon-Ho; Guru Khurshid A</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Long-term oncologic data on patients undergoing robot-assisted radical cystectomy (RARC) are limited and based largely on single-institution series.  OBJECTIVE:  Report survival outcomes of patients who underwent RARC ≥5 yr ago.  DESIGN, SETTING, AND PARTICIPANTS:  Retrospective review of the prospectively populated International Robotic Cystectomy Consortium multi-institutional database identified 743 patients with RARC performed ≥5 yr ago.  Clinical, pathologic, and survival data at the latest follow-up were collected.  Patients with palliative RARC were excluded.  Final analysis was performed on 702 patients from 11 institutions in 6 countries.  INTERVENTION:  RARC.  OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:  Outcomes of interest, recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were plotted using Kaplan-Meier survival curves.  A Cox proportional hazards model was used to identify factors that predicted outcomes.  RESULTS AND LIMITATIONS:  Pathologic organ-confined (OC) disease was found in 62% of patients.  Soft tissue surgical margins (SMs) were positive in 8%.  Median lymph node (LN) yield was 16, and 21% of patients had positive LNs.  Median follow-up was 67 mo (interquartile range: 18-84 mo).  Five-year RFS, CSS, and OS were 67%, 75%, and 50%, respectively.  Non-OC disease and SMs were associated with poorer RFS, CSS, and OS on multivariable analysis.  Age predicted poorer CSS and OS.  Adjuvant chemotherapy and positive SMs were predictors of RFS (hazard ratio: 3.20 and 2.16; p<0.001 and p<0.005, respectively).  Stratified survival curves demonstrated poorer outcomes for positive SM, LN, and non-OC disease.  Retrospective interrogation and lack of contemporaneous comparison groups that underwent open radical cystectomy were major limitations.  CONCLUSIONS:  The largest multi-institutional series to date reported long-term survival outcomes after RARC.  PATIENT SUMMARY:  Patients who underwent robot-assisted radical cystectomy for bladder cancer have acceptable long-term survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRL3xc9kwqF8VUIs6wFK5xJfW6udTcc2eY1vuenvOci6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfltVSqsg%253D%253D&md5=a8fd9b09fd080f175ccafb1a00181c2e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2015.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2015.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DRaza%26aufirst%3DS.%2BJ.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DPeabody%26aufirst%3DJ.%2BO.%26aulast%3DWiklund%26aufirst%3DP.%26aulast%3DScherr%26aufirst%3DD.%2BS.%26aulast%3DAl-Daghmin%26aufirst%3DA.%26aulast%3DDibaj%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DDasgupta%26aufirst%3DP.%26aulast%3DMottrie%26aufirst%3DA.%26aulast%3DMenon%26aufirst%3DM.%26aulast%3DYuh%26aufirst%3DB.%26aulast%3DRichstone%26aufirst%3DL.%26aulast%3DSaar%26aufirst%3DM.%26aulast%3DStoeckle%26aufirst%3DM.%26aulast%3DHosseini%26aufirst%3DA.%26aulast%3DKaouk%26aufirst%3DJ.%26aulast%3DMohler%26aufirst%3DJ.%2BL.%26aulast%3DRha%26aufirst%3DK.%2BH.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DGuru%26aufirst%3DK.%2BA.%26atitle%3DLong-term%2520oncologic%2520outcomes%2520following%2520robot-assisted%2520radical%2520cystectomy%253A%2520results%2520from%2520the%2520International%2520Robotic%2520Cystectomy%2520Consortium%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D68%26spage%3D721%26epage%3D728%26doi%3D10.1016%2Fj.eururo.2015.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiklund, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annerstedt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bochner, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montorsi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peabody, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redorta, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenzl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, J.</span></span> <span> </span><span class="NLM_article-title">Pasadena Consensus Panel. Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consenus Panel</span>. <i>Eur. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1016/j.eururo.2014.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.eururo.2014.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25582930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC2MvmtVSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=363-375&author=T.+G.+Wilsonauthor=K.+Guruauthor=R.+C.+Rosenauthor=P.+Wiklundauthor=M.+Annerstedtauthor=B.+H.+Bochnerauthor=K.+G.+Chanauthor=F.+Montorsiauthor=A.+Mottrieauthor=D.+Murphyauthor=G.+Novaraauthor=J.+O.+Peabodyauthor=J.+P.+Redortaauthor=E.+C.+Skinnerauthor=G.+Thalmannauthor=A.+Stenzlauthor=B.+Yuhauthor=J.+Catto&title=Pasadena+Consensus+Panel.+Best+practices+in+robot-assisted+radical+cystectomy+and+urinary+reconstruction%3A+recommendations+of+the+Pasadena+Consenus+Panel&doi=10.1016%2Fj.eururo.2014.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel</span></div><div class="casAuthors">Wilson Timothy G; Guru Khurshid; Rosen Raymond C; Wiklund Peter; Annerstedt Magnus; Bochner Bernard H; Chan Kevin G; Yuh Bertram; Montorsi Francesco; Mottrie Alexandre; Murphy Declan; Novara Giacomo; Peabody James O; Palou Redorta Joan; Skinner Eila C; Thalmann George; Stenzl Arnulf; Catto James</div><div class="citationInfo"><span class="NLM_cas:title">European urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  Robot-assisted surgery is increasingly used for radical cystectomy (RC) and urinary reconstruction.  Sufficient data have accumulated to allow evidence-based consensus on key issues such as perioperative management, comparative effectiveness on surgical complications, and oncologic short- to midterm outcomes.  OBJECTIVE:  A 2-d conference of experts on RC and urinary reconstruction was organized in Pasadena, California, and the City of Hope Cancer Center in Duarte, California, to systematically review existing peer-reviewed literature on robot-assisted RC (RARC), extended lymphadenectomy, and urinary reconstruction.  No commercial support was obtained for the conference.  EVIDENCE ACQUISITION:  A systematic review of the literature was performed in agreement with the PRISMA statement.  EVIDENCE SYNTHESIS:  Systematic literature reviews and individual presentations were discussed, and consensus on all key issues was obtained.  Most operative, intermediate-term oncologic, functional, and complication outcomes are similar between open RC (ORC) and RARC.  RARC consistently results in less blood loss and a reduced need for transfusion during surgery.  RARC generally requires longer operative time than ORC, particularly with intracorporeal reconstruction.  Robotic assistance provides ergonomic value for surgeons.  Surgeon experience and institutional volume strongly predict favorable outcomes for either open or robotic techniques.  CONCLUSIONS:  RARC appears to be similar to ORC in terms of operative, pathologic, intermediate-term oncologic, complication, and most functional outcomes.  RARC consistently results in less blood loss and a reduced need for transfusion during surgery.  RARC can be more expensive than ORC, although high procedural volume may attenuate this difference.  PATIENT SUMMARY:  Robot-assisted radical cystectomy (RARC) is an alternative to open surgery for patients with bladder cancer who require removal of their bladder and reconstruction of their urinary tract.  RARC appears to be similar to open surgery for most important outcomes such as the rate of complications and intermediate-term cancer-specific survival.  Although RARC has some ergonomic advantages for surgeons and may result in less blood loss during surgery, it is more time consuming and may be more expensive than open surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLXSlQSB8SfpggzHGM8X5CfW6udTcc2eZVugeIoaVvULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvmtVSkug%253D%253D&md5=10dc9a6d36fab4707a3c945273acaad8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2014.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2014.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BG.%26aulast%3DGuru%26aufirst%3DK.%26aulast%3DRosen%26aufirst%3DR.%2BC.%26aulast%3DWiklund%26aufirst%3DP.%26aulast%3DAnnerstedt%26aufirst%3DM.%26aulast%3DBochner%26aufirst%3DB.%2BH.%26aulast%3DChan%26aufirst%3DK.%2BG.%26aulast%3DMontorsi%26aufirst%3DF.%26aulast%3DMottrie%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DNovara%26aufirst%3DG.%26aulast%3DPeabody%26aufirst%3DJ.%2BO.%26aulast%3DRedorta%26aufirst%3DJ.%2BP.%26aulast%3DSkinner%26aufirst%3DE.%2BC.%26aulast%3DThalmann%26aufirst%3DG.%26aulast%3DStenzl%26aufirst%3DA.%26aulast%3DYuh%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DJ.%26atitle%3DPasadena%2520Consensus%2520Panel.%2520Best%2520practices%2520in%2520robot-assisted%2520radical%2520cystectomy%2520and%2520urinary%2520reconstruction%253A%2520recommendations%2520of%2520the%2520Pasadena%2520Consenus%2520Panel%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D67%26spage%3D363%26epage%3D375%26doi%3D10.1016%2Fj.eururo.2014.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, E. R.</span></span> <span> </span><span class="NLM_article-title">EGF receptor trafficking: consequences for signaling and cancer</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2013.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.tcb.2013.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=24295852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2gt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=26-34&author=A.+Tomasauthor=C.+E.+Futterauthor=E.+R.+Eden&title=EGF+receptor+trafficking%3A+consequences+for+signaling+and+cancer&doi=10.1016%2Fj.tcb.2013.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">EGF receptor trafficking: consequences for signaling and cancer</span></div><div class="casAuthors">Tomas, Alejandra; Futter, Clare E.; Eden, Emily R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-34</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The ligand-stimulated epidermal growth factor receptor (EGFR) has been extensively studied in the anal. of mol. mechanisms regulating endocytic traffic and the role of that traffic in signal transduction.  Although such studies have largely focused on mitogenic signaling and dysregulated traffic in tumorigenesis, there is growing interest in the potential role of EGFR traffic in cell survival and the consequent response to cancer therapy.  Here we review recent advances in our understanding of mol. mechanisms regulating ligand-stimulated EGFR activation, internalization, and post-endocytic sorting.  The role of EGFR overexpression/mutation and new modulators of EGFR traffic in cancer and the response to cancer therapeutics are also discussed.  Finally, we speculate on the relationship between EGFR traffic and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLWxypVYs-bVg90H21EOLACvtfcHk0liRHGLP2YI4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2gt7zP&md5=850921a0c652f9401704f4152db482a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2013.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2013.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DTomas%26aufirst%3DA.%26aulast%3DFutter%26aufirst%3DC.%2BE.%26aulast%3DEden%26aufirst%3DE.%2BR.%26atitle%3DEGF%2520receptor%2520trafficking%253A%2520consequences%2520for%2520signaling%2520and%2520cancer%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26spage%3D26%26epage%3D34%26doi%3D10.1016%2Fj.tcb.2013.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yewale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baradia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vhora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, A.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor targeting in cancer: A review of trends and strategies</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">8690</span>– <span class="NLM_lpage">8707</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.07.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.biomaterials.2013.07.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23953842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=8690-8707&author=C.+Yewaleauthor=D.+Baradiaauthor=I.+Vhoraauthor=S.+Patilauthor=A.+Misra&title=Epidermal+growth+factor+receptor+targeting+in+cancer%3A+A+review+of+trends+and+strategies&doi=10.1016%2Fj.biomaterials.2013.07.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor targeting in cancer: A review of trends and strategies</span></div><div class="casAuthors">Yewale, Chetan; Baradia, Dipesh; Vhora, Imran; Patil, Sushilkumar; Misra, Ambikanandan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">8690-8707</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The epidermal growth factor receptor (EGFR) is a cell-surface receptor belonging to ErbB family of tyrosine kinase and it plays a vital role in the regulation of cell proliferation, survival and differentiation.  However; EGFR is aberrantly activated by various mechanisms like receptor overexpression, mutation, ligand-dependent receptor dimerization, ligand-independent activation and is assocd. with development of variety of tumors.  Therefore, specific EGFR inhibition is one of the key targets for cancer therapy.  Two major approaches have been developed and demonstrated benefits in clin. trials for targeting EGFR; monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs).  EGFR inhibitors like, cetuximab, panitumumab, etc. (mAbs) and gefitinib, erlotinib, lapatinib, etc. (TKIs) are now com. available for treatment of variety of cancers.  Recently, many other agents like peptides, nanobodies, affibodies and antisense oligonucleotide have also shown better efficacy in targeting and inhibiting EGFR.  Now a days, efforts are being focused to identify mol. markers that can predict patients more likely to respond to anti-EGFR therapy; to find out combinatorial approaches with EGFR inhibitors and to bring new therapeutic agents with clin. efficacy.  In this review we have outlined the role of EGFR in cancer, different types of EGFR inhibitors, preclin. and clin. status of EGFR inhibitors as well as summarized the recent efforts made in the field of mol. EGFR targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP89tYD6VDorVg90H21EOLACvtfcHk0liRHGLP2YI4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL&md5=e7ca806ebdfe6a6f48962cf3c8620468</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.07.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.07.100%26sid%3Dliteratum%253Aachs%26aulast%3DYewale%26aufirst%3DC.%26aulast%3DBaradia%26aufirst%3DD.%26aulast%3DVhora%26aufirst%3DI.%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520targeting%2520in%2520cancer%253A%2520A%2520review%2520of%2520trends%2520and%2520strategies%26jtitle%3DBiomaterials%26date%3D2013%26volume%3D34%26spage%3D8690%26epage%3D8707%26doi%3D10.1016%2Fj.biomaterials.2013.07.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vourganti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apolo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metwalli, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the epidermal growth factor receptor in bladder cancer</span>. <i>J. Carcinog. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>04</i></span>,  <span class="NLM_fpage">2157</span>– <span class="NLM_lpage">2518</span>, <span class="refDoi"> DOI: 10.4172/2157-2518.1000143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.4172%2F2157-2518.1000143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=04&publication_year=2013&pages=2157-2518&author=M.+D.+Weintraubauthor=S.+Vourgantiauthor=Q.+Liauthor=A.+B.+Apoloauthor=A.+R.+Metwalliauthor=P.+K.+Agarwal&title=Targeting+the+epidermal+growth+factor+receptor+in+bladder+cancer&doi=10.4172%2F2157-2518.1000143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4172%2F2157-2518.1000143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4172%252F2157-2518.1000143%26sid%3Dliteratum%253Aachs%26aulast%3DWeintraub%26aufirst%3DM.%2BD.%26aulast%3DVourganti%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DApolo%26aufirst%3DA.%2BB.%26aulast%3DMetwalli%26aufirst%3DA.%2BR.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26atitle%3DTargeting%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520in%2520bladder%2520cancer%26jtitle%3DJ.%2520Carcinog.%2520Mutagen.%26date%3D2013%26volume%3D04%26spage%3D2157%26epage%3D2518%26doi%3D10.4172%2F2157-2518.1000143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniele, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span> <span> </span><span class="NLM_article-title">Monoclonal antibodies targeting the epidermal growth factor receptor</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.2174/1389450053765842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.2174%2F1389450053765842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=15857288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlansb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=275-287&author=R.+Biancoauthor=G.+Danieleauthor=F.+Ciardielloauthor=G.+Tortora&title=Monoclonal+antibodies+targeting+the+epidermal+growth+factor+receptor&doi=10.2174%2F1389450053765842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies targeting the epidermal growth factor receptor</span></div><div class="casAuthors">Bianco, R.; Daniele, G.; Ciardiello, F.; Tortora, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-287</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The epidermal growth factor receptor (EGFR, HER1) autocrine pathway contributes to a no. of highly relevant processes in cancer development and progression, including cell proliferation, regulation of apoptotic cell death, angiogenesis and metastatic spread.  The crucial role that EGFR plays in human cancers has led to an extensive search for selective inhibitors of its signaling pathway.  The results of a large body of preclin. studies and clin. trials thus far conducted suggest that targeting the EGFR could bring a significant contribution to cancer therapy.  A variety of different approaches are currently being used to target the EGFR.  The most promising strategies in clin. development include monoclonal antibodies, to prevent ligand binding, and small mols. inhibitors of the tyrosine kinase enzymic activity, that inhibit autophosphorylation and downstream intracellular signaling.  Several blocking monoclonal antibodies against the EGFR have been developed.  Among these, IMC-225 is a chimeric human-mouse monoclonal IgG1 antibody that has been the first anti-EGFR targeted therapy to enter clin. evaluation in cancer patients in Phase II and III studies, alone or in combination with conventional radiotherapy and chemotherapy.  However, other antibodies against EGFR have demonstrated antitumor activity in several preclin. models of human cancer and are currently under investigation in the clin. setting, such as ICR62, ABX-EGF and EMD72000.  This review will focus on all the preclin. data available on monoclonal antibodies engineered against the EGF receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogab5NnAS547Vg90H21EOLACvtfcHk0liRHGLP2YI4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlansb0%253D&md5=8f85552acb124d817863a3e0b0b3b0dc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1389450053765842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450053765842%26sid%3Dliteratum%253Aachs%26aulast%3DBianco%26aufirst%3DR.%26aulast%3DDaniele%26aufirst%3DG.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DTortora%26aufirst%3DG.%26atitle%3DMonoclonal%2520antibodies%2520targeting%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2005%26volume%3D6%26spage%3D275%26epage%3D287%26doi%3D10.2174%2F1389450053765842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartore-Bianchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichelatti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolantonio, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dosso, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzucchelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frattini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siena, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span> <span> </span><span class="NLM_article-title">PIK3CA mutations in colorectal cancer associated with clinical resistance to EGFR-targeted monoclonal antibodies</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1851</span>– <span class="NLM_lpage">1857</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-2466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1158%2F0008-5472.CAN-08-2466" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=1851-1857&author=A.+Sartore-Bianchiauthor=M.+Martiniauthor=F.+Molinariauthor=S.+Veroneseauthor=M.+Nichelattiauthor=S.+Artaleauthor=F.+D.+Nicolantonioauthor=P.+Salettiauthor=S.+D.+Dossoauthor=L.+Mazzucchelliauthor=M.+Frattiniauthor=S.+Sienaauthor=A.+Bardelli&title=PIK3CA+mutations+in+colorectal+cancer+associated+with+clinical+resistance+to+EGFR-targeted+monoclonal+antibodies&doi=10.1158%2F0008-5472.CAN-08-2466"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-2466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-2466%26sid%3Dliteratum%253Aachs%26aulast%3DSartore-Bianchi%26aufirst%3DA.%26aulast%3DMartini%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DF.%26aulast%3DVeronese%26aufirst%3DS.%26aulast%3DNichelatti%26aufirst%3DM.%26aulast%3DArtale%26aufirst%3DS.%26aulast%3DNicolantonio%26aufirst%3DF.%2BD.%26aulast%3DSaletti%26aufirst%3DP.%26aulast%3DDosso%26aufirst%3DS.%2BD.%26aulast%3DMazzucchelli%26aufirst%3DL.%26aulast%3DFrattini%26aufirst%3DM.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DPIK3CA%2520mutations%2520in%2520colorectal%2520cancer%2520associated%2520with%2520clinical%2520resistance%2520to%2520EGFR-targeted%2520monoclonal%2520antibodies%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D1851%26epage%3D1857%26doi%3D10.1158%2F0008-5472.CAN-08-2466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janmaat, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span> <span> </span><span class="NLM_article-title">Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1634/theoncologist.8-6-576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1634%2Ftheoncologist.8-6-576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=14657536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSqs7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=576-586&author=M.+L.+Janmaatauthor=G.+Giaccone&title=Small-molecule+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitors&doi=10.1634%2Ftheoncologist.8-6-576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">small-molecule epidermal growth factor receptor tyrosine kinase inhibitors</span></div><div class="casAuthors">Janmaat, Maarten L.; Giaccone, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576-586</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1083-7159</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">A review.  The growth and proliferation of cells are usually tightly regulated processes that are activated by stimuli from their environment.  Epidermal growth factor (EGF)-related peptides represent a class of mols. that can trigger cell proliferation, among several cellular processes, such as differentiation, migration, and survival.  Binding of EGF-like peptides to the EGF receptor (EGFR) at the cell surface leads to a cascade of intracellular reactions that transduce signals to the nucleus, resulting in particular gene expression patterns.  However, in many tumor cells, the regulation of EGFR activity is lost, due to increased or aberrant expression of the receptor or its ligands, and this contributes to many processes important for tumor growth, including cell proliferation, survival, angiogenesis, invasion, and metastasis.  Many strategies have been developed that specifically target the EGFR and inhibit its activity.  Of these, small-mol. tyrosine kinase inhibitors represent one of the most promising classes of anticancer agents.  Here, we describe the status of small-mol. EGFR tyrosine kinase inhibitors in preclin. and clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQzJhkHxRx57Vg90H21EOLACvtfcHk0li8IcfY_cMzOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSqs7rJ&md5=3ea6c899e55d7997d24d994fc83f3013</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.8-6-576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.8-6-576%26sid%3Dliteratum%253Aachs%26aulast%3DJanmaat%26aufirst%3DM.%2BL.%26aulast%3DGiaccone%26aufirst%3DG.%26atitle%3DSmall-molecule%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DOncologist%26date%3D2003%26volume%3D8%26spage%3D576%26epage%3D586%26doi%3D10.1634%2Ftheoncologist.8-6-576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steadman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blayney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, S. E.</span></span> <span> </span><span class="NLM_article-title">Pheophorbide-a is a specific probe for ABCG2 function and inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">1242</span>– <span class="NLM_lpage">1246</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-03-3298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1158%2F0008-5472.CAN-03-3298" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1242-1246&author=R.+W.+Robeyauthor=K.+Steadmanauthor=O.+Polgarauthor=K.+Morisakiauthor=M.+Blayneyauthor=P.+Mistryauthor=S.+E.+Bates&title=Pheophorbide-a+is+a+specific+probe+for+ABCG2+function+and+inhibition&doi=10.1158%2F0008-5472.CAN-03-3298"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-03-3298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-03-3298%26sid%3Dliteratum%253Aachs%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DSteadman%26aufirst%3DK.%26aulast%3DPolgar%26aufirst%3DO.%26aulast%3DMorisaki%26aufirst%3DK.%26aulast%3DBlayney%26aufirst%3DM.%26aulast%3DMistry%26aufirst%3DP.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DPheophorbide-a%2520is%2520a%2520specific%2520probe%2520for%2520ABCG2%2520function%2520and%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D1242%26epage%3D1246%26doi%3D10.1158%2F0008-5472.CAN-03-3298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span> <span> </span><span class="NLM_article-title">The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy in inhibiting ABCG2</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2463</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-1599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1158%2F1078-0432.CCR-06-1599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=17438106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1enu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2463-2470&author=W.+Liuauthor=M.+R.+Baerauthor=M.+J.+Bowmanauthor=P.+Peraauthor=X.+Zhengauthor=J.+Morganauthor=R.+K.+Pandeyauthor=A.+R.+Oseroff&title=The+tyrosine+kinase+inhibitor+imatinib+mesylate+enhances+the+efficacy+of+photodynamic+therapy+in+inhibiting+ABCG2&doi=10.1158%2F1078-0432.CCR-06-1599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2</span></div><div class="casAuthors">Liu, Weiguo; Baer, Maria R.; Bowman, Mary Jo; Pera, Paula; Zheng, Xiang; Morgan, Janet; Pandey, Ravindra A.; Oseroff, Allan R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2463-2470</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The ATP-binding cassette protein ABCG2 (breast cancer resistance protein) effluxes some of the photosensitizers used in photodynamic therapy (PDT) and, thus, may confer resistance to this treatment modality.  Tyrosine kinase inhibitors (TKI) can block the function of ABCG2.  Therefore, we tested the effects of the TKI imatinib mesylate (Gleevec) on photosensitizer accumulation and in vitro and in vivo PDT efficacy.  Exptl. Design: Energy-dependent photosensitizer efflux and imatinib mesylate's effects on intracellular accumulation of clin. used second- and first-generation photosensitizers were studied by flow cytometry in murine and human cells with and without ABCG2 expression.  Effects of ABCG2 inhibition on PDT were examd. in vitro using cell viability assays and in vivo measuring photosensitizer accumulation and time to regrowth in a RIF-1 tumor model.  RESULTS: Energy-dependent efflux of 2-(1-hexyloxethyl)-2-devinyl pyropheophorbide-a (HPPH, Photochlor), endogenous protoporphyrin IX (PpIX) synthesized from 5-aminolevulenic acid, and the benzoporphyrin deriv. monoacid ring A (BPD-MA, Verteporfin) was shown in ABCG2+ cell lines, but the first-generation multimeric photosensitizer porfimer sodium (Photofrin) and a novel deriv. of HPPH conjugated to galactose were minimally transported.  Imatinib mesylate increased accumulation of HPPH, PpIX, and BPD-MA from 1.3- to 6-fold in ABCG2+ cells, but not in ABCG2- cells, and enhanced PDT efficacy both in vitro and in vivo.  CONCLUSIONS: Second-generation clin. photosensitizers are transported out of cells by ABCG2, and this effect can be abrogated by coadministration of imatinib mesylate.  By increasing intracellular photosensitizer levels in ABCG2+ tumors, imatinib mesylate or other ABCG2 transport inhibitors may enhance efficacy and selectivity of clin. PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFAA8XTpfO_bVg90H21EOLACvtfcHk0li8IcfY_cMzOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1enu7c%253D&md5=b9f644cc459248c414ba29aeb0b82ac8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1599%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBaer%26aufirst%3DM.%2BR.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26atitle%3DThe%2520tyrosine%2520kinase%2520inhibitor%2520imatinib%2520mesylate%2520enhances%2520the%2520efficacy%2520of%2520photodynamic%2520therapy%2520in%2520inhibiting%2520ABCG2%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D2463%26epage%3D2470%26doi%3D10.1158%2F1078-0432.CCR-06-1599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Substrate affinity of photosensitizers derived from chlorophyll-<i>a</i>: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/mp100154j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100154j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1789-1804&author=J.+Morganauthor=J.+D.+Jacksonauthor=X.+Zhengauthor=S.+K.+Pandeyauthor=R.+K.+Pandey&title=Substrate+affinity+of+photosensitizers+derived+from+chlorophyll-a%3A+The+ABCG2+transporter+affects+the+phototoxic+response+of+side+population+stem+cell-like+cancer+cells+to+photodynamic+therapy&doi=10.1021%2Fmp100154j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Affinity of Photosensitizers Derived from Chlorophyll-a: The ABCG2 Transporter Affects the Phototoxic Response of Side Population Stem Cell-like Cancer Cells to Photodynamic Therapy</span></div><div class="casAuthors">Morgan, Janet; Jackson, Jennifer D.; Zheng, Xiang; Pandey, Suresh K.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1804</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photosensitizers (PS) synthesized with the aim of optimizing photodynamic therapy (PDT) of tumors do not always fulfill their potential when tested in vitro and in vivo in different tumor models.  The ATP-dependent transporter ABCG2, a multidrug resistant pump expressed at variable levels in cancerous cells, can bind and efflux a wide range of structurally different classes of compds. including several PS used preclinically and clin. such as porphyrins and chlorins.  ABCG2 may lower intracellular levels of substrate PS below the threshold for cell death in tumors treated by PDT, leaving resistant cells to repopulate the tumor.  To det. some of the structural factors that affect substrate affinity of PS for ABCG2, we used an ABCG2-expressing cell line (HEK 293 482R) and its nonexpressing counterpart, and tyrosine kinase ABCG2 inhibitors in a simple flow cytometric assay to identify PS effluxed by the ABCG2 pump.  We tested a series of conjugates of substrate PS with different groups attached at different positions on the tetrapyrrole macrocycle to examine whether a change in affinity for the pump occurred and whether such changes depended on the position or the structure/type of the attached group.  PS without substitutions including pyropheophorbides and purpurinimides were generally substrates for ABCG2, but carbohydrate groups conjugated at positions 8, 12, 13, and 17 but not at position 3 abrogated ABCG2 affinity regardless of structure or linking moiety.  At position 3, affinity was retained with the addn. of iodobenzene, alkyl chains and monosaccharides, but not with disaccharides.  This suggests that structural characteristics at position 3 may offer important contributions to requirements for binding to ABCG2.  We examd. several tumor cell lines for ABCG2 activity, and found that although some cell lines had negligible ABCG2 activity in bulk, they contained a small ABCG2-expressing side population (SP) thought to contain cells which are responsible for initiating tumor regrowth.  We examd. the relevance of the SP to PDT resistance with ABCG2 substrates in vitro and in vivo in the murine mammary tumor 4T1.  We show for the first time in vivo that the substrate PS HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a) but not the nonsubstrate PS HPPH-Gal (a galactose conjugate of HPPH) selectively preserved the SP which was primarily responsible for regrowth in vitro.  The SP could be targeted by addn. of imatinib mesylate, a tyrosine kinase inhibitor which inhibits the ATPase activity of ABCG2, and prevents efflux of substrates.  A PDT resistant SP may be responsible for recurrences obsd. both preclinically and clin.  To prevent ABCG2 mediated resistance, choosing nonsubstrate PS or administering an ABCG2 inhibitor alongside a substrate PS might be advantageous when treating ABCG2-expressing tumors with PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSGTD8kwyhrVg90H21EOLACvtfcHk0lh0A6Aip28s-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM&md5=668a1009391c86ad4b55abd75c67e7ff</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fmp100154j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100154j%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DJ.%2BD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DSubstrate%2520affinity%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%253A%2520The%2520ABCG2%2520transporter%2520affects%2520the%2520phototoxic%2520response%2520of%2520side%2520population%2520stem%2520cell-like%2520cancer%2520cells%2520to%2520photodynamic%2520therapy%26jtitle%3DMol.%2520Pharm.%26date%3D2010%26volume%3D7%26spage%3D1789%26epage%3D1804%26doi%3D10.1021%2Fmp100154j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spring, B. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span> <span> </span><span class="NLM_article-title">The role of photodynamic therapy in overcoming cancer drug resistance</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1476</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1039/C4PP00495G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2FC4PP00495G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25856800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=1476-1491&author=B.+Q.+Springauthor=I.+Rizviauthor=N.+Xuauthor=T.+Hasan&title=The+role+of+photodynamic+therapy+in+overcoming+cancer+drug+resistance&doi=10.1039%2FC4PP00495G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The role of photodynamic therapy in overcoming cancer drug resistance</span></div><div class="casAuthors">Spring, Bryan Q.; Rizvi, Imran; Xu, Nan; Hasan, Tayyaba</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1476-1491</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Many modalities of cancer therapy induce mechanisms of treatment resistance and escape pathways during chronic treatments, including photodynamic therapy (PDT).  It is conceivable that resistance induced by one treatment might be overcome by another treatment.  Emerging evidence suggests that the unique mechanisms of tumor cell and microenvironment damage produced by PDT could be utilized to overcome cancer drug resistance, to mitigate the compensatory induction of survival pathways and even to re-sensitize resistant cells to std. therapies.  Approaches that capture the unique features of PDT, therefore, offer promising factors for increasing the efficacy of a broad range of therapeutic modalities.  Here, we highlight key preclin. findings utilizing PDT to overcome classical drug resistance or escape pathways and thus enhance the efficacy of many pharmaceuticals, possibly explaining the clin. observations of the PDT response to otherwise treatment-resistant diseases.  With the development of nanotechnol., it is possible that light activation may be used not only to damage and sensitize tumors but also to enable controlled drug release to inhibit escape pathways that may lead to resistance or cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqaooNTs325bVg90H21EOLACvtfcHk0lh0A6Aip28s-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCqsrw%253D&md5=ead7f9e6cfccef2ea4705c668a59e081</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC4PP00495G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4PP00495G%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DB.%2BQ.%26aulast%3DRizvi%26aufirst%3DI.%26aulast%3DXu%26aufirst%3DN.%26aulast%3DHasan%26aufirst%3DT.%26atitle%3DThe%2520role%2520of%2520photodynamic%2520therapy%2520in%2520overcoming%2520cancer%2520drug%2520resistance%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2015%26volume%3D14%26spage%3D1476%26epage%3D1491%26doi%3D10.1039%2FC4PP00495G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagiya, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurabayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furihata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, S.</span></span> <span> </span><span class="NLM_article-title">Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulenic acid (ALA)-induced tumor-specific protoporphyrin IX accumulation in bladder cancer</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">288</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1016/j.pdpdt.2013.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.pdpdt.2013.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23993855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlGltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=288-295&author=Y.+Hagiyaauthor=H.+Fukuharaauthor=K.+Matsumotoauthor=Y.+Endoauthor=M.+Nakajimaauthor=T.+Tanakaauthor=I.+Okuraauthor=A.+Kurabayashiauthor=M.+Furihataauthor=K.+Inoueauthor=T.+Shuinauthor=S.+Ogura&title=Expression+levels+of+PEPT1+and+ABCG2+play+key+roles+in+5-aminolevulenic+acid+%28ALA%29-induced+tumor-specific+protoporphyrin+IX+accumulation+in+bladder+cancer&doi=10.1016%2Fj.pdpdt.2013.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer</span></div><div class="casAuthors">Hagiya, Yuichiro; Fukuhara, Hideo; Matsumoto, Kentaro; Endo, Yoshio; Nakajima, Motowo; Tanaka, Tohru; Okura, Ichiro; Kurabayashi, Atsushi; Furihata, Mutsuo; Inoue, Keiji; Shuin, Taro; Ogura, Shun-ichiro</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">288-295</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A detection method widely used of late in cancer surgery is 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD), which relies on the tumor-specific accumulation of photosensitizing protoporphyrin IX (PpIX) after the administration of ALA.  In this regard, we recently reported that peptide transporter PEPT1 and human ATP-binding cassette transporter ABCG2 are key players in regulating intracellular PpIX levels.  In the present study, we re-evaluated in vivo the expression of genes involved in the porphyrin biosynthesis pathway.  Using quant. real-time (qRT)-PCR, we measured the mRNA levels in a clin. specimen of bladder cancer from a patient who had been subjected to ALA-PDD.We confirmed that PEPT1 and ABCG2 are major contributors to the regulation of.  We confirmed that PEPT1 and ABCG2 are major contributors to the regulation of tumor-specific PpIX accumulation.  QRT-PCR anal. revealed a predominantly high level of PEPT1 mRNA and a very low level of ABCG2 mRNA in the bladder cancer, corresponding to the roles of these genes in vitro.  These findings were further confirmed by immunohistochem. studies with PEPT1- and ABCG2-specific antibodies.  The induction of PEPT1 gene and the suppression of ABCG2 gene expression are among the key mol. mechanisms underlying tumor-specific PpIX accumulation after the administration of ALA in bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhcBz8tBp6H7Vg90H21EOLACvtfcHk0lh0A6Aip28s-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlGltr4%253D&md5=7f46eb5ae350654f805595a31d78c195</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2013.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2013.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DHagiya%26aufirst%3DY.%26aulast%3DFukuhara%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DOkura%26aufirst%3DI.%26aulast%3DKurabayashi%26aufirst%3DA.%26aulast%3DFurihata%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DShuin%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DS.%26atitle%3DExpression%2520levels%2520of%2520PEPT1%2520and%2520ABCG2%2520play%2520key%2520roles%2520in%25205-aminolevulenic%2520acid%2520%2528ALA%2529-induced%2520tumor-specific%2520protoporphyrin%2520IX%2520accumulation%2520in%2520bladder%2520cancer%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2013%26volume%3D10%26spage%3D288%26epage%3D295%26doi%3D10.1016%2Fj.pdpdt.2013.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hepburn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeratterapillay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Sherif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, H. D.</span></span> <span> </span><span class="NLM_article-title">Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e50690</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0050690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1371%2Fjournal.pone.0050690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23226356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=A.+C.+Hepburnauthor=R.+Veeratterapillayauthor=S.+C.+Williamsonauthor=A.+El-Sherifauthor=N.+Sahayauthor=H.+D.+Thomas&title=Side+population+in+human+non-muscle+invasive+bladder+cancer+enriches+for+cancer+stem+cells+that+are+maintained+by+MAPK+signaling&doi=10.1371%2Fjournal.pone.0050690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling</span></div><div class="casAuthors">Hepburn, Anastasia C.; Veeratterapillay, Rajan; Williamson, Stuart C.; El-Sherif, Amira; Sahay, Neha; Thomas, Huw D.; Mantilla, Alejandra; Pickard, Robert S.; Robson, Craig N.; Heer, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e50690</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Side population (SP) and ABC transporter expression enrich for stem cells in numerous tissues.  We explored if this phenotype characterised human bladder cancer stem cells (CSCs) and attempted to identify regulatory mechanisms.  Focusing on non-muscle invasive bladder cancer (NMIBC), multiple human cell lines were used to characterize SP and ABC transporter expression.  In vitro and in vivo phenotypic and functional assessments of CSC behavior were undertaken.  Expression of putative CSC marker ABCG2 was assessed in clin. NMIBC samples (n = 148), and a role for MAPK signalling, a central mechanism of bladder tumorigenesis, was investigated.  Results showed that the ABCG2 transporter was predominantly expressed and was up-regulated in the SP fraction by 3-fold (ABCG2hi) relative to the non-SP (NSP) fraction (ABCG2low).  ABCG2hi SP cells displayed enrichment of stem cell markers (Nanog, Notch1 and SOX2) and a three-fold increase in colony forming efficiency (CFE) in comparison to ABCG2low NSP cells.  In vivo, ABCG2hi SP cells enriched for tumor growth compared with ABCG2low NSP cells, consistent with CSCs.  PERK was constitutively active in ABCG2hi SP cells and MEK inhibition also inhibited the ABCG2hi SP phenotype and significantly suppressed CFE.  Furthermore, on examg. clin. NMIBC samples, ABCG2 expression correlated with increased recurrence and decreased progression free survival.  Addnl., pERK expression also correlated with decreased progression free survival, while a pos. correlation was further demonstrated between ABCG2 and pERK expression.  In conclusion, we confirm ABCG2hi SP enriches for CSCs in human NMIBC and MAPK/ERK pathway is a suitable therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhXFmNaVX6e7Vg90H21EOLACvtfcHk0lj0tpwwGIZCLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqtrfN&md5=c93d2c038599d5a44c857ac2ce55d901</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0050690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0050690%26sid%3Dliteratum%253Aachs%26aulast%3DHepburn%26aufirst%3DA.%2BC.%26aulast%3DVeeratterapillay%26aufirst%3DR.%26aulast%3DWilliamson%26aufirst%3DS.%2BC.%26aulast%3DEl-Sherif%26aufirst%3DA.%26aulast%3DSahay%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DH.%2BD.%26atitle%3DSide%2520population%2520in%2520human%2520non-muscle%2520invasive%2520bladder%2520cancer%2520enriches%2520for%2520cancer%2520stem%2520cells%2520that%2520are%2520maintained%2520by%2520MAPK%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0050690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, M. A.</span></span> <span> </span><span class="NLM_article-title">Treatment options in non-muscle invasive bladder cancer after BCG failure</span>. <i>Indian J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.4103/0970-1591.166475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.4103%2F0970-1591.166475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=26604442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BC28rgsFOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=312-319&author=N.+A.+Brooksauthor=M.+A.+O%E2%80%99Donnell&title=Treatment+options+in+non-muscle+invasive+bladder+cancer+after+BCG+failure&doi=10.4103%2F0970-1591.166475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options in non-muscle-invasive bladder cancer after BCG failure</span></div><div class="casAuthors">Brooks Nathan A; O'Donnell Michael A</div><div class="citationInfo"><span class="NLM_cas:title">Indian journal of urology : IJU : journal of the Urological Society of India</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-9</span>
        ISSN:<span class="NLM_cas:issn">0970-1591</span>.
    </div><div class="casAbstract">Bladder cancer is the ninth-most prevalent cancer worldwide.  Most patients with urothelial cell carcinoma of the bladder present with non-muscle-invasive disease and are treated with bacillus Calmette-Guerin (BCG) intravesical therapy.  Many of these patients experience disease recurrence after BCG failure.  Radical cystectomy is the recommended treatment for high-risk patients failing BCG.  However, many patients are unfit for or unwilling to undergo this procedure.  We searched the published literature on the treatment of non-muscle-invasive bladder cancer (NMIBC) after BCG failure.  We review current evidence regarding intravesical therapy with gemcitabine, mitomycin combined with thermo-chemotherapy, docetaxel, nab-paclitaxel, photodynamic therapy (PDT), BCG with interferon (IFN), and combination sequentially administered chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSRoa-Gbph8Lhcr74wzj5o5fW6udTcc2ebBGu3vEWm0rrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgsFOksg%253D%253D&md5=92b81293c28623f01e835a27cfc4bc69</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4103%2F0970-1591.166475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0970-1591.166475%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DN.%2BA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%2BA.%26atitle%3DTreatment%2520options%2520in%2520non-muscle%2520invasive%2520bladder%2520cancer%2520after%2520BCG%2520failure%26jtitle%3DIndian%2520J.%2520Urol.%26date%3D2015%26volume%3D31%26spage%3D312%26epage%3D319%26doi%3D10.4103%2F0970-1591.166475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azar, F. S.</span>, <span class="NLM_string-name">Intes, X.</span></span>, Eds.;  <i>Translational Multimodality Optical Imaging</i>; <span class="NLM_publisher-name">Artech House</span>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=F.+S.+Azar&author=X.+Intes&title=Translational+Multimodality+Optical+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAzar%26aufirst%3DF.%2BS.%26btitle%3DTranslational%2520Multimodality%2520Optical%2520Imaging%26pub%3DArtech%2520House%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1039/B915149B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2FB915149B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=20694259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=340-362&author=M.+Ethirajanauthor=Y.+Chenauthor=P.+Joshiauthor=R.+K.+Pandey&title=The+role+of+porphyrin+chemistry+in+tumor+imaging+and+photodynamic+therapy&doi=10.1039%2FB915149B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span></div><div class="casAuthors">Ethirajan, Manivannan; Chen, Yihui; Joshi, Penny; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">340-362</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In recent years several review articles and books have been published on the use of porphyrin-based compds. in photodynamic therapy (PDT).  This crit. review is focused on (i) the basic concept of PDT, (ii) advantages of long-wavelength absorbing photosensitizers (PS), (iii) a brief discussion on recent advances in developing PDT agents, and (iv) the various synthetic strategies designed at the Roswell Park Cancer Institute, Buffalo, for developing highly effective long-wavelength PDT agents and their utility in constructing the conjugates with tumor-imaging and therapeutic potential (Theranostics).  The clin. status of certain selected PDT agents is also summarized (205 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaO6TvgtDibVg90H21EOLACvtfcHk0lj0tpwwGIZCLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF&md5=b462478255e32db5d073a892c64e2d52</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FB915149B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB915149B%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520porphyrin%2520chemistry%2520in%2520tumor%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D340%26epage%3D362%26doi%3D10.1039%2FB915149B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumlin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoudia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic therapy</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1996.tb02442.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.1996.tb02442.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=194-204&author=R.+K.+Pandeyauthor=A.+B.+Sumlinauthor=S.+Constantineauthor=M.+Aoudiaauthor=W.+R.+Potterauthor=D.+A.+Bellnierauthor=B.+W.+Hendersonauthor=M.+A.+Rodgersauthor=K.+M.+Smithauthor=T.+J.+Dougherty&title=Alkyl+ether+analogs+of+chlorophyll-a+derivatives%3A+Part+1.+Synthesis%2C+photophysical+properties+and+photodynamic+therapy&doi=10.1111%2Fj.1751-1097.1996.tb02442.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1996.tb02442.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1996.tb02442.x%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DSumlin%26aufirst%3DA.%2BB.%26aulast%3DConstantine%26aufirst%3DS.%26aulast%3DAoudia%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DW.%2BR.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DRodgers%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAlkyl%2520ether%2520analogs%2520of%2520chlorophyll-a%2520derivatives%253A%2520Part%25201.%2520Synthesis%252C%2520photophysical%2520properties%2520and%2520photodynamic%2520therapy%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1996%26volume%3D64%26spage%3D194%26epage%3D204%26doi%3D10.1111%2Fj.1751-1097.1996.tb02442.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weishaupt, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">An <i>in vivo</i> quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4000</span>– <span class="NLM_lpage">4007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=9307285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4000-4007&author=B.+W.+Hendersonauthor=D.+A.+Bellnierauthor=W.+R.+Grecoauthor=A.+Sharmaauthor=R.+K.+Pandeyauthor=L.+A.+Vaughanauthor=K.+R.+Weishauptauthor=T.+J.+Dougherty&title=An+in+vivo+quantitative+structure-activity+relationship+for+a+congeneric+series+of+pyropheophorbide+derivatives+as+photosensitizers+for+photodynamic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Henderson, Barbara W.; Bellnier, David A.; Greco, William R.; Sharma, Amarnath; Pandey, Ravindra K.; Vaughan, Lurine A.; Weishaupt, Kenneth R.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4000-4007</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An in vivo quant. structure-activity relationship (QSAR) study was carried out on a congeneric series of pyropheophorbide photosensitizers to identify structural features crit. for their antitumor activity in photodynamic therapy (PDT).  The structural elements evaluated in this study include the length and shape (alkyl, alkenyl, cyclic, and secondary analogs) of the ether side chain.  C3H mice, harboring the radiation-induced fibrosarcoma tumor model, were used to study three biol. response endpoints: tumor growth delay, tumor cell lethality, and vascular perfusion.  All three endpoints revealed highly similar QSAR patterns that constituted a function of the alkyl ether chain length and drug lipophilicity, which is defined as the log of the octanol:water partition coeff. (log P).  When the illumination of tumor, tumor cells, or cutaneous vasculature occurred 24 h after sensitizer administration, activities were minimal with analogs of log P ≤ 5, increased dramatically between log P of 5-6, and peaked between log P of 5.6-6.6.  Activities declined gradually with higher log P.  The lack of activity of the least-lipophilic analogs was explained in large part by their poor biodistribution characteristics, which yielded negligible tumor and plasma drug levels at the time of treatment with light.  The progressively lower potencies of the most lipophilic analogs cannot be explained through the overall tumor and plasma pharmacokinetics of photosensitizer because tumor and plasma concns. progressively increased with lipophilicity.  When compensated for differences in tumor photosensitizer concn., the 1-hexyl deriv. (optimal lipophilicity) was 5-fold more potent than the 1-dodecyl deriv. (more lipophilic) and 3-fold more potent than the 1-pentyl analog (less lipophilic), indicating that, in addn. to the overall tumor pharmacokinetics, pharmacodynamic factors may influence PDT activity.  Drug lipophilicity was highly predictive for photodynamic activity.  QSAR modeling revealed that direct antitumor effects and vascular PDT effects may be governed by common mechanisms, and that the mere assocn. of high levels of photosensitizer in the tumor tissue is not sufficient for optimal PDT efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8jr9wz9QNVbVg90H21EOLACvtfcHk0ljIn-ZgYoRvZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D&md5=a1b891da5bee6c012242bc129ea28636</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DVaughan%26aufirst%3DL.%2BA.%26aulast%3DWeishaupt%26aufirst%3DK.%2BR.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAn%2520in%2520vivo%2520quantitative%2520structure-activity%2520relationship%2520for%2520a%2520congeneric%2520series%2520of%2520pyropheophorbide%2520derivatives%2520as%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4000%26epage%3D4007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation of cRGD peptide to chlorophyll-a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.1021/mp200018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1186-1197&author=A.+Srivatsanauthor=E.+Ethirajanauthor=S.+K.+Pandeyauthor=S.+Dubeyauthor=X.+Zhengauthor=T.-H.+Liuauthor=M.+Shibataauthor=J.+Missertauthor=J.+Morganauthor=R.+K.+Pandey&title=Conjugation+of+cRGD+peptide+to+chlorophyll-a+based+photosensitizer+%28HPPH%29+alters+its+pharmacokinetics+with+enhanced+tumor-imaging+and+photosensitizing+%28PDT%29+efficacy&doi=10.1021%2Fmp200018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of cRGD Peptide to Chlorophyll a Based Photosensitizer (HPPH) Alters Its Pharmacokinetics with Enhanced Tumor-Imaging and Photosensitizing (PDT) Efficacy</span></div><div class="casAuthors">Srivatsan, Avinash; Ethirajan, Manivannan; Pandey, Suresh K.; Dubey, Shipra; Zheng, Xiang; Liu, Ting-Hsiu; Shibata, Masayuki; Missert, Joseph; Morgan, Janet; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1186-1197</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The αvβ3 integrin receptor plays an important role in human metastasis and tumor-induced angiogenesis.  Cyclic Arg-Gly-Asp (cRGD) peptide represents a selective αvβ3 integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.  For developing photosensitizers with enhanced PDT efficacy, we here report the synthesis of a series of bifunctional agents in which the 3-(1'-hexyloxyethyl)-3-devinylpyropheophorbide a (HPPH), a chlorophyll-based photosensitizer, was conjugated to cRGD and the related analogs.  The cell uptake and in vitro PDT efficacy of the conjugates were studied in αvβ3 integrin overexpressing U87 and 4T1 cell lines whereas the in vivo PDT efficacy and fluorescence-imaging potential of the conjugates were compared with the corresponding nonconjugated photosensitizer HPPH in 4T1 tumors.  Compared to HPPH, the HPPH-cRGD conjugate in which the arginine and aspartic acid moieties were available for binding to two subunits of αvβ3 integrin showed faster clearance, enhanced tumor imaging and enhanced PDT efficacy at 2-4 h postinjection.  Mol. modeling studies also confirmed that the presence of the HPPH moiety in HPPH-cRGD conjugate does not interfere with specific recognition of cRGD by αvβ3 integrin.  Compared to U87 and 4T1 cells the HPPH-cRGD showed significantly low photosensitizing efficacy in A431 (αvβ3 neg.) tumor cells, suggesting possible target specificity of the conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnvNJrWfkErVg90H21EOLACvtfcHk0ljIn-ZgYoRvZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D&md5=19b20682aed1fe3f7acef8a4b7348f11</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fmp200018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200018y%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DEthirajan%26aufirst%3DE.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DDubey%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DT.-H.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMissert%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DConjugation%2520of%2520cRGD%2520peptide%2520to%2520chlorophyll-a%2520based%2520photosensitizer%2520%2528HPPH%2529%2520alters%2520its%2520pharmacokinetics%2520with%2520enhanced%2520tumor-imaging%2520and%2520photosensitizing%2520%2528PDT%2529%2520efficacy%26jtitle%3DMol.%2520Pharm.%26date%3D2011%26volume%3D8%26spage%3D1186%26epage%3D1197%26doi%3D10.1021%2Fmp200018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Conjugation of HPPH to carbohydrates changes its subcellular biodistribution and enhances photodynamic activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4306</span>– <span class="NLM_lpage">4318</span>, <span class="refDoi"> DOI: 10.1021/jm9001617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9001617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4306-4318&author=X.+Zhengauthor=J.+Morganauthor=S.+K.+Pandeyauthor=Y.+Chenauthor=E.+Tracyauthor=H.+Baumannauthor=J.+R.+Missertauthor=C.+Batt&title=Conjugation+of+HPPH+to+carbohydrates+changes+its+subcellular+biodistribution+and+enhances+photodynamic+activity+in+vivo&doi=10.1021%2Fjm9001617"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Fjm9001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9001617%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTracy%26aufirst%3DE.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DBatt%26aufirst%3DC.%26atitle%3DConjugation%2520of%2520HPPH%2520to%2520carbohydrates%2520changes%2520its%2520subcellular%2520biodistribution%2520and%2520enhances%2520photodynamic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4306%26epage%3D4318%26doi%3D10.1021%2Fjm9001617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.2011.00992.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.2011.00992.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1405-1418&author=E.+C.+Tracyauthor=M.+J.+Bowmanauthor=R.+K.+Pandeyauthor=B.+W.+Hendersonauthor=H.+Baumann&title=Cell-type+selective+phototoxicity+achieved+with+chlorophyll-a+derived+photosensitizers+in+a+co-culture+system+of+primary+human+tumor+and+normal+lung+cells&doi=10.1111%2Fj.1751-1097.2011.00992.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2011.00992.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2011.00992.x%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DCell-type%2520selective%2520phototoxicity%2520achieved%2520with%2520chlorophyll-a%2520derived%2520photosensitizers%2520in%2520a%2520co-culture%2520system%2520of%2520primary%2520human%2520tumor%2520and%2520normal%2520lung%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2011%26spage%3D1405%26epage%3D1418%26doi%3D10.1111%2Fj.1751-1097.2011.00992.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Purpurinide carbohydrate conjugates: effect of the position of the carbohydrate moiety in photosensitizing efficacy</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1021/mp060135x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp060135x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Witbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=448-464&author=S.+K.+Pandeyauthor=X.+Zhengauthor=J.+Morganauthor=J.+R.+Missertauthor=T.+H.+Liuauthor=M.+Shibataauthor=D.+A.+Bellnierauthor=A.+R.+Oseroffauthor=B.+W.+Hendersonauthor=T.+J.+Doughertyauthor=R.+K.+Pandey&title=Purpurinide+carbohydrate+conjugates%3A+effect+of+the+position+of+the+carbohydrate+moiety+in+photosensitizing+efficacy&doi=10.1021%2Fmp060135x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Purpurinimide Carbohydrate Conjugates: Effect of the Position of the Carbohydrate Moiety in Photosensitizing Efficacy</span></div><div class="casAuthors">Pandey, Suresh K.; Zheng, Xiang; Morgan, Janet; Missert, Joseph R.; Liu, Ting-Hsiu; Shibata, Masayuki; Bellnier, David A.; Oseroff, Allan R.; Henderson, Barbara W.; Dougherty, Thomas J.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">448-464</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A lactose moiety was regioselectively introduced at various positions of N-hexyl-mesopurpurinimide (a class of chlorin contg. a fused six-membered imide ring system, λmax: 700 nm) to investigate the effect of its presence and position on photosensitizing efficacy.  The resulting novel structures produced a significant difference in in vitro and in vivo efficacy.  Among the positional isomers in which the lactose moiety was introduced at positions 3, 8, and 12, the 3-lactose purpurin-18-N-hexylimide produced the best efficacy.  Compared to these analogs, the lactose moiety joined with an amide bond at position 172, and with an N-benzyl group bearing a -C≡C- linkage at position 132 showed reduced in vitro/in vivo photosensitivity.  A noticeable difference between lactose conjugates in cell uptake (RIF tumor cells) was obsd. at 3 and 24 h postincubation.  Replacing the lactose (Galβ1 → 4Glc) with β-galactose and glucose moieties at position 3 of purpurinimide produced an increase in both cell uptake and in in vitro efficacy, but with reduced in vivo efficacy.  Sites of intracellular localization differed among photosensitizers with and without carbohydrate moieties.  Mol. modeling shows favorable interactions of 3- and 12-lactose-purpurinimide analogs with both galectin-1 and galectin-3, but clear contributions were not found for the conjugate contg. lactose moiety at position 8.  In a comparative ELISA study of the lactose conjugates with free lactose, all carbohydrate-purpurinimides showed binding to both galectins with a significant variation between the batches of galectins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou-ZX2fTBfe7Vg90H21EOLACvtfcHk0liEXlyo7Se_aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Witbw%253D&md5=df0dfb54a62c282b3f726d92e37ed822</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fmp060135x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060135x%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DT.%2BH.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DPurpurinide%2520carbohydrate%2520conjugates%253A%2520effect%2520of%2520the%2520position%2520of%2520the%2520carbohydrate%2520moiety%2520in%2520photosensitizing%2520efficacy%26jtitle%3DMol.%2520Pharm.%26date%3D2007%26volume%3D4%26spage%3D448%26epage%3D464%26doi%3D10.1021%2Fmp060135x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryshuk, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouzeid, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charamisinau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabi, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Multimodality agents for tumor imaging (PET, Fluorescence) and photodynamic therapy, A possible “See and Treat” approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6286</span>– <span class="NLM_lpage">6295</span>, <span class="refDoi"> DOI: 10.1021/jm050427m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050427m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6286-6295&author=S.+K.+Pandeyauthor=A.+L.+Gryshukauthor=M.+Sajjadauthor=X.+Zhengauthor=Y.+Chenauthor=M.+M.+Abouzeidauthor=J.+Morganauthor=I.+Charamisinauauthor=H.+A.+Nabiauthor=A.+Oseroffauthor=R.+K.+Pandey&title=Multimodality+agents+for+tumor+imaging+%28PET%2C+Fluorescence%29+and+photodynamic+therapy%2C+A+possible+%E2%80%9CSee+and+Treat%E2%80%9D+approach&doi=10.1021%2Fjm050427m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm050427m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050427m%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DGryshuk%26aufirst%3DA.%2BL.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAbouzeid%26aufirst%3DM.%2BM.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DCharamisinau%26aufirst%3DI.%26aulast%3DNabi%26aufirst%3DH.%2BA.%26aulast%3DOseroff%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DMultimodality%2520agents%2520for%2520tumor%2520imaging%2520%2528PET%252C%2520Fluorescence%2529%2520and%2520photodynamic%2520therapy%252C%2520A%2520possible%2520%25E2%2580%259CSee%2520and%2520Treat%25E2%2580%259D%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6286%26epage%3D6295%26doi%3D10.1021%2Fjm050427m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3603</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.bmc.2015.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25936263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3603-3617&author=A.+Srivatsanauthor=P.+Peraauthor=P.+Joshiauthor=Y.+Wangauthor=J.+R.+Missertauthor=E.+C.+Tracyauthor=W.+A.+Tabaczynskiauthor=R.+Yaoauthor=M.+Sajjadauthor=H.+Baumannauthor=R.+K.+Pandey&title=Effect+of+chirality+on+cellular+uptake%2C+imaging+and+photodynamic+therapy+of+photosensitizers+derived+from+chlorophyll-a&doi=10.1016%2Fj.bmc.2015.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span></div><div class="casAuthors">Srivatsan, Avinash; Pera, Paula; Joshi, Penny; Wang, Yanfang; Missert, Joseph R.; Tracy, Erin C.; Tabaczynski, Walter A.; Yao, Rutao; Sajjad, Munawwar; Baumann, Heinz; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3603-3617</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously shown that the 124I-analog of Me 3-(1'-m-iodobenzyloxy) ethyl-3-devinyl-pyropheophorbide-a derived as racemic mixt. from chlorophyll-a can be used for PET (positron emission tomog.)-imaging in animal tumor models.  On the other hand, as a non-radioactive analog, it showed excellent fluorescence and photodynamic therapy (PDT) efficacy.  Thus, a single agent in a mixt. of radioactive (124I-) and non-radioactive (127I) material can be used for both dual-imaging and PDT of cancer.  Before advancing to Phase I human clin. trials, we evaluated the activity of the individual isomers as well as the impact of a chiral center at position-31 in directing in vitro/in vivo cellular uptake, intracellular localization, epithelial tumor cell-specific retention, fluorescence/PET imaging, and photosensitizing ability.  The results indicate that both isomers (racemates), either as Me ester or carboxylic acid, were equally effective.  However, the Me ester analogs, due to subcellular deposition into vesicular structures, were preferentially retained.  All derivs. contg. carboxylic acid at the position-172 were noted to be substrate for the ABCG2 (a member of the ATP binding cassette transporters) protein explaining their low retention in lung tumor cells expressing this transporter.  The compds. in which the chirality at position-3 has been substituted by a non-chiral functionality showed reduced cellular uptake, retention and lower PDT efficacy in mice bearing murine Colon26 tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc4VikWQsT3LVg90H21EOLACvtfcHk0liEXlyo7Se_aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D&md5=ce58e5a8ae06afe14296a0de6b87d24f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DEffect%2520of%2520chirality%2520on%2520cellular%2520uptake%252C%2520imaging%2520and%2520photodynamic%2520therapy%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3603%26epage%3D3617%26doi%3D10.1016%2Fj.bmc.2015.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chinchilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najera, C.</span></span> <span> </span><span class="NLM_article-title">The Sonogashira reaction: A booming methodology in synthetic organic chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1021/cr050992x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr050992x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2007&pages=874-922&author=R.+Chinchillaauthor=C.+Najera&title=The+Sonogashira+reaction%3A+A+booming+methodology+in+synthetic+organic+chemistry&doi=10.1021%2Fcr050992x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Sonogashira reaction: a booming methodology in synthetic organic chemistry</span></div><div class="casAuthors">Chinchilla, Rafael; Najera, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-922</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The palladium-catalyzed sp2-sp coupling reaction between aryl or alkenyl halides or triflates and terminal alkynes, with or without the presence of copper(I) cocatalyst, was reviewed.  The mechanism of Sonogashira reaction was discussed, and the catalysts and reaction conditions were explored as well.  In addn., the application of Sonogashira cross-coupling reaction was also introduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ8ePd8RdbSrVg90H21EOLACvtfcHk0lhkc1vMNKDw6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbc%253D&md5=91f627efbf940c60809c2acfe597d3b7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr050992x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr050992x%26sid%3Dliteratum%253Aachs%26aulast%3DChinchilla%26aufirst%3DR.%26aulast%3DNajera%26aufirst%3DC.%26atitle%3DThe%2520Sonogashira%2520reaction%253A%2520A%2520booming%2520methodology%2520in%2520synthetic%2520organic%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2007%26volume%3D107%26spage%3D874%26epage%3D922%26doi%3D10.1021%2Fcr050992x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canteenwala, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khouly, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritzker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, L. Y.</span></span> <span> </span><span class="NLM_article-title">Efficiency of singlet oxygen production from self-assembled nanospheres of molecular micelle-like photosensitizers FC<sub>4</sub>S</span>. <i>J. Mater. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1857</span>– <span class="NLM_lpage">1864</span>, <span class="refDoi"> DOI: 10.1039/b500369e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2Fb500369e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsl2ntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1857-1864&author=C.+Yuauthor=T.+Canteenwalaauthor=M.+E.+El-Khoulyauthor=Y.+Arakiauthor=K.+Pritzkerauthor=O.+Itoauthor=B.+C.+Wilsonauthor=L.+Y.+Chiang&title=Efficiency+of+singlet+oxygen+production+from+self-assembled+nanospheres+of+molecular+micelle-like+photosensitizers+FC4S&doi=10.1039%2Fb500369e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Efficiency of singlet oxygen production from self-assembled nanospheres of molecular micelle-like photosensitizers FC4S</span></div><div class="casAuthors">Yu, Chi; Canteenwala, Taizoon; El-Khouly, Mohamed E.; Araki, Yasuyuki; Pritzker, Kenneth; Ito, Osamu; Wilson, Brian C.; Chiang, Long Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1857-1864</span>CODEN:
                <span class="NLM_cas:coden">JMACEP</span>;
        ISSN:<span class="NLM_cas:issn">0959-9428</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Direct detection of singlet oxygen (1O2) prodn. under irradn. of mol. micelle-like hexa(sulfo-n-butyl)[60]fullerene (FC4S) self-assembled nanospheres at 500-600 nm was obtained by the measurement of its near-IR luminescence at 1270 nm.  This photocatalytic effect makes FC4S a potential alternative sensitizer to TiO2 and feasible for use in the visible region in addn. to its intrinsic high UV efficiency.  Despite having a relatively low optical absorption of FC4S at 600 nm, appreciable 1O2 signal was detected comparable to that of hematoporphyrin derivs. Photofrin at the same molar concn., but less than sulfonated aluminum phthalocyanine, AlS4Pc.  The quantum yield of FC4S for the generation of 1O2 in H2O was roughly estd. to be 0.36 using the relative correlation to that of C60/γ-CD.  The abs. value is not available.  These results demonstrated efficient triplet energy transfer from 3FC4S* to mol. oxygen in the nanosphere structure.  The authors also confirmed certain retention between photocatalytic characteristics of underivatized C60 with that of FC4S, a C60 hexaadduct contg. a single covalent bond between each addend and the fullerene cage, in contrast to other Bingel-type hexamalonate adducts of C60 in the literature with a low 1O2 yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdGy-c_VE357Vg90H21EOLACvtfcHk0lhkc1vMNKDw6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsl2ntbs%253D&md5=1139a88463d2e6d499bb4451bcbdfb9b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fb500369e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb500369e%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%26aulast%3DCanteenwala%26aufirst%3DT.%26aulast%3DEl-Khouly%26aufirst%3DM.%2BE.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DPritzker%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DO.%26aulast%3DWilson%26aufirst%3DB.%2BC.%26aulast%3DChiang%26aufirst%3DL.%2BY.%26atitle%3DEfficiency%2520of%2520singlet%2520oxygen%2520production%2520from%2520self-assembled%2520nanospheres%2520of%2520molecular%2520micelle-like%2520photosensitizers%2520FC4S%26jtitle%3DJ.%2520Mater.%2520Chem.%26date%3D2005%26volume%3D15%26spage%3D1857%26epage%3D1864%26doi%3D10.1039%2Fb500369e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Khouly, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmawar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, O.</span></span> <span> </span><span class="NLM_article-title">Photoinduced processes in a tricomponent molecule consisting of diphenylaminofluorene-dicyanoethylene-methano[60]fullerene</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">884</span>– <span class="NLM_lpage">891</span>, <span class="refDoi"> DOI: 10.1021/jp055324u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp055324u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2006&pages=884-891&author=M.+E.+El-Khoulyauthor=P.+Padmawarauthor=Y.+Arakiauthor=S.+Vermaauthor=L.+Y.+Chiangauthor=O.+Ito&title=Photoinduced+processes+in+a+tricomponent+molecule+consisting+of+diphenylaminofluorene-dicyanoethylene-methano%5B60%5Dfullerene&doi=10.1021%2Fjp055324u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjp055324u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp055324u%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Khouly%26aufirst%3DM.%2BE.%26aulast%3DPadmawar%26aufirst%3DP.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DChiang%26aufirst%3DL.%2BY.%26aulast%3DIto%26aufirst%3DO.%26atitle%3DPhotoinduced%2520processes%2520in%2520a%2520tricomponent%2520molecule%2520consisting%2520of%2520diphenylaminofluorene-dicyanoethylene-methano%255B60%255Dfullerene%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2006%26volume%3D110%26spage%3D884%26epage%3D891%26doi%3D10.1021%2Fjp055324u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redmond, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamlin, J. N.</span></span> <span> </span><span class="NLM_article-title">Comparison of singlet oxygen yields from relevant biological molecules</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1999.tb08240.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.1999.tb08240.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1999&pages=391-475&author=R.+W.+Redmondauthor=J.+N.+Gamlin&title=Comparison+of+singlet+oxygen+yields+from+relevant+biological+molecules&doi=10.1111%2Fj.1751-1097.1999.tb08240.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1999.tb08240.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1999.tb08240.x%26sid%3Dliteratum%253Aachs%26aulast%3DRedmond%26aufirst%3DR.%2BW.%26aulast%3DGamlin%26aufirst%3DJ.%2BN.%26atitle%3DComparison%2520of%2520singlet%2520oxygen%2520yields%2520from%2520relevant%2520biological%2520molecules%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1999%26volume%3D70%26spage%3D391%26epage%3D475%26doi%3D10.1111%2Fj.1751-1097.1999.tb08240.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiggino, K. P.</span></span> <span> </span><span class="NLM_article-title">Singlet oxygen quantum yields of potential porphyrin-based photosensitizers for photodynamic therapy</span>. <i>Photochem. Photobiol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1039/b705853e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2Fb705853e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=17721599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsV2ku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=995-1002&author=S.+Mathaiauthor=T.+A.+Smithauthor=K.+P.+Ghiggino&title=Singlet+oxygen+quantum+yields+of+potential+porphyrin-based+photosensitizers+for+photodynamic+therapy&doi=10.1039%2Fb705853e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Singlet oxygen quantum yields of potential porphyrin-based photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Mathai, Sean; Smith, Trevor A.; Ghiggino, Kenneth P.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemical & Photobiological Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">995-1002</span>CODEN:
                <span class="NLM_cas:coden">PPSHCB</span>;
        ISSN:<span class="NLM_cas:issn">1474-905X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The singlet oxygen formation quantum yield (ΦΔ) for solns. of the di-cation, free-base and metalated forms of hematoporphyrin deriv. (HpD), hematoporphyrin IX (Hp9) and a boronated protoporphyrin (BOPP) are reported using the method of direct detection of the characteristic phosphorescence following polychromatic excitation.  Values of ΦΔ for the free-base form of all the porphyrins and the di-cation forms of Hp9 and HpD are in the range of 0.44 to 0.85 in the solvents investigated.  Incorporation of zinc ions into the macrocycle reduces ΦΔ for all three porphyrins.  BOPP facilitates the coordination of certain transition metals (Mn, Co and Cu) compared to Hp9 and HpD and results in a dramatic decrease in ΦΔ.  The exptl. data suggest the introduction of low energy charge transfer states assocd. with the disruption of the planarity of the macrocyclic ring provides alternative non-radiative deactivation pathways.  In BOPP, this non-planarity is augmented by the large closo-carborane peripheral substituent groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-BcKi3TkwyrVg90H21EOLACvtfcHk0li_LRTKHnHXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsV2ku78%253D&md5=4b3b0187ddc05fc8439ca2cceaa57aac</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2Fb705853e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705853e%26sid%3Dliteratum%253Aachs%26aulast%3DMathai%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BA.%26aulast%3DGhiggino%26aufirst%3DK.%2BP.%26atitle%3DSinglet%2520oxygen%2520quantum%2520yields%2520of%2520potential%2520porphyrin-based%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DPhotochem.%2520Photobiol.%2520Sci.%26date%3D2007%26volume%3D6%26spage%3D995%26epage%3D1002%26doi%3D10.1039%2Fb705853e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pitto-Barry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, N. P. E.</span></span> <span> </span><span class="NLM_article-title">Pluronic block-copolymers in medicine: from chemical and biological versatility to rationalization and clinical advances</span>. <i>Polym. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3291</span>– <span class="NLM_lpage">3297</span>, <span class="refDoi"> DOI: 10.1039/c4py00039k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1039%2Fc4py00039k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlGhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=3291-3297&author=A.+Pitto-Barryauthor=N.+P.+E.+Barry&title=Pluronic+block-copolymers+in+medicine%3A+from+chemical+and+biological+versatility+to+rationalization+and+clinical+advances&doi=10.1039%2Fc4py00039k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pluronic block-copolymers in medicine: from chemical and biological versatility to rationalization and clinical advances</span></div><div class="casAuthors">Pitto-Barry, Anais; Barry, Nicolas P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Polymer Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3291-3297</span>CODEN:
                <span class="NLM_cas:coden">PCOHC2</span>;
        ISSN:<span class="NLM_cas:issn">1759-9962</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  This mini-review highlights the latest advances in the chem. and biol. of Pluronic triblock copolymers.  We focus on their applications in medicine, as drug delivery carriers, biol. response modifiers, and pharmaceutical ingredients.  Examples of drug delivery systems and formulations currently in clin. use, clin. trials or preclin. development are highlighted.  We also discuss the role that Pluronic copolymers may play in the innovative design of new nanomedicines in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTea63E_th9LVg90H21EOLACvtfcHk0li_LRTKHnHXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlGhu7s%253D&md5=aecdecc33b3222f426d22044fdf7b25f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2Fc4py00039k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4py00039k%26sid%3Dliteratum%253Aachs%26aulast%3DPitto-Barry%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DN.%2BP.%2BE.%26atitle%3DPluronic%2520block-copolymers%2520in%2520medicine%253A%2520from%2520chemical%2520and%2520biological%2520versatility%2520to%2520rationalization%2520and%2520clinical%2520advances%26jtitle%3DPolym.%2520Chem.%26date%3D2014%26volume%3D5%26spage%3D3291%26epage%3D3297%26doi%3D10.1039%2Fc4py00039k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riss, T. L.</span>; <span class="NLM_string-name">Moravec, R. A.</span>; <span class="NLM_string-name">Niles, A. L.</span>; <span class="NLM_string-name">Duellman, S.</span>; <span class="NLM_string-name">Benink, H. A.</span>; <span class="NLM_string-name">Worzella, T. J.</span>; <span class="NLM_string-name">Minor, L.</span></span> <span> </span><span class="NLM_article-title">Cell Viability Assay</span>. In  <i>Assay Guidance Manual</i> [Online]; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span>, <span class="NLM_string-name">Coussens, N. P.</span>, <span class="NLM_string-name">Brimacombe, K.</span>, <span class="NLM_string-name">Grossman, A.</span>, <span class="NLM_string-name">Arkin, M.</span>, <span class="NLM_string-name">Auld, D.</span>, <span class="NLM_string-name">Austin, C.</span>, <span class="NLM_string-name">Baell, J.</span>, <span class="NLM_string-name">Bejcek, B.</span>, <span class="NLM_string-name">Caaveiro, J. M. M.</span>, <span class="NLM_string-name">Chung, T. D. Y.</span>, <span class="NLM_string-name">Dahlin, J. L.</span>, <span class="NLM_string-name">Devanaryan, V.</span>, <span class="NLM_string-name">Foley, T. L.</span>, <span class="NLM_string-name">Glicksman, M.</span>, <span class="NLM_string-name">Hall, M. D.</span>, <span class="NLM_string-name">Haas, J. V.</span>, <span class="NLM_string-name">Inglese, J.</span>, <span class="NLM_string-name">Iversen, P. W.</span>, <span class="NLM_string-name">Kahl, S. D.</span>, <span class="NLM_string-name">Kales, S. C.</span>, <span class="NLM_string-name">Lal-Nag, M.</span>, <span class="NLM_string-name">Li, Z.</span>, <span class="NLM_string-name">McGee, J.</span>, <span class="NLM_string-name">McManus, O.</span>, <span class="NLM_string-name">Riss, T.</span>, <span class="NLM_string-name">Trask, O. J.,  Jr.</span>, <span class="NLM_string-name">Weidner, J. R.</span>, <span class="NLM_string-name">Wildey, M. J.</span>, <span class="NLM_string-name">Xia, M.</span>, <span class="NLM_string-name">Xu, X.</span></span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2004–2013</span> (updated July 1, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004%E2%80%932013&author=T.+L.+Riss&author=R.+A.+Moravec&author=A.+L.+Niles&author=S.+Duellman&author=H.+A.+Benink&author=T.+J.+Worzella&author=L.+Minorauthor=G.+S.+Sittampalam&author=N.+P.+Coussens&author=K.+Brimacombe&author=A.+Grossman&author=M.+Arkin&author=D.+Auld&author=C.+Austin&author=J.+Baell&author=B.+Bejcek&author=J.+M.+M.+Caaveiro&author=T.+D.+Y.+Chung&author=J.+L.+Dahlin&author=V.+Devanaryan&author=T.+L.+Foley&author=M.+Glicksman&author=M.+D.+Hall&author=J.+V.+Haas&author=J.+Inglese&author=P.+W.+Iversen&author=S.+D.+Kahl&author=S.+C.+Kales&author=M.+Lal-Nag&author=Z.+Li&author=J.+McGee&author=O.+McManus&author=T.+Riss&author=O.+J.+Trask&author=J.+R.+Weidner&author=M.+J.+Wildey&author=M.+Xia&author=X.+Xu&title=Assay+Guidance+Manual"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DT.%2BL.%26atitle%3DCell%2520Viability%2520Assay%26btitle%3DAssay%2520Guidance%2520Manual%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004%25E2%2580%25932013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohulchanskyy, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Structural and epimeric isomers of HPPH: Effects on uptake and photodynamic therapy</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=933-946&author=C.+Saenzauthor=R.+R.+Cherukuauthor=T.+Y.+Ohulchanskyyauthor=P.+Joshiauthor=W.+A.+Tabaczynskiauthor=J.+R.+Missertauthor=Y.+Chenauthor=P.+Peraauthor=E.+Tracyauthor=A.+Markoauthor=D.+Rohrbachauthor=U.+Sunarauthor=H.+Baumannauthor=R.+K.+Pandey&title=Structural+and+epimeric+isomers+of+HPPH%3A+Effects+on+uptake+and+photodynamic+therapy&doi=10.1021%2Facschembio.7b00023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00023%26sid%3Dliteratum%253Aachs%26aulast%3DSaenz%26aufirst%3DC.%26aulast%3DCheruku%26aufirst%3DR.%2BR.%26aulast%3DOhulchanskyy%26aufirst%3DT.%2BY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DTracy%26aufirst%3DE.%26aulast%3DMarko%26aufirst%3DA.%26aulast%3DRohrbach%26aufirst%3DD.%26aulast%3DSunar%26aufirst%3DU.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DStructural%2520and%2520epimeric%2520isomers%2520of%2520HPPH%253A%2520Effects%2520on%2520uptake%2520and%2520photodynamic%2520therapy%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D933%26epage%3D946%26doi%3D10.1021%2Facschembio.7b00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span> <span> </span><span class="NLM_article-title">The role of subcellular localization in initiation of apoptosis by photodynamic therapy</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1997.tb08581.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1111%2Fj.1751-1097.1997.tb08581.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1997&pages=422-426&author=D.+Kesselauthor=Y.+Luoauthor=Y.+Dengauthor=C.+K.+Chang&title=The+role+of+subcellular+localization+in+initiation+of+apoptosis+by+photodynamic+therapy&doi=10.1111%2Fj.1751-1097.1997.tb08581.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1997.tb08581.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1997.tb08581.x%26sid%3Dliteratum%253Aachs%26aulast%3DKessel%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DC.%2BK.%26atitle%3DThe%2520role%2520of%2520subcellular%2520localization%2520in%2520initiation%2520of%2520apoptosis%2520by%2520photodynamic%2520therapy%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1997%26volume%3D65%26spage%3D422%26epage%3D426%26doi%3D10.1111%2Fj.1751-1097.1997.tb08581.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ongarora, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. d. G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolli, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. P.</span></span> <span> </span><span class="NLM_article-title">Intracellular targeting specificity of novel Phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e20786</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0020786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1371%2Fjournal.pone.0020786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=21673971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFaltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=S.+Duttaauthor=B.+G.+Ongaroraauthor=H.+Liauthor=M.+d.+G.+H.+Vicenteauthor=B.+K.+Kolliauthor=K.+P.+Chang&title=Intracellular+targeting+specificity+of+novel+Phthalocyanines+assessed+in+a+host-parasite+model+for+developing+potential+photodynamic+medicine&doi=10.1371%2Fjournal.pone.0020786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine</span></div><div class="casAuthors">Dutta, Sujoy; Ongarora, Benson G.; Li, Hairong; Vicente, Maria da Graca H.; Kolli, Bala K.; Chang, Kwang Poo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e20786</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Photodynamic therapy, unlikely to elicit drug-resistance, deserves attention as a strategy to counter this outstanding problem common to the chemotherapy of all diseases.  Previously, we have broadened the applicability of this modality to photodynamic vaccination by exploiting the unusual properties of the trypanosomatid protozoa, Leishmania, i.e., their innate ability of homing to the phagolysosomes of the antigen-presenting cells and their selective photolysis therein, using transgenic mutants endogenously inducible for porphyrin accumulation.  Here, we extended the utility of this host-parasite model for in vitro photodynamic therapy and vaccination by exploring exogenously supplied photosensitizers.  Seventeen novel phthalocyanines (Pcs) were screened in vitro for their photolytic activity against cultured Leishmania.  Pcs rendered cationic and sol. (csPcs) for cellular uptake were phototoxic to both parasite and host cells, i.e., macrophages and dendritic cells.  The csPcs that targeted to mitochondria were more photolytic than those restricted to the endocytic compartments.  Treatment of infected cells with endocytic csPcs resulted in their accumulation in Leishmania-contg. phagolysosomes, indicative of reaching their target for photodynamic therapy, although their parasite vs. host specificity is limited to a narrow range of csPc concns.  In contrast, Leishmania pre-loaded with csPc were selectively photolyzed intracellularly, leaving host cells viable.  Pre-illumination of such csPc-loaded Leishmania did not hinder their infectivity, but ensured their intracellular lysis.  Ovalbumin (OVA) so delivered by photo-inactivated OVA transfectants to mouse macrophages and dendritic cells were co-presented with MHC Class I mols. by these antigen-presenting cells to activate OVA epitope-specific CD8+T cells.  The in vitro evidence presented here demonstrates for the first time not only the potential of endocytic csPcs for effective photodynamic therapy against Leishmania but also their utility in photo-inactivation of Leishmania to produce a safe carrier to express and deliver a defined antigen with enhanced cell-mediated immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreL85hHqtEK7Vg90H21EOLACvtfcHk0lj7KIVQWme7Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFaltbs%253D&md5=ea20cdc239078e3abd0aa3ecc2fee2cf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0020786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0020786%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DS.%26aulast%3DOngarora%26aufirst%3DB.%2BG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DVicente%26aufirst%3DM.%2Bd.%2BG.%2BH.%26aulast%3DKolli%26aufirst%3DB.%2BK.%26aulast%3DChang%26aufirst%3DK.%2BP.%26atitle%3DIntracellular%2520targeting%2520specificity%2520of%2520novel%2520Phthalocyanines%2520assessed%2520in%2520a%2520host-parasite%2520model%2520for%2520developing%2520potential%2520photodynamic%2520medicine%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0020786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castano, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demidova, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms in photodynamic therapy: part one – photosensitizers, photochemistry and cellular localization</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/S1572-1000(05)00007-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2FS1572-1000%2805%2900007-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=25048432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Wls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=279-293&author=A.+P.+Castanoauthor=T.+N.+Demidovaauthor=M.+R.+Hamblin&title=Mechanisms+in+photodynamic+therapy%3A+part+one+%E2%80%93+photosensitizers%2C+photochemistry+and+cellular+localization&doi=10.1016%2FS1572-1000%2805%2900007-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization</span></div><div class="casAuthors">Castano, Ana P.; Demidova, Tatiana N.; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">279-293</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of non-toxic dyes or photosensitizers (PS) in combination with harmless visible light that is known as photodynamic therapy (PDT) has been known for over a hundred years, but is only now becoming widely used.  Originally developed as a tumor therapy, some of its most successful applications are for non-malignant disease.  In a series of three reviews we will discuss the mechanisms that operate in the field of PDT.  Part one discusses the recent explosion in discovery and chem. synthesis of new PS.  Some guidelines on how to choose an ideal PS for a particular application are presented.  The photochem. and photophysics of PS and the two pathways known as Type I (radicals and reactive oxygen species) and Type II (singlet oxygen) photochem. processes are discussed.  To carry out PDT effectively in vivo, it is necessary to ensure sufficient light reaches all the diseased tissue.  This involves understanding how light travels within various tissues and the relative effects of absorption and scattering.  The fact that most of the PS are also fluorescent allows various optical imaging and monitoring strategies to be combined with PDT.  The most important factor governing the outcome of PDT is how the PS interacts with cells in the target tissue or tumor, and the key aspect of this interaction is the subcellular localization of the PS.  Examples of PS that localize in mitochondria, lysosomes, endoplasmic reticulum, Golgi app. and plasma membranes are given.  Finally the use of 5-aminolevulinic acid as a natural precursor of the heme biosynthetic pathway, stimulates accumulation of the PS protoporphyrin IX is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNeTzOpZvourVg90H21EOLACvtfcHk0lj7KIVQWme7Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Wls7s%253D&md5=77884008762c9f15aa23f5e6338c4567</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS1572-1000%2805%2900007-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1572-1000%252805%252900007-4%26sid%3Dliteratum%253Aachs%26aulast%3DCastano%26aufirst%3DA.%2BP.%26aulast%3DDemidova%26aufirst%3DT.%2BN.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DMechanisms%2520in%2520photodynamic%2520therapy%253A%2520part%2520one%2520%25E2%2580%2593%2520photosensitizers%252C%2520photochemistry%2520and%2520cellular%2520localization%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2004%26volume%3D1%26spage%3D279%26epage%3D293%26doi%3D10.1016%2FS1572-1000%2805%2900007-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Treda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ksiazkiewicz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzela, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walczak, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banaszczyk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peciak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoczynska-Fidelus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieske, P.</span></span> <span> </span><span class="NLM_article-title">EGFR activation leads to cell death independent of P13K/ART/mTOR in an AD293 cell line</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0155230</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0155230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1371%2Fjournal.pone.0155230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=27153109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWlu7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=C.+Tredaauthor=M.+Popedaauthor=M.+Ksiazkiewiczauthor=D.+P.+Grzelaauthor=M.+P.+Walczakauthor=M.+Banaszczykauthor=J.+Peciakauthor=F.+Stoczynska-Fidelusauthor=P.+Rieske&title=EGFR+activation+leads+to+cell+death+independent+of+P13K%2FART%2FmTOR+in+an+AD293+cell+line&doi=10.1371%2Fjournal.pone.0155230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR activation leads to cell death independent of PI3K/AKT/mTOR in an AD293 cell line</span></div><div class="casAuthors">Treda, Cezary; Popeda, Marta; Ksiazkiewicz, Magdalena; Grzela, Dawid P.; Walczak, Maciej P.; Banaszczyk, Mateusz; Peciak, Joanna; Stoczynska-Fidelus, Ewelina; Rieske, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0155230/1-e0155230/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The Epidermal Growth Factor Receptor (EGFR) and its mutations contribute in various ways to tumorigenesis and biol. of human cancers.  They are assocd. with tumor proliferation, progression, drug resistance and the process of apoptosis.  There are also reports that overexpression and activation of wild-type EGFR may lead to cell apoptosis.  To study this phenomenon, we overexpressed in an AD293 cell line two most frequently obsd. forms of the EGFR receptor: wild-type and the constitutively active mutant-EGFR variant III (EGFRvIII).  Then, we compared the effect of EGF stimulation on cell viability and downstream EGFR signaling.  AD293 cells overexpressing wild-type EGFR, despite a significant proliferation increase in serum supplemented medium, underwent apoptosis after EGF stimulation in serum free conditions.  EGFRvIII expressing cells, however, were unaffected by either serum starvation or EGF treatment.  The effect of EGF was completely neutralized by tyrosine kinase inhibitors (TKIs), indicating the specificity of this observation.  Moreover, apoptosis was not prevented by inhibiting EGFR downstream proteins (PI3K, AKT and mTOR).  Here we showed another EGFR function, dependent on environmental factors, which could be employed in therapy and drug design.  We also proposed a new tool for EGFR inhibitor anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2gWMQiOGB0LVg90H21EOLACvtfcHk0lj7KIVQWme7Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWlu7%252FK&md5=21e9bd48f28be44f6e6c88fc1a5f3c93</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0155230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0155230%26sid%3Dliteratum%253Aachs%26aulast%3DTreda%26aufirst%3DC.%26aulast%3DPopeda%26aufirst%3DM.%26aulast%3DKsiazkiewicz%26aufirst%3DM.%26aulast%3DGrzela%26aufirst%3DD.%2BP.%26aulast%3DWalczak%26aufirst%3DM.%2BP.%26aulast%3DBanaszczyk%26aufirst%3DM.%26aulast%3DPeciak%26aufirst%3DJ.%26aulast%3DStoczynska-Fidelus%26aufirst%3DF.%26aulast%3DRieske%26aufirst%3DP.%26atitle%3DEGFR%2520activation%2520leads%2520to%2520cell%2520death%2520independent%2520of%2520P13K%252FART%252FmTOR%2520in%2520an%2520AD293%2520cell%2520line%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0155230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceresa, B. P.</span></span> <span> </span><span class="NLM_article-title">EGFR-mediated apoptosis via STAT3</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2017.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1016%2Fj.yexcr.2017.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=28433699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms1ChsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2017&pages=93-103&author=N.+M.+Jacksonauthor=B.+P.+Ceresa&title=EGFR-mediated+apoptosis+via+STAT3&doi=10.1016%2Fj.yexcr.2017.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR-mediated apoptosis via STAT3</span></div><div class="casAuthors">Jackson, Nicole M.; Ceresa, Brian P.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-103</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Epidermal Growth Factor Receptor (EGFR) is a cell surface receptor with primary implications in cell growth in both normal and malignant tissue.  Paradoxically, cell lines that hyperexpress the EGFR have been documented to undergo receptor-mediated apoptosis.  The underlying mechanism by which EGF-induced apoptosis occurs however remains inexplicit.  In an attempt to identify this mechanism, we assessed downstream effectors of EGFR in MDA-MB-468 cells during conditions of EGF-induced apoptosis.  The effector assessment revealed STAT3 as a potential mediator of EGF-induced apoptosis.  Alternative strategies for activating STAT3, independent of EGFR stimulation, resulted in the induction of the apoptotic pathways.  A redn. in STAT3 expression via RNAi resulted in a significant attenuation of EGF-induced PARP cleavage.  Our findings support STAT3 as a pos. mediator of EGF-induced apoptosis in MDA-MB-468 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEOtRHTfrSyLVg90H21EOLACvtfcHk0lgcjhYp7QD8eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms1ChsL4%253D&md5=2dec72022d91ca27731dcd389eeb9678</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2017.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2017.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DN.%2BM.%26aulast%3DCeresa%26aufirst%3DB.%2BP.%26atitle%3DEGFR-mediated%2520apoptosis%2520via%2520STAT3%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2017%26volume%3D356%26spage%3D93%26epage%3D103%26doi%3D10.1016%2Fj.yexcr.2017.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lainey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouteloup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thepot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tailler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adres, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenaux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehrer, S.</span></span> <span> </span><span class="NLM_article-title">Erlotinib antagonizes efflux via ABC transporters and decreases P-Gp cell surface expression by inhibiting SRC kinase and mTOR pathways in acute myeloid leukemia (AML)</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">2564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=2564&author=E.+Laineyauthor=M.+Sebertauthor=C.+Bouteloupauthor=C.+Leroyauthor=S.+Thepotauthor=M.+Taillerauthor=L.+Adresauthor=C.+Gardinauthor=G.+Kroemerauthor=P.+Fenauxauthor=S.+Boehrer&title=Erlotinib+antagonizes+efflux+via+ABC+transporters+and+decreases+P-Gp+cell+surface+expression+by+inhibiting+SRC+kinase+and+mTOR+pathways+in+acute+myeloid+leukemia+%28AML%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLainey%26aufirst%3DE.%26aulast%3DSebert%26aufirst%3DM.%26aulast%3DBouteloup%26aufirst%3DC.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DThepot%26aufirst%3DS.%26aulast%3DTailler%26aufirst%3DM.%26aulast%3DAdres%26aufirst%3DL.%26aulast%3DGardin%26aufirst%3DC.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DFenaux%26aufirst%3DP.%26aulast%3DBoehrer%26aufirst%3DS.%26atitle%3DErlotinib%2520antagonizes%2520efflux%2520via%2520ABC%2520transporters%2520and%2520decreases%2520P-Gp%2520cell%2520surface%2520expression%2520by%2520inhibiting%2520SRC%2520kinase%2520and%2520mTOR%2520pathways%2520in%2520acute%2520myeloid%2520leukemia%2520%2528AML%2529%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3D2564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mroz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaroslasvsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharkwal, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">Cell death pathways in photodynamic therapy of cancer</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">2516</span>– <span class="NLM_lpage">2539</span>, <span class="refDoi"> DOI: 10.3390/cancers3022516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3390%2Fcancers3022516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=23914299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Siu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=2516-2539&author=P.+Mrozauthor=A.+Yaroslasvskyauthor=C.+B.+Kharkwalauthor=M.+R.+Hamblin&title=Cell+death+pathways+in+photodynamic+therapy+of+cancer&doi=10.3390%2Fcancers3022516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death pathways in photodynamic therapy of cancer</span></div><div class="casAuthors">Mroz, Pawel; Yaroslavsky, Anastasia; Kharkwal, Gitika B.; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2516-2539</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is an emerging cancer therapy that uses the combination of non-toxic dyes or photosensitizers (PS) and harmless visible light to produce reactive oxygen species and destroy tumors.  The PS can be localized in various organelles such as mitochondria, lysosomes, endoplasmic reticulum, Golgi app. and plasma membranes and this sub-cellular location governs much of the signaling that occurs after PDT.  There is an acute stress response that leads to changes in calcium and lipid metab. and causes the prodn. of cytokines and stress response mediators.  Enzymes (particularly protein kinases) are activated and transcription factors are expressed.  Many of the cellular responses center on mitochondria and frequently lead to induction of apoptosis by the mitochondrial pathway involving caspase activation and release of cytochrome c.  Certain specific proteins (such as Bcl-2) are damaged by PDT-induced oxidn. thereby increasing apoptosis, and a build-up of oxidized proteins leads to an ER-stress response that may be increased by proteasome inhibition.  Autophagy plays a role in either inhibiting or enhancing cell death after PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorIEK_ZSI_MrVg90H21EOLACvtfcHk0lgcjhYp7QD8eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Siu7k%253D&md5=cc2393bfb173611c589ac1fcb0b1a377</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fcancers3022516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers3022516%26sid%3Dliteratum%253Aachs%26aulast%3DMroz%26aufirst%3DP.%26aulast%3DYaroslasvsky%26aufirst%3DA.%26aulast%3DKharkwal%26aufirst%3DC.%2BB.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DCell%2520death%2520pathways%2520in%2520photodynamic%2520therapy%2520of%2520cancer%26jtitle%3DCancers%26date%3D2011%26volume%3D3%26spage%3D2516%26epage%3D2539%26doi%3D10.3390%2Fcancers3022516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, H. I.</span></span> <span> </span><span class="NLM_article-title">Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages</span>. <i>JNCI, J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1093/jnci/82.1.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.1093%2Fjnci%2F82.1.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=2293654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADyaK3c%252FnvF2qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=34-38&author=S.+Evansauthor=W.+Mathewsauthor=R.+Perryauthor=D.+Frakerauthor=J.+Nortonauthor=H.+I.+Pass&title=Effect+of+photodynamic+therapy+on+tumor+necrosis+factor+production+by+murine+macrophages&doi=10.1093%2Fjnci%2F82.1.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages</span></div><div class="casAuthors">Evans S; Matthews W; Perry R; Fraker D; Norton J; Pass H I</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-9</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">Photodynamic therapy (PDT) involves the treatment of tumors in the presence of sensitizer, light, and oxygen, causing energy-dependent cytotoxicity.  A vascular effect that causes hemorrhagic tumor necrosis has been described with PDT, but its basis remains undefined.  To investigate the possible role of tumor necrosis factor (TNF) production in the generation of such a vascular effect and/or a direct tumor effect, we treated thioglycollate-elicited murine macrophages with PDT, and we measured the possible production of TNF using the L929 assay.  An energy-dependent production of TNF by macrophage treated with PDT, stimulated or unstimulated with endotoxin, was demonstrated, and TNF production was inhibited at the highest treatment energy levels.  These data represent the first description of cytokine production by PDT-treated macrophages, and may serve as another mechanism of PDT cytotoxicity in vivo, either directly by TNF-mediated tumor necrosis, or indirectly by vascular effects on tumor vessels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJKuxtnmxDaz0SWnHPWbmmfW6udTcc2eZTTu69LXBQxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c%252FnvF2qtQ%253D%253D&md5=0b6d1f995898eb8d58d06bf86c109700</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.1.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.1.34%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DW.%26aulast%3DPerry%26aufirst%3DR.%26aulast%3DFraker%26aufirst%3DD.%26aulast%3DNorton%26aufirst%3DJ.%26aulast%3DPass%26aufirst%3DH.%2BI.%26atitle%3DEffect%2520of%2520photodynamic%2520therapy%2520on%2520tumor%2520necrosis%2520factor%2520production%2520by%2520murine%2520macrophages%26jtitle%3DJNCI%252C%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D34%26epage%3D38%26doi%3D10.1093%2Fjnci%2F82.1.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogue, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solban, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demidenko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoopes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">J Hasan, T.</span></span> <span> </span><span class="NLM_article-title">Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=15701861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=720-727&author=B.+Chenauthor=B.+W.+Pogueauthor=X.+O.+Zhouauthor=J.+A.+Haraauthor=N.+Solbanauthor=E.+Demidenkoauthor=P.+Hoopesauthor=T.+J+Hasan&title=Effect+of+tumor+host+microenvironment+on+photodynamic+therapy+in+a+rat+prostate+tumor+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model</span></div><div class="casAuthors">Chen, Bin; Pogue, Brian W.; Zhou, Xiaodong; O'Hara, Julia A.; Solban, Nicolas; Demidenko, Eugene; Hoopes, P. Jack; Hasan, Tayyaba</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor host microenvironment plays an important role in tumor growth, metastasis, and response to cancer therapy.  In this study, the influence of tumor host environment on tumor pathophysiol., photosensitizer distribution, and photodynamic therapy (PDT) treatment effect was examd. in the metastatic at lymph node and lung (MatLyLu) rat prostate tumor.  MatLyLu tumors implanted in different host environment [i.e., orthotopically (in the prostate) or s.c.] were compared for difference in vessel d., av. vessel size, vascular permeability, tumor vascular endothelial growth factor prodn., and tumor oxygenation.  Uptake of photosensitizer verteporfin in tumors in both sites was detd. by fluorescence microscopy.  To compare tumor response to PDT, both orthotopic and s.c. MatLyLu tumors were given the same doses of verteporfin and laser light treatment, and PDT-induced tumor necrotic area was measured histol.  Orthotopic MatLyLu tumors were found to grow faster, have higher vessel d. and more permeable vasculature, have higher vascular endothelial growth factor protein levels, and have lower tumor hypoxic fraction than the s.c. tumors.  Uptake of photosensitizer verteporfin in the orthotopic tumor was higher than in the s.c. tumors at 15 min after injection (1 mg/kg, i.v.), and became similar at 3 h after injection.  For the vascular targeting PDT treatment (0.25 mg/kg verteporfin, 50 J/cm2 at 50 mW/cm2, 15 min drug-light interval), there was no significant difference in PDT-induced tumor necrotic area between the orthotopic and s.c. tumors, with 85% to 90% necrosis in both types of tumors.  However, tumor necrosis induced by the cellular targeting PDT (1 mg/kg verteporfin, 50 J/cm2 at 50 mW/cm2, 3 h drug-light interval) was significantly different in the orthotopic (64%) vs. the s.c. (29%) tumors.  Tumor host environment can significantly affect photosensitizer verteporfin distribution and PDT treatment effect.  Verteporfin-PDT regimen targeting tumor cells is more sensitive to such influence than the vascular targeting PDT.  Our study showed the importance of tumor host environment in detg. tumor physiol. properties and tumor response to PDT.  To obtain clin. relevant information, orthotopic tumor model should be used in the exptl. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmbZaxKsndpLVg90H21EOLACvtfcHk0lhgHgUnOclhVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWgur8%253D&md5=b87295498c9898412d8f164d765c01f7</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPogue%26aufirst%3DB.%2BW.%26aulast%3DZhou%26aufirst%3DX.%2BO.%26aulast%3DHara%26aufirst%3DJ.%2BA.%26aulast%3DSolban%26aufirst%3DN.%26aulast%3DDemidenko%26aufirst%3DE.%26aulast%3DHoopes%26aufirst%3DP.%26aulast%3DJ%2BHasan%26aufirst%3DT.%26atitle%3DEffect%2520of%2520tumor%2520host%2520microenvironment%2520on%2520photodynamic%2520therapy%2520in%2520a%2520rat%2520prostate%2520tumor%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D720%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yotnda, P.</span></span> <span> </span><span class="NLM_article-title">Production and detection of the reactive oxygen species (ROS) in cancers</span>. <i>J. Vis. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>, <span class="NLM_elocation-id">e3357</span> <span class="refDoi"> DOI: 10.3791/3357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3791%2F3357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=22127014" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Wuauthor=P.+Yotnda&title=Production+and+detection+of+the+reactive+oxygen+species+%28ROS%29+in+cancers&doi=10.3791%2F3357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3791%2F3357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F3357%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DYotnda%26aufirst%3DP.%26atitle%3DProduction%2520and%2520detection%2520of%2520the%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520cancers%26jtitle%3DJ.%2520Vis.%2520Exp.%26date%3D2011%26doi%3D10.3791%2F3357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belhocine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spaepen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dusart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaigne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muylle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgegis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierickx, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamen, P.</span></span> <span> </span><span class="NLM_article-title">[<sup>18</sup>] FFDG PET in Oncology: The best and the worst (Review)</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1249</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.3892/ijo.28.5.1249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=10.3892%2Fijo.28.5.1249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=16596242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;key=1%3ACAS%3A280%3ADC%252BD287ptVeisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2006&pages=1249-1261&author=T.+Belhocineauthor=K.+Spaepenauthor=M.+Dusartauthor=C.+Castaigneauthor=K.+Muylleauthor=P.+Bourgeoisauthor=D.+Bourgegisauthor=L.+Dierickxauthor=P.+Flamen&title=%5B18%5D+FFDG+PET+in+Oncology%3A+The+best+and+the+worst+%28Review%29&doi=10.3892%2Fijo.28.5.1249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">18FDG PET in oncology: the best and the worst (Review)</span></div><div class="casAuthors">Belhocine Tarik; Spaepen Karoline; Dusart Michelle; Castaigne Catherine; Muylle Kristof; Bourgeois Pierre; Bourgeois Daniel; Dierickx Lawrence; Flamen Patrick</div><div class="citationInfo"><span class="NLM_cas:title">International journal of oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1249-61</span>
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    </div><div class="casAbstract">The clinical added-value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18FDG PET) in the management of oncology patients is increasingly documented.  In the present review, we discuss both the benefits and the limitations of 18FDG PET in different cancers.  Considering the literature data and our own experience, we also indicate the best clinical approach to optimize the use of metabolic imaging in oncology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAVO1tTumrTlMGsG_HTXYFfW6udTcc2eZTTu69LXBQxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287ptVeisg%253D%253D&md5=163e338b0781f09f2b70f4a9925bc9fc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.3892%2Fijo.28.5.1249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.28.5.1249%26sid%3Dliteratum%253Aachs%26aulast%3DBelhocine%26aufirst%3DT.%26aulast%3DSpaepen%26aufirst%3DK.%26aulast%3DDusart%26aufirst%3DM.%26aulast%3DCastaigne%26aufirst%3DC.%26aulast%3DMuylle%26aufirst%3DK.%26aulast%3DBourgeois%26aufirst%3DP.%26aulast%3DBourgegis%26aufirst%3DD.%26aulast%3DDierickx%26aufirst%3DL.%26aulast%3DFlamen%26aufirst%3DP.%26atitle%3D%255B18%255D%2520FFDG%2520PET%2520in%2520Oncology%253A%2520The%2520best%2520and%2520the%2520worst%2520%2528Review%2529%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2006%26volume%3D28%26spage%3D1249%26epage%3D1261%26doi%3D10.3892%2Fijo.28.5.1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01927">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_12502"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01927">10.1021/acs.jmedchem.8b01927</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Copies of the NMR (proton and C-13) spectra of certain compounds (Figures S1–S14), variable-temperature NMR spectra of compound <b>5</b> (Figure S15), comparative photophysical properties of compounds <b>1</b>, <b>3</b>, and <b>5</b> (Figures S16–S20), and molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01927/suppl_file/jm8b01927_si_001.pdf">jm8b01927_si_001.pdf (2.18 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01927%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-5%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01927" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a6d134fff24c3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
